Investigating the selectivity of sequence-controlled antimicrobial polymers synthesised by RAFT polymerisation by Kuroki, Agnès
 warwick.ac.uk/lib-publications  
 
 
 
 
 
 
A Thesis Submitted for the Degree of PhD at the University of Warwick 
 
Permanent WRAP URL: 
http://wrap.warwick.ac.uk/1326139    
 
 
 
Copyright and reuse:                     
This thesis is made available online and is protected by original copyright.  
Please scroll down to view the document itself.  
Please refer to the repository record for this item for information to help you to cite it. 
Our policy information is available from the repository home page.  
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
Investigating the selectivity of sequence-controlled 
antimicrobial polymers synthesised by RAFT 
polymerisation 
 
 
 
 
 
 
Agnès Mari Kuroki 
 
 
 
 
 
A thesis submitted in partial fulfilment of the requirements for the degree of  
Doctor of Philosophy in Chemistry 
 
 
 
 
Department of Chemistry 
University of Warwick 
May 2019 
  
   
 
   Page | ii 
 
Table of Contents 
List of Figures ................................................................................................................. v 
List of Tables .................................................................................................................. x 
List of Schemes ............................................................................................................ xiii 
Abbreviations ............................................................................................................... xiv 
Acknowledgements .................................................................................................... xviii 
Declaration.................................................................................................................... xx 
1.1 Key parameters influencing the selectivity of SMAMPs ....................................... 2 
1.2 Sequence Control in Polymeric AMP Mimics ...................................................... 5 
1.2.1 Structural Control via Monomer Architecture ............................................... 5 
1.2.2 Influence of Monomer Sequence .................................................................. 7 
1.3 Design of well-defined multiblock copolymers using RAFT .............................. 12 
1.3.1 Introduction to RAFT polymerisation ......................................................... 12 
1.3.2 Synthesis of block copolymers via RAFT ................................................... 17 
1.4 Conclusion and scope of the thesis ..................................................................... 20 
1.5 References ......................................................................................................... 21 
2.1 Introduction ....................................................................................................... 29 
2.2 Results and discussion ....................................................................................... 32 
2.2.1 Design and synthesis of SMAMPs .............................................................. 32 
2.2.2 Physico-chemical properties of SMAMPs................................................... 36 
2.2.3 Dye leakage study ...................................................................................... 40 
2.2.4 Antibacterial susceptibility assays .............................................................. 41 
2.2.5 Haemocompatibility of SMAMPs............................................................... 42 
2.2.6 Biocompatibility of SMAMPs .................................................................... 48 
2.2.7 Bacterial resistance .................................................................................... 53 
2.3 Conclusion......................................................................................................... 54 
   
 
   Page | iii 
 
2.4 Experimental ..................................................................................................... 55 
2.4.1 Materials .................................................................................................... 55 
2.4.2 Methods ..................................................................................................... 55 
2.4.3 Synthesis .................................................................................................... 60 
2.5 Supporting Figures............................................................................................. 65 
2.6 Supporting Tables .............................................................................................. 81 
2.7 References ......................................................................................................... 90 
3.1 Introduction ....................................................................................................... 97 
3.2 Results and discussion ....................................................................................... 99 
3.2.1 Synthesis and characterisation .................................................................... 99 
3.2.2 Toxicity of SMAMPs towards mammalian cells ....................................... 104 
3.2.3 Antimicrobial activity of SMAMPs .......................................................... 108 
3.2.4 Selectivity of SMAMPs for bacteria over mammalian cells ...................... 111 
3.3 Conclusion....................................................................................................... 114 
3.4 Experimental ................................................................................................... 115 
3.4.1 Materials .................................................................................................. 115 
3.4.2 Methods ................................................................................................... 115 
3.4.3 Synthesis .................................................................................................. 118 
3.5 Supporting Figures........................................................................................... 121 
3.6 Supporting Tables ............................................................................................ 127 
3.7 References ....................................................................................................... 133 
4.1 Introduction ..................................................................................................... 139 
4.2 Results and discussion ..................................................................................... 141 
4.2.1 Synthesis of Bodipy acrylamide (BodipyAM) .......................................... 141 
4.2.2 Labelling of polymers .............................................................................. 142 
   
 
   Page | iv 
 
4.2.3 Interactions with bacterial membrane ....................................................... 144 
4.2.4 Synthesis and properties of guanidinium homopolymers ........................... 148 
4.2.5 Effect of segmentation on cell uptake of guanidinium copolymers ............ 153 
4.2.6 Effect of segmentation on potency against intracellular bacteria ............... 155 
4.3 Conclusion....................................................................................................... 159 
4.4 Experimental ................................................................................................... 160 
4.4.1 Materials. ................................................................................................. 160 
4.4.2 Methods. .................................................................................................. 160 
4.4.3 Synthesis .................................................................................................. 163 
4.5 Supporting Figures........................................................................................... 167 
4.6 Supporting Tables ............................................................................................ 172 
4.7 References ....................................................................................................... 175 
List of publications ...................................................................................................... 185 
 
  
   
 
   Page | v 
 
List of Figures 
 
Figure 2.1 - DMF-SEC chromatograms for successive chain extensions of A-M50Boc (A) and 
1H NMR spectra of SMAMPs on the example of homopolymers and multiblock copolymers 
before and after deprotection in DMSO-d6 and D2O, respectively (B). ............................... 36 
Figure 2.2 - Titration curves of acidified solutions of the cationic polymers A-H100, A-S50, 
A-D50 and A-M50 (concentration of around 0.5 mg.mL-1) neutralised with sodium hydroxide 
(0.2 M). ............................................................................................................................. 37 
Figure 2.3 - Reverse-phase HPLC chromatograms of ammonium polymer library organised 
by monomer distribution: statistical (A), diblock (B) and multiblock (C) copolymers. The runs 
were performed with a gradient of 1 to 95 % ACN over 50 minutes at 37 °C. .................... 38 
Figure 2.4 - Reverse-phase HPLC chromatograms of ammonium polymer library organised 
by molar content of AEAM: 30 % (A), 50 % (B) and 70 % (C) charge content. The runs were 
performed with a gradient of 1 to 95 % ACN over 50 minutes at 37 °C. ............................. 38 
Figure 2.5 –Percentage of acetonitrile corresponding to the elution time of SMAMPs by RP-
HPLC depending on the composition and the architecture (▲ Diblock copolymers, ● 
Multiblock copolymers, ■ Statistical copolymers). ............................................................ 39 
Figure 2.6 - Calcein leakage study on Gram-negative bacterial model (using liposomes 
comprised of a mixture of PE/PG (4:1)) with multiblock copolymers (A-M30, A-M50 and A-
M70) and the homopolymers H0 and A-H100. Normalised fluorescence intensity at λem=537 
nm with λex=492 nm. The sample was added at 30 s time point and vesicles were lysed by 
addition of Triton X at 9 min. ............................................................................................ 40 
Figure 2.7 – Haemolytic activity of ammonium SMAMPs. Normalised haemolysis of human 
red blood cells following incubation at 37 °C for 2 hours in PBS with ammonium SMAMPs 
with 30 (A), 50 (B) and 70% (C) charge content. ............................................................... 43 
Figure 2.8 - Selectivity of the SMAMPs for Gram-negative and Gram-positive bacteria over 
RBCs. Haemocompatibility concentration against the MIC for E. coli (A), P. aeruginosa (B), 
S. aureus (C) and S. epidermidis (D) over RBCs. ............................................................... 47 
Figure 2.9 - Cytotoxicity of ammonium SMAMPs. Viability of 3T3 cells incubated for 72 
hours in presence of statistical (1A), multiblock (1B) and diblock (1C) SMAMPs; and of Caco-
2 cells incubated for 72 hours in presence of statistical (2A), multiblock (2B) and diblock (2C) 
copolymers, using XTT assay. ........................................................................................... 48 
Figure 2.10 – Comparison of IC50 values for ammonium SMAMPs. IC50 of the SMAMPs for 
NIH 3T3 (A) and Caco-2 cells (B) after a 72-hour incubation at 37˚C in presence of the 
cationic polymers, using XTT assay. ................................................................................. 49 
   
 
   Page | vi 
 
Figure 2.11 - Selectivity of SMAMPs for Gram-negative and Gram-positive bacteria over NIH 
3T3 cells. IC50 of the SAMPs with NIH 3T3 cells against their MIC for E. coli (A), P. 
aeruginosa (B), S. aureus (C) and S. epidermidis (D). ....................................................... 51 
Figure 2.12 - Comparison of selectivity of SMAMPs for bacteria over RBCs and NIH 3T3 
cells. TI of the SMAMPs over NIH 3T3 cells against their selectivity over RBCs for E. coli 
(A), P. aeruginosa (B), S. aureus (C) and S. epidermidis (D). ............................................ 52 
Figure 2.13 - Determination of bacterial resistance for copolymers with 30 % AEAM content. 
Evolution of the MIC value of A-S30, A-M30 and A-D30 against a MRSA strain USA300 
over the course of 4 weeks, after incubating the bacteria in presence of sub-MIC 
concentrations of SMAMPs. .............................................................................................. 53 
Figure 2.14 - 1H NMR spectrum of the intermediate product N-t-butoxycarbonyl-1,2-
diaminoethane in CDCl3. ................................................................................................... 65 
Figure 2.15 - 1H NMR spectrum of Boc-AEAM in CDCl3. ................................................ 66 
Figure 2.16 - 13C NMR spectrum of BocAEAM in CDCl3. ................................................ 67 
Figure 2.17 - IR spectrum of BocAEAM. .......................................................................... 68 
Figure 2.18 - 1H NMR spectrum of PABTC in CDCl3. ...................................................... 68 
Figure 2.19 - 13C NMR spectrum of PABTC in CDCl3. ..................................................... 69 
Figure 2.20 – 1H NMR spectra in DMSO-d6 of Boc-protected statistical copolymers for each 
composition. ..................................................................................................................... 69 
Figure 2.21 - 1H NMR spectra in DMSO-d6 of Boc-protected diblock copolymers for each 
composition. ..................................................................................................................... 70 
Figure 2.22 - 1H NMR spectra in DMSO-d6 of A-M30
Boc for each chain extension. ........... 70 
Figure 2.23 - 1H NMR spectra in DMSO-d6 of A-M50
Boc for each chain extension. ........... 71 
Figure 2.24 - 1H NMR spectra in DMSO-d6 of A-M70
Boc for each chain extension. ........... 71 
Figure 2.25 - 1H NMR spectra in DMSO-d6 of Boc-protected multiblock copolymers for each 
composition. ..................................................................................................................... 72 
Figure 2.26 - DMF-SEC chromatograms for statistical copolymers of each composition. ... 72 
Figure 2.27 - DMF-SEC chromatograms for diblock copolymers with 30 % (A), 50 % (B) and 
70 % (C) BocAEAM content. ............................................................................................ 73 
Figure 2.28 - DMF-SEC chromatograms for successive chain extensions of A-M30Boc (A) and 
A-M70Boc (B). ................................................................................................................... 74 
Figure 2.29 - Ratio of the concentration of remaining NIPAM and BocAEAM with overall 
conversion during the polymerisation of A-S30Boc. ............................................................ 75 
Figure 2.30 - 1H NMR spectra in D2O of the deprotected statistical copolymers of each 
composition and in DMSO-d6 for H0................................................................................. 75 
   
 
   Page | vii 
 
Figure 2.31 - 1H NMR spectra in D2O the deprotected diblock copolymers of each composition 
and in DMSO-d6 for H0. ................................................................................................... 76 
Figure 2.32 - HPLC chromatograms of H0 at 20, 37 and 60 °C with a gradient of 1 to 95 % 
ACN over 50 minutes. ....................................................................................................... 76 
Figure 2.33 - Size distribution by volume by DLS of the homopolymers (A), statistical (A), 
diblock (B) and multiblock (C) copolymers at 1 mg mL-1 in PBS. ...................................... 77 
Figure 2.34 - Dye leakage study with (A) statistical (B) diblock and (C) multiblock copolymers 
on Gram-positive bacteria model. Fluorescence was read at 537 nm (emission) at an excitation 
wavelength of 492 nm. The sample was added at 30 s measurement time and vesicles were 
lysed by addition of Triton X at 9 min. .............................................................................. 78 
Figure 2.35 - Dye leakage study with statistical (A) and diblock (B) copolymers on Gram-
negative bacteria model. Fluorescence was read at 537 nm (emission) at an excitation 
wavelength of 492 nm. The sample was added at 30 s measurement time and vesicles were 
lysed by addition of Triton X at 9 min. .............................................................................. 78 
Figure 2.36 - MIC at 30 (A), 50 (B) and 70% (C) AEAM content of various segmentation for 
each bacteria species. ........................................................................................................ 79 
Figure 2.37 - TI of the SAMPs with NIH 3T3 cells against their selectivity with RBCs for E. 
coli (A), P. aeruginosa (B), S. aureus (C) and S. epidermidis (D). ..................................... 80 
Figure 3.1 - Library of the synthesised guanidinium and ammonium polymers. ............... 100 
Figure 3.2 - 1H NMR in DMS-d6 (A) and DMF-SEC chromatograms (B) for successive chain 
extensions of G-T30Boc. ................................................................................................... 101 
Figure 3.3 - 1H NMR spectra in D2O of G-S30, G-T30 and G-D30 after deprotection. ..... 102 
Figure 3.4 – RP-HPLC chromatograms of the ammonium (A) and the guanidinium polymers 
(B) with a gradient of 1 to 80 % ACN in 30 minutes with a 100 mm C18 column. ........... 103 
Figure 3.5 - Haemolytic activity of ammonium and guanidinium SMAMPs. Normalised 
haemolysis of sheep blood cells following incubation at 37 °C for 2 hours in PBS with 
ammonium (A) and guanidinium (B) SMAMPs. .............................................................. 104 
Figure 3.6 - Cytotoxicity of ammonium and guanidinium SMAMPs towards HaCaT. Viability 
of HaCaT cells incubated for 24 hours in presence of statistical (A), tetrablock (B) and diblock 
(C) ammonium and guanidinium SMAMPs using an XTT assay. .................................... 107 
Figure 3.7 - Cytotoxicity of ammonium and guanidinium SMAMPs towards A549 cells. 
Viability of A549 cells incubated for 24 hours in presence of ammonium (A) and guanidinium 
(B) SMAMPs of various monomer sequence using an XTT assay. ................................... 108 
Figure 3.8 – Comparison of the MIC values of ammonium and guanidinium SMAMPs against 
MSSA RN1 (A) and MRSA JE2 (B). .............................................................................. 110 
   
 
   Page | viii 
 
Figure 3.9 - Selectivity graphs of SMAMPs for MSSA RN1 (A) and MRSA JE2 (B) over 
RBCs. Haemocompatibility concentration (lowest value between HC10 and cH, as shown in 
Table 3.3) against the MIC for MSSA RN1 (A) and MRSA JE2 (B), which values are reported 
in Table 3.4. .................................................................................................................... 111 
Figure 3.10 - Selectivity graphs of SMAMPs for MSSA RN1 (A) and MRSA JE2 (B) over 
HaCaT cells. IC50 towards HaCaT cells (values reported in Table 3.3) against the MIC for 
MSSA RN1 (A) and MRSA JE2 (B), which values are reported in Table 3.4. .................. 113 
Figure 3.11 - 1H NMR spectrum of the intermediate product 2-[1,3-Bis(tert-
butoxycarbonyl)guanidine]ethylamine in CDCl3. ............................................................. 121 
Figure 3.12 - 1H NMR spectrum of diBoc-GEAM in CDCl3. ........................................... 121 
Figure 3.13 - 13C NMR spectrum of diBoc-GEAM in CDCl3. .......................................... 122 
Figure 3.14 - IR spectrum of diBocGEAM. ..................................................................... 122 
Figure 3.15 - 1H NMR spectra in DMSO-d6 of G-D30
Boc for each chain extension. ........... 123 
Figure 3.16 - DMF-SEC chromatograms for successive chain extensions of G-D30Boc. .... 123 
Figure 3.17 - DMF-SEC chromatograms for G-S30Boc, G-T30Boc and G-D30Boc. ............... 124 
Figure 3.18 - DMF-SEC chromatograms for successive chain extensions of A-T30Boc. .... 124 
Figure 3.19 - Ratio of the concentration of remaining NIPAM and BocAEAM with overall 
conversion during the polymerisation of G-S30Boc. .......................................................... 125 
Figure 3.20 - 19F NMR spectra in D2O of G-S30 before (A) and after (B) dialysis against NaCl.
 ....................................................................................................................................... 125 
Figure 3.21 - Volume distribution of G-S30 (A), G-T30 (B), G-D30 (C) by DLS in PBS at 37 
°C at 1.024 mg.mL-1 Size and PDI are shown in Table 3.11.............................................. 126 
Figure 4.1- Emission spectrum of BodipyAM (λex=525 nm). ........................................... 142 
Figure 4.2 – Emission spectra of Bodipy functionalised polymers (λex=525 nm). ............. 143 
Figure 4.3 - HPLC chromatograms of the fluorescent polymers (solid line – λ=280nm; dashed 
line - λex=525 nm and λem=537 nm) with a gradient of 1 to 95 % ACN in 35 minutes with a 
100 mm C18 column. ...................................................................................................... 144 
Figure 4.4 – Bacterial membrane interactions of SMAMPs. Binding assay with JE2 of the 
guanidinium SMAMPs after 15 minutes without PI (A) Binding assay with JE2 after 30 
minutes in presence of PI (B) Binding assay with JE2 after 2 hours in presence of PI, no image 
was presented for G-D30 after 2 hours no bacteria were left under these conditions (C). The 
scale bar represents 5 µm. ............................................................................................... 147 
Figure 4.5 - Characterisation of the guanidinium homopolymers. (A) DMF-SEC 
chromatograms of polydiBocGEAM15 and polydiBocGEAM30. (B) RP-HPLC chromatograms 
of the guanidinium homopolymers with a gradient of 1 to 80 % ACN in 30 minutes with a 100 
mm C18 column (λ=280 nm)........................................................................................... 150 
   
 
   Page | ix 
 
Figure 4.6 – Antimicrobial and haemolytic activities of the guanidinium homopolymers. (A) 
Corrected MIC of polyGEAM and the guanidinium block copolymers against MRSA strain 
JE2 obtained by multiplying the MIC expressed in molar concentration with the molar 
percentage of guanidinium functionalities in each polymer. (B) Haemolytic activity of the 
guanidinium homopolymers and their associated copolymers. Normalised haemolysis of 
sheep blood cells following incubation at 37 °C for 2 hours in PBS with guanidinium 
SMAMPs. ....................................................................................................................... 151 
Figure 4.7 – Cytotoxicity of guanidinium SMAMPs towards HaCaT cells. Viability of HaCaT 
cells incubated for 24 hours in presence of guanidinium homopolymers and their associated 
copolymers using an XTT assay. ..................................................................................... 153 
Figure 4.8 – Comparison of cell uptake of guanidinium polymers with architecture. Cellular 
fluorescence measured for HaCaT cells in presence of 128 µg.mL-1 of guanidinium polymers 
for the indicated time and temperature. *: p ≤ 0.05; **: p ≤ 0.01; ***: p ≤ 0.001. ............. 155 
Figure 4.9 –Intracellular activity of guanidinium polymers in HaCaT cells. Counts of 
intracellular bacteria after a polymer treatment at 128 μg.mL-1 at 37 °C for 2 hours against 
RN1 (A) JE2 (B). Treatment with G-D30 at 40 μg.mL-1 for 2 hours against RN1 (C) JE2 (D). 
*: p ≤ 0.05; **: p ≤ 0.01; ***: p ≤ 0.001. ......................................................................... 157 
Figure 4.10 - 1H NMR spectrum of Bodipy acid in CDCl3. .............................................. 167 
Figure 4.11 - 1H NMR spectrum of NHS-Bodipy in CDCl3. ............................................. 168 
Figure 4.12 - 1H NMR spectrum of Bodipy acrylamide in CDCl3. .................................... 169 
Figure 4.13 - Photos of 1 mg.mL-1 solution of the Bodipy functionalised polymers with (A) 
chain extension after deprotection and (B) deprotection after chain extension. ................. 169 
Figure 4.14 - Negative control for the binding assay with MRSA strain JE2 after 2 hours in 
presence of PI. Microscopy images with the BF, green and red channels. The scale bar 
represents 5 µm. .............................................................................................................. 170 
Figure 4.15 - 1H NMR spectra of polydiBocGEAM15 and polydiBocGEAM30 in DMSO-d6.
 ....................................................................................................................................... 170 
Figure 4.16 – Cytotoxicity of guanidinium SAMPs towards A549 cells. Viability of HaCaT 
cells incubated for 24 hours in presence of guanidinium homopolymers and their associated 
copolymers using an XTT assay. ..................................................................................... 171 
  
   
 
   Page | x 
 
List of Tables 
 
Table 2.1 - Library of synthesised Boc-protected polymers. ............................................... 34 
Table 2.2  - Characterisation data of Boc-protected polymers............................................. 35 
Table 2.3 – Comparison of the antimicrobial activity of the ammonium SMAMPs. MIC values 
determined against Gram-negative bacteria E.coli and P. aeruginosa and Gram-positive 
bacteria S. aureus and S. epidermidis. ................................................................................ 42 
Table 2.4 – SMAMP-induced erythrocytes aggregation. Observation of haemagglutination of 
human red blood cells following incubation with ammonium SMAMPs in PBS for 2 hours at 
37 °C. ............................................................................................................................... 44 
Table 2.5. Comparison of the haemocompatibility of the ammonium SMAMPs. HC10, cH and 
haemocompatibility concentration across the SMAMPs of various composition and structure 
determined by haemolysis and haemagglutination assay. ................................................... 45 
Table 2.6 - Selectivity values for E. coli, P. aeruginosa, S. aureus and S. epidermidis over 
RBCs. ............................................................................................................................... 46 
Table 2.7 - Cytotoxicity of SMAMPs. IC50 values of the SMAMPs against NIH 3T3 and Caco-
2 cells obtained using XTT assays after incubation with the cationic polymers at 37 °C for 72 
hours and TI of SMAMPs over 3T3 cells........................................................................... 50 
Table 2.8 - Experimental conditions used for the synthesis of DP 100 homopolymer and 
statistical copolymers of NIPAM and BocAEAM. ............................................................. 81 
Table 2.9 - Experimental conditions used for the synthesis DP 100 diblock copolymers of 
NIPAM (NIP) and BocAEAM (BocA). ............................................................................. 82 
Table 2.10 - Experimental conditions used for the synthesis of A-M30Boc, the DP 100 
heptablock copolymer of NIPAM (NIP) and BocAEAM (BocA) containing 30 % BocAEAM.
 ......................................................................................................................................... 83 
Table 2.11 - Experimental conditions used for the synthesis of A-M50Boc, the DP 100 
decablock copolymer of NIPAM (NIP) and BocAEAM (BocA) containing 50 % BocAEAM.
 ......................................................................................................................................... 84 
Table 2.12 - Experimental conditions used for the synthesis of A-M70Boc, the DP 100 
heptablock copolymer of NIPAM (NIP) and BocAEAM (BocA) containing 70 % BocAEAM.
 ......................................................................................................................................... 85 
Table 2.13. Experimental conditions and characterisation data for the synthesis of the diblock 
copolymers A-D30Boc, A-D50Boc, A-D70Boc. ...................................................................... 86 
Table 2.14. Experimental conditions and characterisation data for the synthesis of the 
heptablock A-M30Boc. ....................................................................................................... 86 
   
 
   Page | xi 
 
Table 2.15. Experimental conditions and characterisation data for the synthesis of the 
decablock A-M50Boc. ......................................................................................................... 87 
Table 2.16. Experimental conditions and characterisation data for the synthesis of the 
heptablock A-M70Boc. ....................................................................................................... 88 
Table 2.17 - Characterisation data of deprotected polymers. .............................................. 88 
Table 2.18 - Therapeutic index values of the SAMPs with Caco-2 cells. ............................ 89 
Table 3.1 - Synthesised Boc-protected polymers. ............................................................. 100 
Table 3.2 - SMAMP-induced erythrocytes aggregation. Observation of haemagglutination of 
sheep blood cells following incubation with ammonium and guanidinium SMAMPs in PBS 
for 2 hours at 37 °C. ........................................................................................................ 105 
Table 3.3 - Comparison of the cytocompatibility of the ammonium and guanidinium 
SMAMPs. Haemocompatibility determined for sheep blood cells using haemolysis and 
haemagglutination assays and IC50 for HaCaT and A549 cells using XTT assays. ............ 106 
Table 3.4 – Comparison of the antimicrobial activity of the SMAMPs. MIC values determined 
against MSSA RN1 and MRSA JE2. ............................................................................... 110 
Table 3.5 - Selectivity of the SMAMPs for MSSA and MRSA over mammalian cells. 
Selectivity values of the SMAMPs for MSSA RN1 and MRSA JE2 over RBCs (as calculated 
using equation 2.1) and TI values for RN1 and JE2 over HaCaT and A549 (as calculated using 
equation 2.2). .................................................................................................................. 112 
Table 3.6 - Experimental conditions used for the synthesis of S30Boc. .............................. 127 
Table 3.7 - Experimental conditions used for the synthesis DP 100 diblock copolymers of 
NIPAM and diBocGEAM. .............................................................................................. 128 
Table 3.8 - Experimental conditions used for the synthesis of G-T30Boc. .......................... 129 
Table 3.9 - Experimental conditions used for the synthesis of A-T30Boc. .......................... 130 
Table 3.10 - Characterisation data of the final Boc-protected polymers. ........................... 131 
Table 3.11 - Characterisation data of deprotected polymers. ............................................ 132 
Table 4.1 – Guanidinium homopolymers induced erythrocytes aggregation. Observation of 
haemagglutination of sheep blood cells following incubation with guanidinium SMAMPs in 
PBS for 2 hours at 37 °C. ................................................................................................ 152 
Table 4.2 - Synthesised Boc-protected polymers. ............................................................. 172 
Table 4.3 - Antimicrobial activity of the Bodipy functionalised compounds ..................... 172 
Table 4.4 - Experimental conditions used for the synthesis of polydiBocGEAM15 and 
polydiBocGEAM30. ......................................................................................................... 173 
Table 4.5 – DMF-SEC data of the Boc-protected guanidinium homopolymers. ................ 173 
Table 4.6 – MIC values for the guanidinium homopolymers. ........................................... 174 
   
 
   Page | xii 
 
Table 4.7 - Fluorescence intensity and correction factor due to the discrepancies in the intrinsic 
fluorescence of the polymers (calculated using a calibration curve). ................................ 174 
 
  
   
 
   Page | xiii 
 
List of Schemes 
 
Scheme 1.1 - Schematic representation of the mode of action of AMPs ............................... 2 
Scheme 1.2 - Schematic representation of the mode of action of AMP mimicking polymers. 
A) Polymer in solution as either random coil (left) or partially segregated (and possibly 
aggregated, right). B) Attachment to bacterial membrane by electrostatic interaction. C) 
Insertion into the hydrophobic domain of the membrane. D) Membrane disruption leading to 
cell death............................................................................................................................. 3 
Scheme 1.3 - Parameters reported to influence the efficiency of polymeric AMP mimics. .... 4 
Scheme 1.4 - Different strategies to vary the biological activity of polymer by changes in 
sequence/monomer distribution. A) Controlled distance of cationic charges. B) Variations in 
proximity of cationic charge and hydrophobic units along the polymer chain. C) Comparison 
of facial amphiphilic monomers with random copolymers. .................................................. 6 
Scheme 1.5 – Structures of the statistical, gradient or block copolymers. ............................. 8 
Scheme 1.6 - The RAFT mechanism. ................................................................................ 13 
Scheme 1.7 – Structure of the R groups of RAFT agents. The leaving group ability (kβ) 
decreases from left to right. ............................................................................................... 15 
Scheme 1.8 – Categories of RAFT agents with different Z groups. Dithioester (A), 
trithiocarbonate (B), xanthate (C) and dithiocarbamate (D). ............................................... 16 
Scheme 2.1 - Schematic representation of structure, composition and monomer sequence of 
synthesised polymers. ....................................................................................................... 33 
Scheme 4.1 - Synthesis of BodipyAM from Bodipy acid. ................................................ 141 
Scheme 4.2 – Library of Bodipy functionalised guanidinium polymers. ........................... 144 
Scheme 4.3 – Chemical structure of (A) polyguanidinium oxanorbornene40 and (B) PHMB41.
 ....................................................................................................................................... 148 
 
  
   
 
   Page | xiv 
 
Abbreviations 
 
ACN Acetonitrile 
A-D30 poly(NIPAM70-b-AEAM30) 
A-D50 poly(NIPAM50-b-AEAM50) 
A-D70 poly(NIPAM30-b-AEAM70) 
AEAM Amino-ethylacrylamide 
A-M30 
poly(NIPAM18-b-AEAM10-b-NIPAM18-b-AEAM10-b-NIPAM18-b-
AEAM10-b-NIPAM18) 
A-M50 
poly(NIPAM10-b-AEAM10-b-NIPAM10-b-AEAM10-b-NIPAM10-b-
AEAM10-b-NIPAM10-b-AEAM10-b-NIPAM10-b-AEAM10) 
A-M70 
poly(AEAM18-b-NIPAM10-b-AEAM18-b-NIPAM10-b-AEAM18-b-
NIPAM10-b-AEAM18) 
AMP Antimicrobial peptide 
A-S30 poly(NIPAM70-s-AEAM30) 
A-S50 poly(NIPAM50-s-AEAM50) 
A-S70 poly(NIPAM30-s-AEAM70) 
A-T30 poly(NIPAM35-b-AEAM15-b-NIPAM35-b-AEAM15) 
ATRP Atom transfer radical polymerisation 
BMA Butyl methacrylate 
BOC tert-butoxycarbonyl 
BocAEAM N-t-butoxycarbonyl-N’-acryloyl-1,2-diaminoethane 
cH Lowest concentration at which aggregation of RBCs is observed 
CL Cardiolipin sodium salt from bovine heart 
CMC Critical micelle concentration 
Con A Concanavalin A 
CPP Cell penetrating peptide 
   
 
   Page | xv 
 
CTA  Chain Transfer Agent 
Ctr Chain transfer coefficient 
Đ Molar mass distribution (Mw/Mn) 
DCM Dichloromethane 
diBocGEAM  1,3-Di-Boc-guanidinoethyl acrylamide  
DLS Dynamic Light Scattering 
DMAEMA 2-(Dimethyl)aminoethylmethacrylate 
DMEM  Dulbecco's Modified Eagle's Medium  
DMF N,N-Dimethyl formamide  
DMSO Dimethyl sulfoxide 
DMSO-d6 Deuterated DMSO 
DP Degree of polymerisation 
E. coli  Escherichia coli 
EDC 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
EtOAc Ethyl acetate 
FA Facially amphiphilic 
G-D30 poly(NIPAM70-b-GEAM30) 
GEAM  Guanidino-ethylacrylamide  
GPC Gel permeation chromatography 
G-S30 poly(NIPAM70-s-GEAM30) 
G-T30 poly(NIPAM35-b-GEAM15-b-NIPAM35-b-GEAM15) 
HC10 Lowest concentration at which 10 % of haemolysis is observed 
HPLC High performance liquid chromatography 
IC50 Inhibitory concentration of 50 % of cells 
LAM Less-activated monomer 
LCST Lower critical solution temperature 
LRP Living radical polymerisation 
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MAM More-activated monomer 
MHB Müller-Hinton Broth 
MIC Minimum inhibitory concentration 
MOPS 3-(N-morpholino)propanesulfonic acid  
MRSA Methicillin-resistant S. aureus 
MS Mass spectroscopy 
MSSA Methicillin-sensitive S. aureus 
NaCl Sodium chloride 
NaOH Sodium hydroxide 
NEt3 Triethylamine 
NHS N-hydroxysuccinimide 
NIPAM N-isopropylacrylamide 
NMP Nitroxide mediated polymerisation 
NMR Nuclear Magnetic Resonance 
P. aeruginosa Pseudomonas aeruginosa 
PABTC (propanoic acid)yl butyl trithiocarbonate 
PBS Phosphate Buffered Saline  
PE 1,2 dioleoyl-sn-glycero-3-phosphoethanolamine 
PEG Poly(ethylene glycol) 
PG 1,2 dioleoyl-sn-glycero-3-phospho-rac(1-glycerol) sodium salt 
PMS N-methyl dibenzopyrazine methyl sulphate 
RAFT Reversible Addition-Fragmentation chain Transfer 
RBC Red blood cell 
RDRP Reversible-deactivation radical polymerisation  
ROMP Ring-opening metathesis polymerisation 
RPMI Roswell Park Memorial Institute medium 
S. aureus  Staphylococcus aureus 
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S. epidermidis  Staphylococcus epidermidis 
SMAMP  Synthetic mimic of antimicrobial peptides 
SEC Size exclusion chromatography 
TFA  Trifluoroacetic acid 
THF Tetrahydrofuran 
TI Therapeutic index 
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 Introduction 
 
 
Bacterial resistance has become a pressing clinical issue for which the World Health 
Organisation has raised awareness due to the low levels of infection control reached 
recently.1-2 This global issue has been considered as a failure in antibiotic drug discovery and 
new types of antibiotics have recently been investigated to tackle it. 
For this reason, new types of antibiotics have recently been investigated. Among 
these, antimicrobial peptides (AMPs) have attracted an increased interest and a few of them 
are currently undergoing clinical trials.3 AMPs are peptides comprised of 10-50 amino-acids 
with cationic and hydrophobic residues, present in the innate immune system of 
multicellular organisms, hence the terminology host-defence peptides.4-5 The majority of 
these peptides, adopt an amphipathic helical conformation with the cationic functionalities 
on one side of the coil and the hydrophobic ones on the other.6 AMPs have demonstrated a 
broad-range antimicrobial activity, which is associated to their mechanism of action based 
on bacterial membrane disruption. Indeed, the positively charged residues of AMPs have 
been shown to interact with the negatively charged phospholipids of bacterial membranes 
(Scheme 1.1).7 Following the binding of AMPs to bacterial membranes, the hydrophobic 
residues of AMPs insert into the membrane, inducing the formation of pores. Once the 
integrity of the bacterial membrane is compromised, there is leakage of the intracellular 
material, which leads to bacterial cell death.8 Remarkably, as AMPs seem to target bacterial 
membrane instead of a specific ligand, they do not seem to evoke bacterial resistance against 
these peptides.9-10 Indeed, only minor structural changes are required for bacteria to exhibit a 
reduced susceptibility towards conventional antibiotics, whereas more significant changes in 
the structure of the bacterial membrane would be necessary to prevent the antimicrobial 
action of AMPs.11-12 This membrane interaction based on electrostatic interactions allows 
AMPs to be selective towards bacteria over mammalian cells to a certain extent.13  
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Scheme 1.1 - Schematic representation of the mode of action of AMPs 
  
Despite the aforementioned advantages, AMPs can present a high toxicity profile 
towards mammalian cells, in particular with red blood cells.14-15 Furthermore, peptides are not 
typically ideal drug candidates as they are costly to produce on large scale and show limited 
pharmacokinetic stability.16 To overcome these challenges, synthetic mimics of AMPs 
(SMAMPs) which possess similar physico-chemical properties to naturally occurring AMPs 
and therefore mimic their mode of action, have been extensively investigated.  
 
1.1 Key parameters influencing the selectivity of SMAMPs 
 
The discovery that the helical chirality of AMPs did not affect their antimicrobial 
activity,17 led researchers to examine a wider range of synthetic strategies.18-20 Perhaps the 
most promising of these are the AMP mimicking polymers since their compositions are readily 
tuneable and easily scalable.21 Remarkably, Mowery et al. reported the antimicrobial activity 
of polymers with a flexible backbone using nylon copolymers, hence demonstrating that a 
specific or regular conformation was not required for SMAMPs to exhibit antimicrobial 
activity.22 
   Chapter 1 
 
   Page | 3 
 
Because most SMAMPs are designed with both cationic and hydrophobic 
functionalities, the balance between positive charge and hydrophobicity on the selectivity 
towards mammalian cells has been extensively studied. Since positive charge, which enables 
the polymers to preferentially interact with bacterial membranes over mammalian cells, often 
confers hydrophilic character to the material, some additional hydrophobic character is 
typically introduced to facilitate membrane disruption (Scheme 1.2).23 Kuroda and co-workers 
synthesised a library of polymethacrylates bearing positive charge with side chains of 
increasing hydrophobicity.24 Highly hydrophobic materials exhibited less selectivity with high 
haemolytic activity, whereas no antimicrobial activity was observed with the most cationic 
(and therefore hydrophilic) polymers. This balance was shown to be quite delicate, as an 
increase in the overall hydrophilicity of the polymer, from polymethacrylate to 
polymethacrylamide, reduced their potency towards bacteria but also their haemolytic 
activity.25 Similar trends were observed with polynorbornenes, with hydrophobicity being 
necessary to disrupt bacterial membranes, but inducing haemolysis if in excess.26-27 
 
Scheme 1.2 - Schematic representation of the mode of action of AMP mimicking 
polymers. (A) Polymer in solution as either random coil (left) or partially segregated (and 
possibly aggregated, right). (B) Attachment to bacterial membrane by electrostatic interaction. 
(C) Insertion into the hydrophobic domain of the membrane. (D) Membrane disruption leading 
to cell death. 
 
In addition, they observed that the molar mass of the polymers played a central role 
in optimising selectivity towards bacteria. Both the antimicrobial and the haemolytic activity 
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increased with the degree of polymerisation for polynorbornenes.27 A similar trend was 
observed with oligomers bearing guanidine moieties, for which a minimum molar mass of 500 
g.mol-1 was required to obtain an active compound.28 However, above a molar mass of 50000 
g.mol-1 there was also a loss of activity, which was attributed to the inability of the longest 
polymers to effectively cross the outer peptidoglycan layer.26 Moreover, control over the molar 
mass distribution is crucial: Mowery and co-workers showed that for the same number average 
molar mass of 3000 g.mol-1, a nylon-3 cationic SMAMP with a broader dispersity resulted in 
greater haemotoxicity than that of the polymer with a lower dispersity: the minimum 
haemolytic concentration varied from 12.5 to 800 μg.mL-1 for a Ð value of 1.15 and 1.06, 
respectively.22 Indeed, it was found that the high molar mass chains within the population were 
responsible for an increase in toxicity towards red blood cells. 
Various studies investigating the type of charge, counter-ion or the length of the 
spacer between the charged pendant moiety and the polymeric backbone have also been 
undertaken.29-32 However, the results generally correlated to the variation in charge to 
hydrophobicity ratio, hence no ulterior structure-activity relationship could be elucidated.29 
 
Scheme 1.3 - Parameters reported to influence the efficiency of polymeric AMP mimics. 
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1.2 Sequence Control in Polymeric AMP Mimics 
 
As mentioned earlier, the α-helical secondary structure of AMPs is not necessary to 
exhibit antimicrobial activity. However, the physico-chemical properties of an AMP seem to 
have a direct impact on their interaction with bacterial membranes, and therefore on the 
antimicrobial activity. One approach to controlling the balance of positive charge to 
hydrophobicity, and hence antimicrobial activity, is to dictate the positioning of relative 
functionalities along a polymeric backbone. In this section, the influence of the distribution of 
functionalities and micellisation of SMAMPs on biological activity is reviewed. 
 
1.2.1 Structural Control via Monomer Architecture 
 
One typical and simple synthetic approach which allows for a degree of spatial control 
of functionalities in SMAMPs is the copolymerisation of hydrophobic and cationic monomers. 
In such cases the distance between functionalities is defined, on one level, by the nature of the 
polymer backbone, and secondly by the sequence of monomers. However, to investigate the 
impact of the relative distance between functionalities, other design strategies have also been 
developed. 
 
In order to establish the influence of the spacing between the alkyl chain and the 
cationic centre, Sambhy et al. designed two types of random copolymers both containing 
pyridinium and methacrylate units.33 For one series, methyl methacrylate was copolymerised 
with a pyridinium monomer quaternised by an alkyl chain substituent. The other copolymer 
series contained a pyridinium monomer quaternised by a methyl group and methacrylate 
monomers bearing pendant alkyl chains (Scheme 1.4A). The separation of the alkyl chain 
from the cationic centre slightly increased the antibacterial activity and significantly increased 
the haemolytic activity. Indeed, for similar composition and alkyl chain length, the disruption 
of cell membranes was promoted by the separation of the charge and the tail, in particular for 
mammalian cells. Therefore, the selectivity against bacteria was increased by situating the 
alkyl chain at the cationic centre. A possible explanation for this effect could be found in the 
mechanism of action of polymeric AMP mimics. When hydrophobicity is spatially separated 
from the charge it is more likely to insert into the hydrophobic domain of the cell membrane, 
rendering these polymers more membrane active. This research underlines the importance of 
the spatial control of hydrophobic and cationic units relative to each other.  
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Scheme 1.4 - Different strategies to vary the biological activity of polymer by changes in 
sequence/monomer distribution. (A) Controlled distance of cationic charges. (B) Variations 
in proximity of cationic charge and hydrophobic units along the polymer chain. (C) 
Comparison of facial amphiphilic monomers with random copolymers. 
 
Song and co-workers developed alternating copolymers obtained by alternated ring-
opening metathesis polymerisation (AROMP) of cationic and hydrophobic monomers.34 
Random copolymer counterparts and homopolymers were synthesised for comparison of their 
antimicrobial activity. Regular spacing between functional groups was shown to improve the 
potency of alternating polymers, which exceeded the antimicrobial activity of the random 
copolymers with similar functionalities in which the distance between pendant groups is not 
strictly periodic (Scheme 1.4B). By comparing the potency of homopolymers and alternating 
polymers towards bacteria, the authors furthermore concluded that a distance of 8 - 10 Å 
between cationic units in an alternating copolymer backbone resulted in optimal membrane 
interaction. However, since the synthesised polymers possessed broad molar mass 
distributions (Ð up to 2.4 for alternating copolymers and 3.5 for homopolymers), it is difficult 
to clearly conclude on the structure-property relationship.  
 
Further investigation of the distribution of functional groups along the polymer 
backbone was undertaken by Gabriel et al.35 The study was directed towards the comparison 
of facially amphiphilic (FA) polynorbornenes synthesised via ring opening metathesis 
polymerisation (ROMP) of dual functional monomers with random amphiphilic copolymers 
derived from mono-functional monomers (Scheme 1.4C). The random amphiphilic polymers 
offered segregation of cationic primary amine moieties and hydrophobic alkyl chains via the 
polymer backbone, whereas FA polymers directed the separation of functionalities 
perpendicularly to the backbone. The FA polymers exhibited higher antimicrobial activity and 
lower toxicity against red blood cells than the segregated counterparts, thus a better selectivity. 
The FA structure might enhance membrane interactions, thus enhancing their disruption.35 
The rigidity of the polynorbornene backbone might emphasize the effect of the facial 
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amphiphilicity of the monomers. A more flexible backbone could allow the polymer chains to 
adapt their conformation more readily in presence of a membrane, thus rendering the initial 
distribution of the functionalities along the polymer backbone less important. Another 
observation was that the change in the ratio of cationic to hydrophobic segregated monomers 
did not influence the antimicrobial or the haemolytic activity. However, as the length of the 
alkyl pendant group had a direct impact on the selectivity, it seems that the local charge to 
hydrophobicity ratio is of greater importance than that of the overall polymer. 
 
In order to mimic the facially amphiphilic structure of AMPs, Tew and co-workers 
designed oligomers using aromatic rings and other functionalities enabling hydrogen-bonding 
to rigidify the polymeric structure. They observed that by limiting rotational degrees of 
freedom around the backbone, the potency against bacteria was increased.36-37 Further systems 
were explored using monomers bearing both a cationic and a hydrophobic pendant group,27 or 
introducing modification in FA monomers affecting the structure of the backbone.38 The 
design of monomers chosen to build the AMP mimics and any modification in the sequence 
of these monomers seemed to have an impact on the local amphiphilicity, therefore affecting 
the interaction of the resulting polymers with cell membranes. These FA systems, among other 
synthetic mimics of AMPs, have been discussed more extensively in a review by Lienkamp 
et al.39  
 
1.2.2 Influence of Monomer Sequence 
 
The self-assembly of AMPs has been demonstrated to play an important role in 
reducing the cytotoxicity and improving the stability of these peptides.40,41 The self-assembly 
of antimicrobial polymers might also have an impact on their activity. Extensive work on the 
modelling of the interactions of antimicrobial polymers with bacterial membrane was carried 
out by Baul and co-workers (Scheme 1.5A).42 Although specific conformations are not 
necessary, it was established that the interactions of polymers with bacterial membranes were 
enhanced by their ability to segregate cationic and hydrophobic groups. Additional 
simulations showed that the strength of the adsorption of antimicrobial polymers to bacterial 
membranes depended on the monomer sequence, correlating to their ability to phase 
segregate.43 Amphiphilic block copolymers, in comparison to their random copolymer 
anologues, are more likely to undergo phase segregation in an aqueous environment and are 
therefore the subject of recent studies. 
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An early investigation performed by Sauvet and co-workers compared multiblock 
poly(siloxane)s bearing quarternised ammonium units with their statistical counterparts 
(Scheme 1.5B).44 No influence of the polymer architecture on the antimicrobial activity was 
observed. However, the haemolytic activity of the macromolecules were not investigated, 
preventing a conclusion about their selectivity. 
 
 
Scheme 1.5 – Structures of the statistical, gradient or block copolymers. 
 
 
Similarly, Wang et al. explored the antimicrobial activity of diblock and random 
copolymers of 2-(dimethyl)aminoethylmethacrylate (DMAEMA) and butylmethacrylate 
(BMA) as shown in Scheme 1.5C.45 Despite the level of activity against microorganisms not 
varying with the segmentation of the polymers, the haemolytic activity was substantially 
   Chapter 1 
 
   Page | 9 
 
decreased for diblock copolymers making them more selective against bacteria, in comparison 
to their random copolymer equivalents. A study of gradient and diblock nylon-3 copolymers 
synthesised from β-lactams bearing primary amine and hydrophobic pendant groups was 
performed by Liu and co-workers (Scheme 1.5D).46 While haemolytic activity was 
diminished, the antimicrobial activity was also reported to be lower for the diblocks as 
compared to gradient copolymers. However, none of these works investigated the presence of 
self-assemblies in solution. 
 
Oda et al. designed diblock and random copolymers of cationic and hydrophobic vinyl 
ethers using cationic polymerisation (Scheme 1.5E).47 Although the antimicrobial activity was 
similar for both types of polymers, the study demonstrated that the block copolymers were far 
less haemolytic than their random copolymer equivalents. Interestingly, block copolymers 
displayed antimicrobial activity below their critical micelle concentration (CMC). However, 
they were considered to form unimolecular aggregates with a cationic shell at low 
concentration, which allowed a shielding of the hydrophobic domain from red blood cells, 
thus reducing the haemolytic activity. This is supported by molecular dynamic investigations 
on statistical copolymers performed by Taresco and co-workers (Scheme 1.5F).48 A flower-
like micelle model was used to fit the structure adopted by the random copolymers in solution 
indicating the formation of phase segregated systems even without a block or block-like 
architecture. A further difference with the block copolymers in the study by Oda et al. was the 
increased levels of haemagglutination (RBC aggregation) in comparison to the random 
copolymers. This could be a result of the phase separation of block copolymers leading to 
enhanced presentation of cationic charges compared to statistical copolymers. The increased 
interaction with anionic groups on RBC membranes would consequently result in cross-
linking and aggregation. 
 
A study by Nederberg and co-workers on triblock poly(carbonate)s synthesised by 
ring-opening polymerisation revealed similar observations concerning antimicrobial activity 
and haemolysis (Scheme 1.5G).49 The polymers self-assembled in aqueous solution into 
flower-like micelles, which were able to efficiently disrupt bacterial membranes while 
maintaining low haemolysis levels. Indeed, in this case minimum inhibitory concentration 
(MIC) values were higher than the reported CMC of the polymers in buffer, hence the 
antimicrobial activity was attributed to the micellar structure. On the contrary, Judzewitsch 
and co-workers found that with a ternary copolymer system (hydrophobic, neutral hydrophilic 
and cationic monomers), segregating all three functionalities resulted in a lower antimicrobial 
activity compared to a statistical counterpart (Scheme 1.5H).50 This reduction in activity was 
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attributed to the formation of stable micelles, preventing interactions of the hydrophobic 
moieties with bacterial membrane. However, when the hydrophobic and hydrophilic 
monomers were incorporated in the same block and the cationic functionalities segregated in 
a different block, the MIC towards both Gram-negative and Gram-positive bacteria was 
improved.50 
 
Costanza et al. investigated block copolymers obtained by the coupling of 
polypeptides, containing phenyl alanine and lysine, with poly(ethylene glycol) (PEG) of 
varied lengths (Scheme 1.5I).51 These block copolymers formed particles in aqueous solution, 
and it was found that a long PEG block (5000 g.mol-1), shielded the biologically active block, 
which reduced the haemolytic activity, as well as the antimicrobial activity.  
 
The influence of the shape of polymeric nano-objects on the inhibition of bacterial 
growth was investigated by Yao and co-workers through comparison of a diblock copolymer 
comprising a cationic polyDMAEMA block and a hydrophobic methacrylate-derived block 
bearing triethoxysilyl pendant groups which were synthesised via RAFT polymerisation 
(Scheme 1.5J).52 Phase separated bulk materials were cross-linked and re-dispersed resulting 
in spherical, cylindrical and sheet-like assemblies. However, the antimicrobial activity was 
not affected by the morphology, indicating that increased contact area is not needed to improve 
antibacterial activity for these polymers. Furthermore, cross-linking of the polymers may have 
interfered with the effective insertion into the hydrophobic membrane domain. However, the 
impact of the shape on the toxicity against mammalian cells was not investigated. 
 
In summary, although an alpha-helical shape, as found for AMPs, is not necessary for 
a successful antimicrobial polymer, the distribution of functionalities along the polymer chain 
certainly has an impact on their biological activity. However, while empirical evidence proves 
that distance between charges or the proximity of cationic domains to hydrophobic domains 
influence the membrane activity, no clear correlation for that effect has been established as 
yet. Nonetheless, in the case of polymers which possess a controlled segregation of 
functionalities i.e. block copolymers and facially amphiphilic polymers, the inluence is more 
definitive, and certainly micellisation seems to profoundly influence antimicrobial behavior. 
With the cationic corona shielding the hydrophobic domain, disruption of bacterial 
membranes seems less favoured within stable micelles. 
 
The precise distribution of functionality, positive charge and hydrophobic moieties 
along the backbone has been demonstrated to have an impact on the selectivity of AMP 
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mimics. Although achieving such defined sequences in SMAMPs can be synthetically 
challenging, reversible-deactivation radical polymerisation (RDRP) techniques have made 
promising progress in the synthesis of sequence-controlled block copolymers with robust and 
easily scalable approaches.53-55  
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1.3 Design of well-defined multiblock copolymers using RAFT 
 
Radical polymerisation is now widely exploited for the  synthesise of precision 
polymers with the emergence of RDRP techniques which allows control over the molar mass, 
molar mass distribution and, crucially, confers “living” character to the polymer chains (i.e. 
the opportunity to reinitiate from the ω-chain end, yielding block copolymers).56 Amongst 
those methods, nitroxide-mediated polymerisation (NMP),57-59 atom transfer radical 
polymerisation (ATRP)60-62 and reversible addition-fragmentation chain transfer (RAFT)63-64 
polymerisation have been the most extensively studied and utilised.65 This part of the 
introduction will focus on the latter and its application in the synthesis of block copolymers. 
 
1.3.1 Introduction to RAFT polymerisation 
 
RAFT polymerisation is an extremely robust and versatile technique which is used to 
readily obtain polymers of defined molar mass with narrow molar mass distributions for a 
range of monomer families including (meth)acrylates, (meth)acrylamides, styrenics and vinyl 
ethers.64, 66-67 RAFT is based on the degenerative transfer of the radical centre between 
polymers chains through addition to a chain transfer agent (CTA) (or RAFT agent), providing 
a reversible activation/deactivation mechanism which affords all polymeric chains an equal 
opportunity to grow using only a small fraction of radical species.67 The mechanism of RAFT 
polymerisation is shown in Scheme 1.6.  
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Scheme 1.6 - The RAFT mechanism. 
 
As in conventional radical polymerisation, radical species (I˙) are generated and may 
undergo radical addition to monomer to form a polymeric radical species P˙n (kp). In the pre-
equilibrium stage of the polymerisation, P˙n will add (kadd) to the thiocarbonylthio of the CTA 
(1). The intermediate radical (2) can revert back to (1) and P˙n (-kadd) or fragment (kβ) to yield 
a polymer chain with a thiocarbonylthio end-group (3), or macro-CTA, and a new CTA-
derived radical R˙. The latter can in turn undergo addition to monomer (kiR then kp) to form a 
polymeric radical P˙m, during the re-initiation step. The process then reaches the main 
equilibrium, ideally once all of the CTA (1) is consumed to give macro-CTA (3). At this stage, 
the radical is exchanged between two polymer chains, through the formation (kaddP) and 
fragmentation (-kaddP) of a radical intermediate (4). Since the process nonetheless involves the 
co-existence of radical species, bimolecular termination events will inevitably occur via either 
combination (ktc) or disproportionation (ktd), yielding “dead chains”. However, this 
mechanism of degenerative transfer offers all polymer chains the opportunity to propagate at 
a uniform rate with only a small fraction of the population existing as radical species, thereby 
limiting the extent of termination events. Thus, when the amount of CTA present is greater 
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than the amount of radical species produced by the initiator, the majority of the α-chain ends 
will be derived from the R group of the CTA, whilst ω-chain ends will possess the 
thiocarbonylthio group. Provided that the CTA is consumed rapidly and quantitatively, and 
exchange of radical species via the thiocarbonylthio moiety is efficient, the molar mass of the 
polymer chains is dictated by the ratio [M]/[CTA] and the population possesses a narrow 
molar mass distribution. The theoretical number-average molar mass (Mn,th) is calculated using 
Equation 1.1. 
 
𝑀n,th =  
([𝑀]0 − [𝑀]𝑡) × 𝑀M
[CTA]0 + 2𝑓[I]0(1 − e−𝑘𝑑𝑡)(1 −
𝑓𝑐
2 )
+ 𝑀CTA 
Equation 1.1 - Calculation of Mn,th. 
 
Where [M]0, [CTA]0, [I]0 are the initial concentrations (in mol.L
-1) of the monomer, CTA and 
the initiator respectively; [M]t is the monomer concentration at time t; MM and MCTA are the 
molar masses (in g.mol-1) of the monomer and the CTA, respectively; kd is the decomposition 
rate constant (in s-1) of the azo-initiator; and t represents the polymerisation time (in seconds). 
The factor “2” accounts for the fact that one molecule of azo-initiator yields two primary 
radicals with the efficiency f (assumed to be equal to 0.5 in this study). The term 1 – (fc /2) 
represents the number of chains produced in a radical-radical termination event with fc 
representing the coupling factor. An fc value of 1 means that 100 % of bimolecular 
terminations occur via combination, whereas a value of 0 indicates that 100 % of bimolecular 
terminations occur via disproportionation. However, in an optimal experimental design, the 
fraction of dead chains should be negligible compared to CTA-derived chains, hence Equation 
1 can be simplified to give Equation 1.2. 
  
𝑀n,th ≈  
([𝑀]0 − [𝑀]𝑡) × 𝑀M
[CTA]0
+ 𝑀CTA  
Equation 1.2 - Approximation on the calculation of Mn,th. 
 
During a RAFT polymerisation, control over molar mass distribution is dictated by 
the R and Z group of the CTA, which should be selected in accordance to monomer reactivity. 
Indeed, the type of R group affects the pre-equilibrium stage, during which a rapid and full 
consumption of the radical R˙ should occur, as mentioned previously. In order to achieve this, 
the fragmentation of the intermediate (2) towards R˙ (kβ), the radical derived from the R group 
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of the CTA, has to be more favourable than towards P˙n (k-add), followed by a rapid addition of 
R˙ to monomer (kiR ˃ kp).67 The fragmentation of the intermediate (2) is determined by the 
partition coefficient Φ given by Equation 1.3:  
 
𝛷 =
𝑘𝛽
𝑘−𝑎𝑑𝑑 + 𝑘𝛽
 
Equation 1.3 - Determination of the partition coefficient Φ. 
 
Polymers with narrow molar mass distributions can be obtained when Φ ≥ 0.5 (kβ ≥ k-
add), corresponding to R˙ being a better homolytic leaving group than P˙n. The fragmentation 
of the intermediate (2) will depend on the monomer being polymerised, since k-add decreases 
in the following order: methacrylates ≥ methacrylamides ˃˃ styrenics ≥ acrylates ˃˃ 
acrylamides > vinyl esters. The stability of R˙ is related to polar and steric effects. Hence the 
R group should be designed according to the type of monomer being polymerised. A series of 
typical R-group structures given in order of their ability as a homolytic leaving group are 
shown in Scheme 1.7.68 When the appropriate relative reactivity is chosen, the CTA is fully 
consumed at the start of the process, allowing for the main equilibrium to take place. 
 
 
 
Scheme 1.7 – Structure of the R groups of RAFT agents. The leaving group ability (kβ) 
decreases from left to right. 
 
During the main equilibrium, the exchange rate of the radical centre between the 
polymer chains should be greater than the propagation rate. This difference is ensured by a 
greater reactivity of the polymeric radical towards the thiocarbonylthio group compared to the 
monomer (kaddP ˃˃ kp).
69 These kinetics considerations can be translated into the chain transfer 
coefficient (Ctr) which depends on the rate of chain transfer (ktr) and propagation (kp) as shown 
in Equations 1.4 and 1.5. 
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𝐶𝑡𝑟 =
𝑘𝑡𝑟
𝑘𝑝
 
Equation 1.4 – Determination of the chain transfer constant Ctr. 
 
 
𝑘𝑡𝑟 = 𝛷. 𝑘𝑎𝑑𝑑  
Equation 1.5 – Determination of the rate of chain transfer ktr. 
 
In order to obtain polymers with low molar mass distribution (Ð < 1.2), CTAs with 
high Ctr (at least 10) are recommended.
70 The Ctr of a reaction depends on the monomer and 
the Z group of the CTA.69 Indeed, there are two categories of vinyl monomers: the more-
activated monomers (MAMs), such as (meth)acrylates, (meth)acrylamides and styrenic 
derivatives, which have a high reactivity to radicals, and the less-activated monomers (LAMs) 
such as vinyl esters and vinyl amides. The propagating radicals derived from LAMs are less 
stable than those produced from MAMs. By varying the Z group, the reactivity of the CTA 
and its derived radical intermediate (4) can be modified. Dithioesters and trithiocarbonates 
(Scheme 1.8A and B) were shown to be highly reactive, thus are suited for the polymerisation 
of MAMs. However, for the polymerisation of LAMs xanthates and dithiocarbamates are 
more appropriate (Scheme 1.8C and D) RAFT agents, as they have a lower reactivity towards 
radical addition. The variety in this R and Z group chemistry, which has been extensively 
reviewed, offer the ability to polymerise a wide range of different monomer types with control 
over molar mass and molar mass distribution.64, 66, 68-69, 71-72  
 
 
Scheme 1.8 – Categories of RAFT agents with different Z groups. Dithioester (A), 
trithiocarbonate (B), xanthate (C) and dithiocarbamate (D). 
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1.3.2 Synthesis of block copolymers via RAFT 
 
The livingness of RAFT polymerisation permits the sequential addition of monomer 
to obtain highly defined structures called block copolymers comprised of blocks of different 
monomers.73-74 The RAFT mechanism allows all polymer chains to grow using only a small 
fraction of active radical species, meaning a high proportion of the polymer chains are “living” 
i.e. possessing the thiocarbonylthio moiety, as expressed by Equation 1.6.53  
 
𝐿 (%) =  
[𝐶𝑇𝐴]0
[𝐶𝑇𝐴]0 + 2𝑓[𝐼]0(1 − 𝑒−𝑘𝑑𝑡)(
1 − 𝑓𝑐
2 )
 
 
Equation 1.6 - Theoretical determination of the relative amount of living polymer chains 
using an azo-initiator compound. 
 
The fraction of living chains, L (%), can be calculated using Equation 1.3, where 
[CTA]0 and [I]0 are the initial concentrations of CTA and initiator, respectively, kd and f 
describe the thermal decomposition of the initiator and 1-fc/2 the termination mechanisms. 
Utilising a high ratio of [CTA]/[I]consumed results in a very high fraction of the “living” ω-chain 
ends, offering the possibility of efficient chain extension(s). In this regard, a low flux of radical 
species is beneficial. However, the rate of propagation (Rp) in RAFT polymerisation is 
proportional to the concentration of active radical species, which itself is related to the initial 
initiator concentration and the rate at which is decomposes, as for conventional radical 
polymerisation (Equation 1.7).63 
 
𝑅𝑝 = 𝑘𝑝[𝑀][𝑃˙] = 𝑘𝑝[𝑀]√
𝑓. 𝑘𝑑[𝐼]0𝑒−𝑘𝑑𝑡
𝑘𝑡
 
Equation 1.7 - Theoretical determination of the rate of propagation for RAFT 
polymerisation. 
 
Where [M] and [P˙] are the concentrations of monomer and polymeric radical species, 
respectively; kp and kt are the rate of propagation and termination, respectively; f is the initiator 
efficiency and [I]0 is the initiator concentration at time t. Therefore, monomer conversion is 
strongly correlated to the initiator concentration. In order to successfully conduct a RAFT 
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polymerisation to high monomer conversion, yielding polymers with a narrow molar mass 
distribution and also a high fraction of living chains, a fine optimisation of the [M]/[CTA]/[I] 
ratio has to be established. 
 
When synthesising a block copolymer by RAFT, one of the key parameters to take 
into account is the choice of the Z group of the CTA, since its ability to stabilise the 
intermediate radical must be compatible with the radical derived from each monomer.70 
Additionally, the order of the chain extensions is governed by the reactivity of the monomers.75 
The first block acts as a macroCTA for the polymerisation of the second block, hence the 
reactivity of the propagating radical of the first block will affect the chain extension with the 
second monomer. Indeed, conditions which allow to proceed to the main equilibrium (i.e. R 
being an efficient homolytic leaving group and R˙ adding to monomer) must again be satisfied. 
The order of the synthesis of block copolymers require careful optimisation: the more 
activated monomers, which polymers are better homolytic leaving group, should be 
polymerised prior to the LAMs in order to ensure the successful chain extension of all the 
polymer chains.64, 70 
 
The other aspect to take into consideration in the preparation of block copolymers 
using a degenerative transfer mechanism such as RAFT is that a continuous source of 
exogenous radicals are required.70 The radicals generated from the decomposition of the 
initiator will react with the newly added monomer and propagate, yielding homopolymers of 
the second monomer. The proportion of this undesired homopolymer is related to the ratio of 
(macro)CTA to radicals introduced.  Under conventional RAFT conditions, this ratio will be 
relatively low, and therefore the majority of polymer chains in the final population will be the 
desired AB block copolymer. However, when targeting further block extensions, the presence 
of undesired polymer chains (dead chains and initiator derived chains) is compounded and can 
become non-negligible, typically leading to a poorly defined population.  
 
When targeting multiple block extensions via RAFT, to yield multiblock copolymers, 
conditions must be carefully considered in order to minimise the contribution of dead and 
initiator derived chains.76 Traditionally, this entails using a relatively high ratio of CTA to 
initiator and stopping each polymerisation cycle at moderate monomer conversion (<70 %), 
thereby requiring timely and costly purification steps between each block extension.77-78 
However, in 2013 Gody and co-workers demonstrated how well-defined multiblock 
copolymers could be readily prepared via RAFT in a one-pot system through a rigorously 
considered approach.53, 76, 79 By polymerising acrylamide monomers, which possess a high 
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kp/(kt)
1/2 compared to most other vinyl monomers, and working at high monomer 
concentrations, near-quantitative monomer conversion could be achieved for each 
polymerisation cycle with very low initiator concentrations. This system could be further 
optimised by using water as solvent, which further increases the kp of acrylamides. Finally, it 
was shown how targeting a low degree of polymerisation for each RAFT polymerisation cycle 
and using rapidly decomposing azo-initiators permitted the one-pot synthesis of a well-defined 
multiblock copolymer with an unprecedented number of blocks (21) in a short time frame (2 
h per block).79 Well-defined polyacrylate and polymethacrylate multiblock copolymers have 
also since been successfully prepared by carefully optimising the conditions of the RAFT 
process.80-82 With such time and resource-efficiency, complex multiblock copolymer 
architectures are becoming increasingly accessible and offer enormous potential for industrial 
applications.83-84  
  
   Chapter 1 
 
   Page | 20 
 
1.4 Conclusion and scope of the thesis 
 
The activity and selectivity of antimicrobial polymers are governed by the interactions 
of the polymer chains with bacterial membranes. Recent studies investigated variations in 
polymer structure which dictate the relative distribution of cationic moieties and hydrophobic 
domains. In this context, the distribution of the functionalities along the polymer backbone 
seems to alter the interactions of the polymer chains with bacterial membrane. The multiblock 
approach provides access to an intermediate in terms of distribution of functional groups 
compared to other typical sequences (alternating, statistical, gradient, diblock). The activity 
of the defined copolymers could then be compared with that of the statistical monomer 
distributions, which would help in establishing an in-depth structure-activity relationship for 
these antimicrobial systems. Therefore, this study could be a starting point for the exploration 
of more efficient antimicrobial polymers. Additionally, as multiblock copolymers can easily 
be scaled up by using RAFT technology, and that their production cost is relatively low, they 
could be a potentially attractive alternative to current antibiotics.  
 
The aim of this thesis is to study the structure-activity relationship of antimicrobial 
block copolymers obtained by RAFT. The first experimental chapter focuses on the synthesis 
of amphiphilic ammonium SMAMPs. The content of positive charge (0, 30, 50, 70 and 100 
%), as well as the degree of segmentation (statistical, multiblock and diblock) were varied. 
This library will permit to determine the optimal charge content for these primary amine-
functional SMAMPs, but also to investigate the effect of their sequence on the activity against 
a range of bacteria in addition to their compatibility towards mammalian cells.  
Subsequently, guanidinium-rich polymers are synthesised in order to mimic AMPs 
containing arginine residues. For this system, a single chemical composition is targeted (30 % 
charge content), but the monomer distribution is varied in a similar fashion to the lysine 
mimics. A systematic comparison of guanidinium containing polymers with their ammonium 
counterparts is established to determine the ideal candidates to tackle MRSA (type of charge 
and polymer sequence).  
In the final chapter, the interactions of guanidinium SMAMPs of different sequence 
with bacterial membrane is described. In order to explain the impact of monomer distribution 
on the antimicrobial activity, guanidinium homopolymers of comparable length to the cationic 
block of the block copolymers are investigated. Due to the similarities of the guanidinium-
rich polymers with cell penetrating peptides (CPPs), their use as treatment against intracellular 
bacteria is explored. 
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 Sequence control as a powerful tool 
for improving the selectivity of antimicrobial 
polymers 
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Abstract 
 
In order to tackle the current development of bacterial resistance against conventional 
antibiotics, antimicrobial polymers represent a promising alternative since their mechanism of 
action relies on bacterial membrane disruption. This study investigates the effect of 
segregation of hydrophobic and cationic functionalities within antimicrobial polymers on their 
selectivity between bacteria and mammalian cells. Using RAFT polymerisation, statistical, 
highly segmented multiblock and diblock copolymers were synthesised in a controlled 
manner. Polymers were analysed by HPLC and the monomer sequence was found to have a 
significant influence on their overall hydrophobicity. In addition, the molar ratio of cationic 
co-monomer was varied to yield a small library of bioactive macromolecules. The 
antimicrobial properties of these compounds were probed against pathogenic bacteria 
(Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and Staphylococcus 
epidermidis) and their biocompatibility was assessed with haemolysis and erythrocyte 
aggregation assays, as well as mammalian cell viability assays. In all cases, the diblock and 
multiblock copolymers were found to outperform statistical copolymers, and for polymers 
with a low content of cationic co-monomer (30 %), the multiblock copolymer showed 
tremendously increased selectivity for P. aeruginosa and S. epidermidis compared to its 
statistical and diblock copolymer analogues. This work highlights the remarkable effect of 
monomer distribution on both the physical properties of the materials and their interaction 
with biological systems. Due to the selectivity of multiblock copolymers towards certain 
bacterial strains, the presented materials are a promising platform for the treatment of 
infections and a valuable tool to combat antimicrobial resistance. 
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2.1 Introduction 
 
As an increasing number of studies emphasise the alarming situation concerning life-
threatening infectious diseases caused by antibiotic resistant bacteria,1-3 health organizations 
urge the discovery of novel antibiotics.4-6 The development of antimicrobial resistance (AMR) 
is partly due to the narrow range of available antibiotics which have reached their limitations 
in infection treatment because of their high target specificity.7 In such context, antimicrobial 
peptides (AMPs) have recently attracted interest as they were shown to target bacterial 
membranes instead of specific ligands.8-9 These peptides have an amphipathic structure which 
can adopt a facially amphiphilic arrangement with hydrophobic groups on one side and 
cationic moieties on the other side of the molecule.8 Although the precise mechanism of their 
toxicity towards bacterial is still under investigation, the cationic groups of the AMPs are 
thought to bind to the negatively charged phospholipids present on bacterial membranes via 
electrostatic interactions, upon which the hydrophobic functionalities induce membrane 
disruption, hence inducing cell death.8 Due to the less anionic surface of mammalian cells, 
AMPs preferentially interact with bacterial membranes. Despite their selectivity, AMPs can 
be relatively toxic towards mammalian cells.10-11 Furthermore, their isolation or production on 
a large scale is expensive and they showed limited pharmacokinetic stability.12 In order to 
overcome these issues, a wide range of synthetic mimics have been developed in recent years 
from oligomers to polymers using different methodologies.13 The key structural parameters 
which were found to affect the antimicrobial activity of polymers were the balance of cationic 
to hydrophobic moieties, the nature of the charge, as well as the molar mass of the polymer.14-
25 Current research focuses on reducing the toxicity of synthetic mimics of antimicrobial 
peptides (SMAMPs) against mammalian cells, and more interestingly towards red blood cells 
(RBCs), by investigating new structural parameters.26-28  
 
The activity of some AMPs is highly dependent on their structural organisation, and 
mimicking their quaternary structure using polymers by self-assembly into nano-sized objects, 
is a substantial challenge which could potentially improve the performance of SMAMPs.8, 29-
30 As mentioned in the previous chapter, Yao et al. studied the influence of the morphology of 
cationic nano-objects on antimicrobial activity, using self-assembled diblock copolymer 
comprised of polyDMAEMA and a hydrophobic methacrylate-derived block bearing 
triethoxysilyl pendant groups.28 Interestingly, spherical, cylindrical and sheet-like assemblies 
had similar potency towards bacteria after cross-linking. A different study using PEGylated 
cationic nanoparticles based on a diblock copolymer of PEG and a cationic polypeptide looked 
into the influence of the length of the PEG block. A clear reduction in both antimicrobial and 
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haemolytic activity of the nanoparticles was observed with a long PEG block (5000 g.mol-
1).31-32 However, the effect of the morphology of cationic nanoparticles on the toxicity against 
mammalian cells was not addressed in those studies.  
 
Intramolecular interactions of SMAMPs have been studied to a greater extent, since the 
helical structure of certain AMPs was thought to be responsible for their activity. However, it 
was demonstrated that this structural feature was not required for SMAMPs to exhibit 
antimicrobial activity. A flexible polymeric backbone was sufficient for the polymers to adopt 
a facially amphiphilic conformation which can induce bacterial membrane disruption, 
according to Mowery and co-workers.21 The influence of polymer conformation on the 
potency of SMAMPs was highlighted with the study of single-chain nanoparticles (SCNPs). 
Nguyen et al. reported a high antimicrobial activity of SCNPs obtained from statistical 
copolymers of PEGacrylates with a primary amine functionalised acrylamide and an acrylate 
bearing a hydrophobic group (the hydrophobicity of the acrylate was screened to optimise the 
antimicrobial activity of the SCNPs).33 Similarly, unimolecular aggregates with a cationic 
shell and a hydrophobic core obtained from the folding of a diblock copolymer were studied 
by Oda and co-workers.34 The diblock copolymer exhibited reduced haemolytic activity 
compared to the statistical copolymer, which did not aggregate in solution, but increased 
haemagglutination. These results demonstrate the effect of the conformation of single 
polymeric chains on the interactions with bacterial and mammalian cells. 
 
The effect of monomer sequence on the biological properties of SMAMPs was 
investigated using poly(DMAEMA-co-BMA) by comparing a diblock copolymer with its 
statistical counterpart.35 The antimicrobial activity was similar for both structures, but the 
haemolytic activity was decreased for the diblock copolymer. Similar observations were 
reported using gradient and diblock cationic nylon-3 copolymers: haemolytic activity was 
decreased with the diblock copolymer whilst the antimicrobial properties were unchanged.36 
As the micellisation of these systems were not analysed, the difference in haemolytic activity 
could either be attributed to the formation of self-assemblies or to the segregation of the 
cationic and hydrophobic functionalities of SMAMPs. Monomer sequence not only affects the 
intermolecular interactions of SMAMPs i.e. self-assembly, but also their intramolecular 
interactions resulting in self-folding.37-38 As previously discussed, inter- and intramolecular 
assemblies of cationic polymers seem to have an important effect on their antimicrobial 
activity and haemocompatibility, but beyond diblock and gradient copolymers, SMAMPs with 
controlled monomer sequences have yet to be investigated.  
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In this context, multiblock copolymers can provide an intermediate degree of functional 
segregation somewhere in between diblock and statistical copolymers.39 Indeed, by varying 
the number of discreet functional blocks while (maintaining an overall composition), and 
thereby the length of cationic and hydrophobic domains within the polymer chain, a structure-
activity relationship in terms of their antimicrobial activity/selectivity could potentially be 
established. The synthesis of well-defined multiblock copolymers has been reported via living 
radical polymerisation (LRP)40-41 techniques, namely Cu(0)-mediated radical 
polymerisation42-43 and reversible addition-fragmentation chain transfer (RAFT)44-45  
polymerisation. The latter was shown to be a versatile and robust technique, compatible with 
a wide range of monomers and solvent systems to obtain polymers with narrow molar mass 
distributions.40-41 Furthermore, careful optimisation of the reaction conditions allows for the 
preparation of multiblock copolymers using a one-pot sequential polymerisation approach.46 
Although the process is indeed more complicated than that required to synthesise diblock or 
statistical copolymers, multiblock copolymers are still more suitable for scale-up than AMPs, 
as recently demonstrated via RAFT polymerisation in emulsion or in tubular reactors.47-49  
 
This chapter describes the design and synthesis of poly(aminoethyl acrylamide)-co-
poly(N-isopropylacrylamide) copolymers containing different molar ratios of primary amine 
functionality (30, 50 and 70 %) and monomer distributions (statistical, multiblock and diblock 
copolymers) via RAFT polymerisation. The influence of AEAM content and monomer 
sequence on the biological activity was assessed, through consideration of the different 
physico-chemical properties of the cationic polymers. The antimicrobial activity of the 
polymers against Gram-negative and Gram-positive bacterial strains were evaluated, followed 
by the study of their compatibility towards mammalian cells (erythrocytes, fibroblasts and 
colorectal epithelial cells). The selectivity of the ammonium SMAMPs could then be 
established, following which an ideal charge content and monomer distribution can be selected 
within the library with which to direct further studies. 
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2.2 Results and discussion 
 
2.2.1 Design and synthesis of SMAMPs 
 
 In order to study the effect of monomer distribution on the biological properties of 
SMAMPs, a library of ammonium polymers were synthesised via RAFT polymerisation. 
Acrylamides were chosen as a monomer family for this study due to their high rate constant 
of propagation (kp) and their limited susceptibility to degradation, allowing the synthesis of 
multiblock copolymers in a straightforward manner.45, 50 The hydrophobic monomer which 
was selected for the synthesis of SMAMPs was N-isopropylacrylamide (NIPAM) as it bears 
the same pendant functionality as leucine. Furthermore, its hydrophobicity is relatively low 
compared to monomers which have been used in previous studies, and therefore should lead 
to polymers with a high biocompatibility and reduce the chances of inducing self-assembly in 
aqueous solution, hence the fundamental influence of monomer distribution may be 
assessed.51-53 The cationic monomer chosen for the design of antimicrobial polymers was an 
acrylamide-based lysine mimic: amino-ethylacrylamide (AEAM). Although AEAM could be 
polymerised in a buffer to avoid aminolysis of the trithiocarbonate group of the CTA during 
the polymerisation process, the solution polymerisation of NIPAM in aqueous conditions 
would be challenging as it is a thermo-responsive monomer.54-55 In order to conduct the 
polymerisation in an organic solvent, the Boc-protected equivalent of AEAM (Boc-AEAM) 
was polymerised, which also facilitated the characterisation of the polymers (Figures 2.14-
2.17).  
 
 As mentioned previously, the balance between cationic and hydrophobic character is 
a key parameter for the optimisation of the properties of SMAMPs, a range of AEAM content 
was screened (0, 30, 50, 70 and 100 mol %). In order to study the influence of monomer 
sequence on antimicrobial activity and toxicity against mammalian cells, monomer 
distribution was varied from statistical, multiblock and diblock copolymers for the copolymers 
with 30, 50 and 70 % of AEAM (Scheme 2.1). The SMAMPs were labelled according to their 
type of charge (A for ammonium), degree of segregation (H, S, M and D for homopolymer, 
statistical, multiblock and diblock copolymers, respectively) and their content of cationic co-
monomer in molar % (0, 30, 50, 70 and 100) with protected polymers labelled Boc.  
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Scheme 2.1 - Schematic representation of structure, composition and monomer sequence 
of synthesised polymers. 
 
As a loss in antimicrobial activity was shown with polymers of over 50000 g.mol-1, 
the targeted molar mass of the SMAMPs had to be chosen carefully.56 In this study, 
copolymers with a final molar mass of around 10000 g.mol-1 was targeted, setting the degree 
of polymerisation (DP) to 100, as the maximum number of blocks increases with the length 
of the polymer chain. Since monomer to initiator ratio is related to conversion, and that CTA 
to initiator ratio affects livingness, it follows that higher livingness is obtained when a lower 
DP is targeted, meaning more chain extensions may be successfully performed. The shortest 
block length that was targeted was a DP of 10, since it has been shown that, for a polyNAM 
multiblock copolymer, a significant number of living chains would fail to contain the total 
number of blocks, by targeting DPs below 6, considering the molar mass distribution of well-
defined polymers.57 By taking this limitation into consideration, multiblock copolymers were 
designed with the highest number of blocks compatible for each composition. Therefore, 
seven blocks were targeted for polymers with 30 and 70 % BocAEAM content, (A-M30Boc 
and A-M70Boc, respectively) and ten blocks for A-M50Boc which contained 50 % of 
BocAEAM, each in an alternating fashion (Table 2.1). From the design of these polymers, 
modifying the structure from statistical to multiblock and diblock copolymer should 
demonstrate the effect of the segregation of cationic and hydrophobic functionalities, whilst 
maintaining the overall polymer length and chemical composition. 
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Table 2.1 - Library of synthesised Boc-protected polymers. 
 
BocAEAM 
content (%) 
30 50 70 
Statistical 
copolymers 
NIPAM70-s- BocAEAM30 NIPAM50-s- BocAEAM50 NIPAM30-s- BocAEAM70 
Diblock 
copolymers 
NIPAM70-b- BocAEAM30 NIPAM50-b- BocAEAM50 NIPAM30-b- BocAEAM70 
Multiblock 
copolymers 
NIPAM18-b- BocAEAM10-b-
NIPAM18-b- BocAEAM10-b-
NIPAM18-b- BocAEAM10-b-
NIPAM18 
NIPAM10-b- BocAEAM10-b-
NIPAM10-b-BocAEAM10-b-
NIPAM10-b-BocAEAM10-b-
NIPAM10-b- BocAEAM10-b-
NIPAM10-b- BocAEAM10 
BocAEAM18-b-NIPAM10-b- 
BocAEAM18-b-NIPAM10-b- 
BocAEAM18-b-NIPAM10-b- 
BocAEAM18 
 
 
(Propanoic acid)yl butyl trithiocarbonate (PABTC) was chosen as the chain transfer 
agent (CTA) since it permits the control of the polymerisation of acrylamides and its alkyl 
chain is relatively short compared to the overall length of the polymer chain, hence allows to 
better study the influence of monomer sequence (Figures 2.18 and 2.19).46 Additionally, a 
carboxylic acid end-group on SMAMPs has been shown previously to exhibit lower 
haemotoxicity .58 The solvent system which was chosen for the polymerisations was a mixture 
of 1,4-dioxane and water (8/2). Dioxane solubilised the monomers as well as the polymers, 
while the presence of water permitted the use of VA-044, a water-soluble initiator with a high 
decomposition rate coefficient (kd) and a 10 hour half-life of 44 °C (in water), and has been 
shown to increase the kp of acrylamide monomers (Tables 2.8-2.12).
59 Optimisation of 
monomer and initiator concentrations enabled quantitative monomer conversion to be 
achieved after each block extension, confirmed by 1H NMR spectroscopy (Figures 2.20-2.25), 
to obtain the desired (protected) statistical, multiblock and diblock copolymers in a one-pot 
sequential polymerisation process. SEC traces exhibited a clear shift to higher molar mass 
with each block extension, and molar mass distribution remained relatively narrow throughout 
(Đ ≤ 1.38) for all copolymers (Table 2.2, 2.13-2.16, Figures 2.1A, 2.26-2.28). However, 
populations at both low and high molar mass was observed on the SEC chromatograms of 
multiblock copolymers, particularly after the 4th chain extension (Figures 2.1A and 2.28). The 
tail at low molar mass indicate the presence of initiator derived chains, whereas the shoulder 
at high molar mass can be attributed to the accumulation of dead polymer chains (which have 
terminated by combination). These defects can be related to the decrease in the livingness of 
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the polymer chains after each chain extension, due to the addition of initiator. Furthermore, 
the discrepancy between the experimental molar mass values and the theoretical values can be 
attributed to differences in hydrodynamic volume between the polymers and the PMMA 
standards used to calibrate the SEC system.  
 
A kinetic study of the statistical copolymer A-S30Boc was undertaken using 1H NMR 
and high performance liquid chromatography (HPLC) to determine the rate of incorporation 
for each monomer in the polymer, as the vinyl peaks of NIPAM and BocAEAM overlap in 1H 
NMR spectra. The ratio of the concentrations of unconsumed NIPAM to BocAEAM against 
the overall monomer conversion did not follow a pyramidal or inverse-pyramidal trend, hence 
the monomers should be evenly distributed in the statistical copolymers (Figure 2.29). 
 
 
Table 2.2  - Characterisation data of Boc-protected polymers. 
 
 
Sample  
BocAEAM 
content (%) 
M
n,th
[a]  
(g mol-1) 
M
n,SEC
[b] 
(g mol-1) 
Đ[b] 
Homopolymer 
H0 0 12000 14400 1.10 
A-H100Boc 100 21200 21000 1.11 
Statistical 
A-S30Boc 32 15400 17900 1.09 
A-S50Boc 50 17400 18800 1.09 
A-S70Boc 70 19600 21600 1.12 
Multiblock 
A-M30Boc 30 13800 15800 1.29 
A-M50Boc 50 16600 17100 1.38 
A-M70Boc 70 19400 17400 1.34 
Diblock 
A-D30Boc 30 15000 16200 1.10 
A-D50Boc 49 14900 17500 1.17 
A-D70Boc 71 18500 19000 1.20 
 
[a] Theoretical molar mass of the protected polymers calculated from equation 2.5. 
[b] Determined for the protected polymers by SEC/RI in DMF using PMMA as molecular weight standards. 
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The polymers were then quantitatively deprotected using hydrochloric acid, which 
was confirmed by the disappearance of the signal (1.3 ppm) associated with the Boc-protecting 
groups in 1H NMR spectra as well as by the shift of the CH2 (from 3.3 to 3.1 ppm) adjacent to 
the amine pendant groups (Figures 2.1B, 2.30 and 2.31).60  
 
 
Figure 2.1 - DMF-SEC chromatograms for successive chain extensions of A-M50
Boc
 (A) 
and 
1
H NMR spectra of SMAMPs on the example of homopolymers and multiblock 
copolymers before and after deprotection in DMSO-d6 and D2O, respectively (B). 
 
2.2.2 Physico-chemical properties of SMAMPs 
 
As electrostatic interactions play a major role in the binding of SMAMPs to bacterial 
membranes, the polymers should possess net positive charge in a physiological environment. 
The protonation of the primary amines was investigated using potentiometric titration. By 
comparing the behaviour of statistical, multiblock and diblock copolymers of similar AEAM 
content (A-S50, AM-50 and A-D50), the effect of segregation of functionalities on the pKa of 
the primary amine pendant groups can be evaluated. The pKa of the primary amines of the 
cationic homopolymer A-H100 (Figure 2.2) was of 8.1, which was significantly reduced 
compared to the pKa of the amine from the lysine side chain at 8.9.
61 Indeed, the deprotonation 
of the primary amines of A-H100 is favoured by the suppression of electrostatic repulsion 
between amine functionalities in close proximity.62 The three copolymers had similar pKa 
values compared to A-H100: 7.9 for both A-S50 and A-M50, 7.8 for A-D50. As the majority 
of the primary amines are protonated at physiological pH, the library of ammonium 
copolymers would be positively charged during biological assays. However, the titration 
curves of A-D50 and A-M50 were steeper than that of A-S50 (Figure 2.2). Therefore, A-S50 
would have a higher buffering capacity than its diblock and multiblock copolymer 
counterparts. Indeed, a study using poly(ethyleneimine)s suggested that once the pKa of the 
secondary amine was reached, the polymer chain would avoid having neighbouring positive 
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charges by protonating every second site, until the pH was decreased even further.63 In the 
case of polyAEAM-co-NIPAM, the deprotonation of amine functionalities which are in close 
proximity to one another would be promoted by electrostatic repulsion. Therefore, it is 
postulated that deprotonation is favoured in the diblock and multiblock copolymers (A-M50 
and A-D50), for which primary amines are comprised in segments, compared to the statistical 
copolymer, explaining the results obtained from potentiometric titration. 
 
Figure 2.2 - Titration curves of acidified solutions of the cationic polymers A-H100, A-
S50, A-D50 and A-M50 (concentration of around 0.5 mg.mL
-1
) neutralised with sodium 
hydroxide (0.2 M). 
 
While positively charged groups are necessary for the antimicrobial activity of 
SMAMPs, the balance between positive charge and hydrophobicity has a significant impact 
on their selectivity.13-14 For this reason, the effect of monomer distribution on the overall 
hydrophobicity of SMAMPs was assessed using reverse-phase HPLC (RP-HPLC). Non 
water-soluble diblock and statistical copolymers have previously been studied by RP-HPLC, 
showing that for a similar chemical composition, the elution time varied between the two 
structures.64 By monitoring the elution profiles of the ammonium polymer library the 
hydrophobicity of the polymers can be assessed, with longer elution time indicating a more 
hydrophobic polymer in a reverse-phase system (Figures 2.3 and 2.4). 
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Figure 2.3 - Reverse-phase HPLC chromatograms of ammonium polymer library 
organised by monomer distribution: statistical (A), diblock (B) and multiblock (C) 
copolymers. The runs were performed with a gradient of 1 to 95 % ACN over 50 minutes at 
37 °C. 
 
For each copolymer architecture (statistical, multiblock or diblock), the elution time 
decreased with increasing AEAM content (Figure 2.3). This is to be expected since the 
hydrophilicity of the polymers would increase substantially when the molar content of AEAM 
is increased. Measurements were also conducted at 20 and 60 °C to assess if it would modify 
the elution profile of polyNIPAM, which is known to have a low LCST in water. No 
significant difference was observed in the elution profile of the homopolymer, which could be 
explained by the presence of ACN in the eluent mixture or to the concentration of the sample 
in the column (Figure 2.32).65  
 
 
Figure 2.4 - Reverse-phase HPLC chromatograms of ammonium polymer library 
organised by molar content of AEAM: 30 % (A), 50 % (B) and 70 % (C) charge content. 
The runs were performed with a gradient of 1 to 95 % ACN over 50 minutes at 37 °C. 
Additionally, for similar AEAM content, the elution profile varied with monomer 
distribution, indicating the diblock copolymers were the most hydrophobic, followed by 
multiblock copolymers and finally, the statistical counterparts (Figure 2.4). Interestingly, this 
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trend was observed for all three compositions (30, 50 and 70 % AEAM content). Since the 
multiblock copolymers represent an intermediate level of monomer distribution between 
diblock and statistical copolymers, it is unsurprising that their elution profiles lie between their 
counterparts: the more segregated the functionalities, the higher the overall hydrophobicity of 
the copolymer (Figure 2.5). This observation demonstrates that the hydrophobicity of the 
polymers do not only depend on their composition but also on the monomer sequence, which 
could have an impact on their biological properties.  
 
Figure 2.5 –Percentage of acetonitrile corresponding to the elution time of SMAMPs by 
RP-HPLC depending on the composition and the architecture (▲ Diblock copolymers, ● 
Multiblock copolymers, ■ Statistical copolymers). 
 
As the amphiphilic properties of the polymers might induce self-assembly, dynamic 
light scattering (DLS) was used to investigate the behaviour of the polymers in phosphate 
buffer saline (PBS) at 37 °C (Figure 2.33, Table 2.17).66 Population under 10 nm in size was 
observed by DLS for all the cationic copolymers at 1 mg.mL-1, indicating single polymer 
chains, whereas aggregation was observed with the polyNIPAM homopolymer H0 (580 nm). 
Although the domains of statistical and multiblock copolymers might be too small to induce 
any self-assembly, the absence of micelles in solutions of diblock copolymers might be related 
to the concentration. This result further supports that the variation in hydrophobicity 
depending on monomer sequence is not associated with intermolecular interactions. 
Furthermore, any variation in biological activity with monomer distribution can be directly 
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linked to the segregation level of the hydrophobic and cationic functionalities, and not with 
the self-assemblies.  
2.2.3 Dye leakage study 
 
Before investigating the antimicrobial activity, the ability of ammonium SMAMPs to 
disrupt bacterial membranes was examined using a dye leakage assay. Liposomes comprised 
of 1,2 dioleoyl-sn-glycero-3-phosphoethanolamine/1,2 dioleoyl-sn-glycero-3-phospho-rac(1-
glycerol) (4:1) (PE/PG) or cardiolipin, mimicking Gram-negative and Gram-positive bacteria, 
respectively, were loaded with calcein, a self-quenching fluorescent dye.56 Upon dye leakage, 
the fluorescence level of the vesicle solution increases, indicating membrane disruption. All 
polymers, except for H0, induced an increase in fluorescence intensity against both Gram-
positive (Figure 2.34) and Gram-negative (Figures 2.6 and 2.35) bacteria models. In most 
cases, the fluorescence intensity of the vesicle solution increased with increasing charge 
content of SMAMPs, which demonstrates the importance of their electrostatic interactions in 
membrane disruption. Statistical, multiblock and diblock copolymers exhibited similar dye 
leakage profiles (Figures 2.6, 2.34 and 2.35). Although this assay is not quantitative, as 
demonstrated by Tew et al., it indicates that the SMAMPs are membrane active, a property 
which seems to be independent of the monomer distribution.56  
 
Figure 2.6 - Calcein leakage study on Gram-negative bacterial model (using liposomes 
comprised of a mixture of PE/PG (4:1)) with multiblock copolymers (A-M30, A-M50 and 
A-M70) and the homopolymers H0 and A-H100. Normalised fluorescence intensity at 
   Chapter 2 
 
   Page | 41 
 
λem=537 nm with λex=492 nm. The sample was added at 30 s time point and vesicles were 
lysed by addition of Triton X at 9 min. 
 
2.2.4 Antibacterial susceptibility assays 
 
Growth inhibition was studied using two strains of Gram-negative bacteria: 
Escherichia coli (E. coli) and Pseudomonas aeruginosa (P. aeruginosa); and two Gram-
positive strains: Staphylococcus aureus (S. aureus) and Staphylococcus epidermidis (S. 
epidermidis). The minimum inhibitory concentration (MIC) against each strain, the minimum 
concentration at which no bacterial growth was observed, was determined for each polymer 
as a measure of their antimicrobial activity (Table 2.3 and Figure 2.36). For statistical and 
diblock copolymers, the antimicrobial activity against all four strains increased with AEAM 
content as shown on Table 2.3, which is consistent with previous studies.17 As demonstrated 
with the calcein leakage assay, an increased charge content promotes interaction of the 
polymers with bacterial membrane. However, for multiblock copolymers no clear trend with 
AEAM content could be established. 
The influence of monomer distribution on antimicrobial activity was first assessed for 
the set of polymers with 30 % AEAM. A drastic reduction in MIC was observed moving from 
the statistical copolymer (A-S30), which was inactive towards most bacterial strains tested 
(MIC > 1024 μg.mL-1, except against S. epidermidis with MIC=32 µg.mL-1), to the multiblock 
and diblock copolymers (A-D30 and A-M30), which had MIC values as low as 4 µg.mL-1. 
Activity against the Gram-negative P. aeruginosa, was particularly affected by monomer 
distribution, with MICs decreasing from over 1000 (A-S30) to 32 and 8 µg.mL-1 for A-D30 
and A-M30, respectively (Table 2.3), which could be due to the difference in the composition 
of the bacterial cell envelope.67 Indeed, Gram-negative bacteria possess an outer membrane 
(OM), which is a lipid bilayer comprised of an outer leaflet of lipopolysaccharides and an 
inner leaflet of phospholipids.68 As lipopolysaccharides have long saturated acyl chains 
(leading to an increased membrane stiffness) combined with hydrophilic saccharides, they 
provide Gram-negative bacteria with an additional protective barrier, compared to Gram-
positive bacteria. The multiblock copolymer was shown to have an intermediate 
hydrophobicity between that of its statistical and diblock copolymer counterparts, hence the 
difference in its antimicrobial activity seems more likely to be related to the presence of 
segments, rather than to the difference in hydrophobicity of the overall copolymer. Indeed, the 
cationic domains in the multiblock structure might lead to stronger interactions of SMAMPs 
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with the hydrophilic outer layer of the OM, compared its statistical copolymer counterpart, 
therefore enhancing OM permeabilisation. 
Table 2.3 – Comparison of the antimicrobial activity of the ammonium SMAMPs. MIC 
values determined against Gram-negative bacteria E.coli and P. aeruginosa and Gram-
positive bacteria S. aureus and S. epidermidis. 
 
Sample  
MIC[a] (μg.mL-1) 
E. coli P. aeruginosa S. aureus S. epidermidis 
H0 > 1024 > 1024 > 1024 > 1024 
A-H100 4 4 4 32 
A-S30 > 1024 > 1024 > 1024 32 
A-S50 64 128 8 2 
A-S70 64 64 4 2 
A-M30 128 8 64 4 
A-M50 1024 64 32 8 
A-M70 1024 32 4 4 
A-D30 512 32 128 32 
A-D50 64 64 8 4 
A-D70 32 32 8 4 
 
 [a] MIC is the minimum inhibitory concentration at which no visible bacteria growth can be observed. 
 
2.2.5 Haemocompatibility of SMAMPs  
 
Although the main requirement for SMAMPs is a high potency against bacteria, their 
toxicity towards mammalian cells has to be minimised in order to be considered as a viable 
alternative to antibiotics. Since blood is the principal vector distributing active compounds to 
cells, and that cationic compounds have been shown to exhibit a high toxicity towards red 
blood cells (RBCs), the haemocompatibility of the ammonium SMAMPs was investigated.53 
The first assay was directed towards the investigation of the lysis of the RBCs in the presence 
of the polymers, since they were shown to be membrane active in the calcein leakage studies. 
The haemolytic concentration HC10 (concentration to elicit 10 % haemolysis following 2 h 
incubation), was determined at concentrations between 2 and 1024 μg.mL-1 in PBS.69 
Remarkably, only A-H100 lysed RBCs (Table 2.4, Figure 2.7), indicating that the presence of 
isopropyl groups of NIPAM is responsible for reducing the haemolytic activity of the rest of 
the polymer library.  
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Figure 2.7 – Haemolytic activity of ammonium SMAMPs. Normalised haemolysis of 
human red blood cells following incubation at 37 °C for 2 hours in PBS with ammonium 
SMAMPs with 30 (A), 50 (B) and 70% (C) charge content. 
 
To obtain a complete picture of the haemocompatibility of the polymers, 
haemagglutination, which is not necessarily related to haemolytic activity, was studied as well 
since positively charged polymers can interact with negatively charged sialic acid groups at 
the surface of RBCs, leading to intercellular binding.19 The haemagglutination concentration 
cH, which is the lowest concentration at which agglutination of RBCs is induced, was 
determined (Tables 2.4 and 2.5).34 In line with the screening of cationic polymethacrylates of 
varying charge content by Locock and co-workers, A-H100 induced haemagglutination at low 
concentration (16 µg.mL-1), whereas no aggregates were observed for H0, which further 
indicates the haemocompatibility of polyNIPAM.19 Interestingly, the three diblock 
copolymers (A-D30, A-D50 and A-D70) and A-M30, had cH values of over 1000 μg.mL
-1, 
whilst their statistical copolymer counterparts induced haemagglutination from 32 μg.mL-1. 
Therefore, with similar AEAM content, the segregation of cationic and hydrophobic 
functionalities seems to affect the aggregation of RBCs. These observations could be 
explained by the cross-linking of RBCs being more efficient when the cationic moieties are 
distributed along the full length of the chain, as opposed to when charges are located on 
specific domains of the macromolecule. Although A-M30 has 3 cationic segments separated 
by polyNIPAM blocks, it did not induce any haemagglutination, whereas A-M50 and A-M70 
did. This result could be explained by the fact that A-M30 is the only multiblock copolymer 
without cationic functionalities at the end of the polymer chain. Furthermore, the four cationic 
copolymers which did not induce any haemagglutination (A-D30, A-D50, A-D70 and A-
M30), are also the most hydrophobic SMAMPs, according to HPLC data (Figure 2.5). Another 
hypothesis would be that the aggregation of RBCs could be prevented by maintaining a certain 
level of hydrophobicity. In any case, monomer distribution appears a key structural parameter 
affecting the haemocompatibility of SMAMPs.  
 
   Chapter 2 
 
   Page | 44 
 
Table 2.4 – SMAMP-induced erythrocytes aggregation. Observation of haemagglutination 
of human red blood cells following incubation with ammonium SMAMPs in PBS for 2 hours 
at 37 °C. 
 sample 
/concentration 
(μg.mL-1) 
1024 512 256 128 64 32 16 8 4 2 
H0 -  -  -  -  -  -  -  -  -  -  
A-H100 +++ +++ +++ +++ +++ ++ + - - - 
A-S30 ++ ++ ++ ++ + + - - - - 
A-S50 +++ +++ +++ ++ + + - - - - 
A-S70 +++ +++ +++ ++ ++ + - - - - 
A-M30 - - - - - - - - - - 
A-M50 +++ +++ ++ ++ ++ + - - - - 
A-M70 +++ +++ +++ +++ ++ + - - - - 
A-D30 - - - - - - - - - - 
A-D50 - - - - - - - - - - 
A-D70 - - - - - - - - - - 
 
Haemagglutination strength: +++ strong; ++ moderate; + weak; - none. 
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Table 2.5. Comparison of the haemocompatibility of the ammonium SMAMPs. HC10, cH 
and haemocompatibility concentration across the SMAMPs of various composition and 
structure determined by haemolysis and haemagglutination assay.  
Sample  
HC
10
[a] 
(μg.mL-1) 
c
 H
 [b] 
(μg.mL-1) 
Haemocompatibility 
concentration[c] 
(μg.mL-1) 
H0 > 1024 > 1024 > 1024 
A-H100 512 16 16 
A-S30 > 1024 32 32 
A-S50 > 1024 32 32 
A-S70 > 1024 32 32 
A-M30 > 1024 > 1024 > 1024 
A-M50 > 1024 32 32 
A-M70 > 1024 32 32 
A-D30 > 1024 > 1024 > 1024 
A-D50 > 1024 > 1024 > 1024 
A-D70 > 1024 > 1024 > 1024 
 
[a] HC10 is the minimum concentration at which at least 10 % of the maximum lysis was observed following 2 h 
incubation. 
[b] cH is the lowest concentration at which the polymers induce aggregation of RBCs. 
[c] The haemocompatibility concentration was determined as the lowest value between HC10 and cH. All polymers 
were non-haemolytic within the range of concentrations tested (except H100, for which HC10 was still higher than 
cH), hence the haemocompatibility concentration was identical to cH for all present SMAMPs. 
 
In order to simultaneously compare the haemocompatibility and the antimicrobial 
activity for the library of SMAMPs, a selectivity value was determined for each bacterial strain 
using the ratio between the haemocompatibility concentration (which is the lowest value of 
HC10 and cH, Table 2.5) and the MIC against the given strain (Table 2.3). This value is a 
powerful tool to measure the potential of SMAMPs, as only those with a pronounced activity 
against bacteria and no effect on RBCs, would exhibit high selectivity values.20 As none of 
the SMAMPs were haemolytic, the haemocompatibility concentration was identical to the 
haemagglutination concentration, hence the latter was used to calculate the selectivity for 
bacteria over RBCs (Equation 2.1, Table 2.6).  
𝑆𝑒𝑙𝑒𝑐𝑡𝑖𝑣𝑖𝑡𝑦 =
𝑐𝐻
𝑀𝐼𝐶
 
Equation 2.1 – Equation for the selectivity against RBCs for a specific bacterial strain. 
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The highest selectivity values against all four bacterial strains over RBCs were 
obtained with the diblocks (A-D30, A-D50, A-D70) and A-M30. Additionally, monomer 
distribution was shown to affect the selectivity of the polymers: at 30 % AEAM content, A-
M30 was found to be the most selective, followed by A-D30, then A-S30 (for example the 
values for P. aeruginosa were 0.03, 32 and 128, respectively). 
 
Table 2.6 - Selectivity values for E. coli, P. aeruginosa, S. aureus and S. epidermidis over 
RBCs. 
Sample  
Selectivity[a] 
E. coli P. aeruginosa S. aureus S. epidermidis 
H0 > 1 > 1 > 1 > 1 
A-H100 4 4 4 0.5 
A-S30 0.03 0.03 0.03 1 
A-S50 0.5 0.25 4 16 
A-S70 0.5 0.5 8 16 
A-M30 > 8 > 128 > 16 > 256 
A-M50 0.03 0.5 1 4 
A-M70 0.03 1 8 8 
A-D30 > 2 > 32 > 8 > 32 
A-D50 > 16 > 16 > 128 > 256 
A-D70 > 32 > 32 > 128 > 256 
 
[a] Selectivity was determined using equation 2.1. 
 
Additionally, the selectivity of the ammonium SMAMPs towards bacteria over RBCs 
was illustrated by comparing the MIC of a particular bacterial strain against the 
haemocompatibility concentration. Figure 2.8 depicts the selectivity of the SMAMPs by 
dividing them into categories with the most inactive and haemotoxic polymers in the bottom-
right corner (highlighted in red; IV), most potent and haemocompatible species in the top-left 
corner (I), and two yellow intermediate zones in the top-right (II) and bottom-left (III) corner 
being the inactive but haemocompatible polymers and active but haemotoxic polymers, 
respectively. For statistical and diblock copolymers, increasing AEAM content improved the 
selectivity towards the four species of bacteria studied. The most selective polymers against 
all four strains over RBCs appear to be the diblock copolymers (A-D30, A-D50 and A-D70) 
and the multiblock copolymer A-M30, which is also highlighted with the selectivity values 
(Table 2.6). The most noteworthy variation in selectivity with monomer distribution was 
observed for SMAMPs with an AEAM content of 30 %: A-S30 was haemotoxic and non-
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active towards bacteria except against S. epidermidis (red zone IV), whereas A-M30 and A-
D30 were haemocompatible and highly active against all four strains (green zone I). This trend 
was also illustrated with the selectivity values. For SMAMPs with 50 and 70 % AEAM 
content, the diblock had a higher selectivity for bacteria over RBCs compared to its statistical 
and multiblock copolymer counterparts due to an increased haemocompatibility. Altering the 
monomer distribution of SMAMPs, whilst maintaining an overall chemical composition, can 
significantly influence the selectivity for bacteria over RBCs. 
 
 
Figure 2.8 - Selectivity of the SMAMPs for Gram-negative and Gram-positive bacteria 
over RBCs. Haemocompatibility concentration against the MIC for E. coli (A), P. aeruginosa 
(B), S. aureus (C) and S. epidermidis (D) over RBCs. 
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2.2.6 Biocompatibility of SMAMPs 
 
Potential applications for SMAMPs include their use as wound dressings or as oral 
antibiotics. As such, murine embryonic fibroblasts (NIH 3T3) and human colorectal epithelial 
cells (Caco-2) were pertinent in vitro models to determine the biocompatibility of the 
SMAMPs. NIH 3T3 are one of the most commonly used fibroblast cell lines, and is involved 
in the synthesis of extracellular matrix, hence playing a critical role in wound healing. 
Additionally, Caco-2 cells are well characterised colorectal cells that can be used as a model 
for intestinal absorption.70  
To determine the toxicity of SMAMPs towards these mammalian cells, NIH 3T3 and 
Caco-2 cells were incubated with polymer concentrations ranging from 32 to 1024 μg.mL-1 
for 3 days. As expected, H0 displayed no toxicity at any of the concentrations used, while A-
H100 showed pronounced interference with cell viability (Figure 2.9) for both cell lines.  
 
Figure 2.9 - Cytotoxicity of ammonium SMAMPs. Viability of 3T3 cells incubated for 72 
hours in presence of statistical (1A), multiblock (1B) and diblock (1C) SMAMPs; and of Caco-
2 cells incubated for 72 hours in presence of statistical (2A), multiblock (2B) and diblock (2C) 
copolymers, using XTT assay.  
 
The inhibitory concentration (IC50) values, which is the polymer concentration at 
which cell viability is inhibited by 50 %, were calculated for NIH 3T3 and Caco-2 using the 
toxicity curves from Figure 2.9 (Table 2.7, Figure 2.10). As expected, the toxicity towards 
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both cell lines increased with content of cationic functionalities, which is similar to the trend 
observed with haemotoxicity. These results could be attributed to an enhancement of the 
interactions of the polymers with the cell membrane when their charge content is increased. 
For both cell lines, the IC50 value was similar for the statistical, multiblock and diblock 
copolymers of 50 and 70 % AEAM content (Figure 2.10). Monomer distribution did not 
appear to significantly influence the toxicity of the SMAMPs towards fibroblasts and 
epithelial cells, except for the SMAMPs with 30 % AEAM content, as their IC50 towards Caco-
2 cells decreased with segregation of functionalities from A-S30, to A-M30 and A-D30 (> 
1024, 310 and 180 μg.mL-1, respectively).  
 
Figure 2.10 – Comparison of IC50 values for ammonium SMAMPs. IC50 of the SMAMPs 
for NIH 3T3 (A) and Caco-2 cells (B) after a 72-hour incubation at 37˚C in presence of the 
cationic polymers, using XTT assay. 
 
Additionally, the SMAMPs were more toxic towards Caco-2 cells than NIH 3T3 cells, 
which might be due to increased uptake by colorectal cells.71 These cytotoxicity results seem 
to indicate the potential application of the SMAMPs lies in the direction of skin wound 
treatment rather than oral use. Therefore, the following discussions relative to cytotoxicity 
will be based on the results obtained with NIH 3T3 cells. Similarly to the selectivity of bacteria 
over RBCs which was previously introduced, the therapeutic index (TI), which was obtained 
from the ratio of the IC50 for the mammalian cells to the MIC for each bacterial strain, 
indicated the relative toxicity of a SMAMP towards bacteria in comparison to mammalian 
cells (Equation 2.2, Table 2.7).72 
𝑇𝐼 =
𝐼𝐶50
𝑀𝐼𝐶
 
Equation 2.2 – Equation for the therapeutic index (TI) with a cell line for a specific 
bacteria species. 
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Interestingly, the TI of A-M30 over 3T3 cells appeared to be the highest for the four 
bacterial strains studied: > 8, 128, 16 and 256 for E.coli, P. aeruginosa, S. aureus and S. 
epidermidis, respectively.  Therefore, the ammonium multiblock copolymer with 30 % AEAM 
content appears to be a broad spectrum SMAMP which can target both Gram-negative and 
Gram positive bacteria whilst maintaining a low toxicity towards fibroblasts (and epithelial 
cells).  
Table 2.7 - Cytotoxicity of SMAMPs. IC50 values of the SMAMPs against NIH 3T3 and 
Caco-2 cells obtained using XTT assays after incubation with the cationic polymers at 37 °C 
for 72 hours and TI of SMAMPs over 3T3 cells. 
 
Sample 
name 
IC
50
[a] (μg.mL-1) Therapeutic Index (TI) [b] 
3T3 Caco-2 
3T3 
E. coli P. aeruginosa S. aureus S. epidermidis 
H0 > 1024 > 1024 > 1 > 1 > 1 > 1 
A-H100 < 32 < 32 < 8 < 8 < 8 < 1 
A-S30 > 1024 > 1024 > 1 > 1 > 1 > 1 
A-S50 760 90 12 6 95 381 
A-S70 150 < 32 2 2 37 74 
A-M30 > 1024 310 > 8 > 128 > 16 > 256 
A-M50 320 60 0.3 5 10 40 
A-M70 50 < 32 0.4 1.5 12 12 
A-D30 > 1024 180 > 2 > 32 8 > 32 
A-D50 330 80 5 5 41 83 
A-D70 180 80 6 6 23 46 
 
[a] IC50 was determined as the concentration at which 50 % inhibition occurred. 
[b] Therapeutic index (TI) was calculated as the ratio the IC50 towards 3T3 against the MIC of the bacterial species. 
 
In parallel to the selectivity graphs for RBCs, the IC50 was compared against the MIC 
for each bacterial strain to illustrate the TI over NIH 3T3 (Figure 2.11). A-M30 appeared as 
the ideal candidate against the four strains of bacteria studied. Indeed, at 30 % AEAM content, 
the segregation of AEAM and NIPAM functionalities allowed for the improvement of the 
selectivity: A-S30 was non-toxic towards 3T3 cells combined with a poor antimicrobial 
activity, whereas A-D30 and A-M30 exhibited a low mammalian cell toxicity and a high 
potency against Gram-negative and Gram-positive bacteria. Although A-D50 and A-D70 were 
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shown to be as selective as A-M30 over RBCs, their selectivity for bacteria over NIH 3T3 was 
much lower, as displayed in Figure 2.11. 
 
 
 
Figure 2.11 - Selectivity of SMAMPs for Gram-negative and Gram-positive bacteria over 
NIH 3T3 cells. IC50 of the SAMPs with NIH 3T3 cells against their MIC for E. coli (A), P. 
aeruginosa (B), S. aureus (C) and S. epidermidis (D). 
 
The overall performance of SAMPs was analysed for each bacterial species by 
illustrating the TI for NIH 3T3 cells against the selectivity over RBCs (Figure 2.12 only 
displays the samples with a value of at least 1 for both parameters, whereas Figure 2.37 
includes all data). The most promising polymers are located in the top-right green corner 
which represents the SMAMPs with selectivity and TI values of 10 and above. The most 
outstanding candidate from these graphs was A-M30, as it displayed the highest values 
regarding selectivity for both P. aeruginosa and S. epidermidis over 3T3 cells and RBCs.  
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Figure 2.12 - Comparison of selectivity of SMAMPs for bacteria over RBCs and NIH 
3T3 cells. TI of the SMAMPs over NIH 3T3 cells against their selectivity over RBCs for E. 
coli (A), P. aeruginosa (B), S. aureus (C) and S. epidermidis (D). 
 
Despite similar chemical composition, A-M30 outperforms A-S30 and A-D30, which 
highlights the importance of charge segregation on the overall performance of the ammonium 
SMAMPs. The multiblock copolymer did not induce erythrocyte aggregation, unlike its 
statistical copolymer counterpart, and was less toxic towards mammalian cells as compared 
to its diblock copolymer analogue. Furthermore, A-M30 displayed a high membrane activity 
against a wide range of pathogenic bacteria. It should be emphasised that the present polymers 
show a pronounced activity against Gram-negative bacteria despite the additional protection 
from their outer membrane. Therefore, the multiblock copolymer with 30 % charge content 
appeared as a promising candidate for the treatment of bacterial infections. The compatibility 
of the ammonium SMAMPs with fibroblasts renders them interesting candidates as 
antimicrobial material in skin wound healing treatments. 
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2.2.7 Bacterial resistance 
 
One of the main issues with currently used antibiotics is the ability of bacteria to 
develop resistance against them, rendering the antibiotics inactive following prolonged 
contact with the bacteria (at non-lethal doses).1 However, as previously mentioned, bacteria 
do not seem to acquire resistance against SMAMPs as easily, since the polymers are designed 
to directly target bacterial membrane. In order to demonstrate the potential of the SMAMPs 
in this study for long-term treatment of bacterial infections, the evolution of the MIC value 
against a MRSA strain (USA 300) was studied for A-S30, A-M30 and A-D30 over the course 
of 4 weeks, with exposure at a sub-MIC (1/10) concentration. The antibacterial activity did 
not vary throughout the assay (Figure 2.13) and no resistant mutants could be detected in the 
final bacterial suspension. Therefore, the development of bacterial resistance against these 
polymers is not easily acquired, and this observation is valid across the different monomer 
distributions studied (statistical, multiblock and diblock copolymers). Indeed, a similar 
mechanism of antimicrobial action based on membrane disruption for the herein presented 
SMAMPs, as supported by the dye leakage assays, would explain the retention of 
antimicrobial activity. 
 
 
Figure 2.13 - Determination of bacterial resistance for copolymers with 30 % AEAM 
content. Evolution of the MIC value of A-S30, A-M30 and A-D30 against a MRSA strain 
USA300 over the course of 4 weeks, after incubating the bacteria in presence of sub-MIC 
concentrations of SMAMPs. 
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2.3 Conclusion 
 
SMAMPs based on a cationic (AEAM) and a hydrophobic monomer (NIPAM) were 
synthesised with different AEAM content (30, 50 or 70 %) and various degrees of segregation, 
by exploiting RAFT polymerisation. NIPAM was a suitable choice of co-monomer since no 
haemolytic activity was observed for the copolymers, whilst the antimicrobial potency of the 
copolymers was maintained. From this study, monomer distribution appeared to have an 
impact on various levels. Firstly, the hydrophobicity of the polymers increased with increasing 
length and decreasing number of discreet segments, thus introducing an additional handle to 
tune hydrophobicity. Furthermore, at 30 % charge content, antimicrobial activity was shown 
to be affected by monomer distribution, particularly against Gram-negative bacteria. This 
improvement in activity could be the result of enhanced interactions of cationic moieties with 
the outer membrane of bacteria, when these functionalities are organised in domains. The 
antimicrobial activity of the ammonium copolymers was attributed to bacterial membrane 
disruption, following dye leakage assays. 
After establishing the antimicrobial activity of the ammonium polymers, the selectivity 
with erythrocytes, epithelial cells and fibroblasts was examined. In all cases, diblock 
copolymers were found to outperform statistical copolymers, and at 30 % AEAM content, the 
multiblock copolymer exhibited much greater selectivity for P. aeruginosa and S. epidermidis 
compared to its statistical and diblock analogues. These results are independent to any self-
assembling behaviour as, within the tested concentrations, the SMAMPs are likely to be in 
their unimolecular form. The one-pot multiblock copolymer synthesis approach utilised in this 
study has highlighted the influence of monomer distribution on the physical properties of the 
materials, which in turn influences their interaction with biological systems. By investigating 
a range of design parameters using SMAMPs in order to reduce toxicity towards mammalian 
cells and limit bacterial resistance, this study might aid in finding alternatives to standard 
antibiotics. 
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2.4 Experimental 
 
2.4.1 Materials 
 
Acetone (97 %), acryloyl chloride (97 %), 2-bromopropionic acid (≥99 %), 
butanethiol (99 %), carbon disulphide (≥99 %), chloroform (CHCl3, 99 %), dichloromethane 
(DCM, 99 %), 1,4-dioxane (99 %), ethylacetate (EtOAc, 99 %), ethylenediamine (≥99 %), 
hydrochloric acid (HCl), sodium hydroxide (NaOH), triethylamine (NEt3, ≥99 %) and 
trifluoroacetic acid (TFA, 99 %) were purchased from Sigma-Aldrich and used without further 
purification. Sodium chloride (NaCl, Fischer-Scientific, ≥99 %), Boc-anhydride (Fluka, 98 
%) and 2,2'-azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride (VA-044, Wako) were also 
used without further purification. Mili-Q water was directly used as a solvent for 
polymerisations. N-isopropylacrylamide (NIPAM, Sigma-Aldrich, 97 %) was recrystallised 
in n-hexane. Lipids 1,2 dioleoyl-sn-glycero-3-phosphotehanolamine (PE), 1,2 dioleoyl-sn-
glycero-3-phospho-rac(1-glycerol) sodium salt (PG), Cardiolipin sodium salt from bovine 
heart (CL), Nutrient Agar, Dulbecco's Modified Eagle's Medium (DMEM), Müller-Hinton 
Broth (MHB), Roswell Park Memorial Institute medium (RPMI-1640) , 3-(N-
morpholino)propanesulfonic acid (MOPS), Phosphate Buffered Saline (PBS) tablets, 
Concanavalin A (Con A) and Triton X were purchased from Sigma-Aldrich. Milli-Q filtered 
water was used to prepare solutions, according to their recommended concentration and the 
solutions were autoclaved prior to their usage in order to ensure sterility. The utilised bacteria 
strains were P. aeruginosa ATCC® 27853™, E. coli ATCC® 25922™, S. epidermidis ATCC® 
35984™, S. aureus ATCC® 29213™ and S. aureus USA 300 (for the development resistance 
assay). Human red blood cells were obtained from the Australian Redcross.  
 
2.4.2 Methods 
 
2.4.2.1 Nuclear Magnetic Resonance (NMR) Spectroscopy 
 
1H NMR spectra were recorded on a Bruker Advance 300 spectrometer (300 MHz) at 
27 °C in DMSO, CDCl3 or D2O. For 
1H NMR, the delay time (dl) was 2 s. Chemical shift 
values (δ) are reported in ppm. The residual proton signal of the solvent was used as internal 
standard.  
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2.4.2.2 Size exclusion chromatography (SEC) 
Molar mass distributions were measured using an Agilent 390-LC MDS instrument equipped 
with differential refractive index (DRI), viscometry (VS), dual angle light scatter (LS) and 
dual wavelength UV detectors. The system was equipped with 2 x PLgel Mixed D columns 
(300 x 7.5 mm) and a PLgel 5 µm guard column. The eluent was DMF with 5 mmol NH4BF4 
additive. Samples were run at 1 mL.min-1 at 50°C. Poly(methyl methacrylate) standards 
(Agilent EasyVials) were used for calibration between 955,000 - 550 gmol-1. Analyte samples 
were filtered through a nylon membrane with 0.22 μm pore size before injection. Respectively, 
experimental molar mass (Mn,SEC) and dispersity (Đ) values of synthesized polymers were 
determined by conventional calibration using Agilent GPC/SEC software. 
2.4.2.3 Mass spectroscopy (MS) 
MS analysis was carried out with Agilent1100 HPLC coupled with Agilent 6130B 
single quadruple mass spectrometer equipped with electrospray ionisation source. Mobile 
phase was 80 % methanol with 20 % water at flow rate at 0.2 mL.min-1. Mass spectrometer 
was operated in electrospray positive (or negative) ion mode with a scan range 50-500 m/z. 
Source conditions are: capillary at (-)4000V; nebuliser gas (N2) at 15 psi; dry gas (N2) at 7 
L.min-1;Temperature at 300 °C. Calibration was done with ESI tuning mix from Agilent. 
2.4.2.4 Fluorescence spectrometer 
The fluorescent intensity was monitored using Agilent Technologies Cary Eclipse 
Fluorescence Spectrophotometer. The solutions of vesicles were introduced in a polystyrene 
cuvette for the measurements. 
2.4.2.5 High performance liquid chromatography (HPLC) 
HPLC was performed using an Agilent 1260 infinity series stack equipped with an 
Agilent 1260 binary pump and degasser.  The flow rate was set to 1.0 mL.min-1 and samples 
were injected using Agilent 1260 autosampler with a 100 μL injection volume.  The 
temperature of the column was set at 37 °C. The HPLC was fitted with a phenomenex Lunar 
C18 column (150 x 4.6 mm) with 5 micron packing (100Ǻ). Detection was achieved using an 
Agilent 1260 variable wavelength detector. UV detection was monitored at λ = 309 nm. 
Methods were edited and run using Agilent OpenLAB online software and data was analysed 
using Agilent OpenLAB offline software. Mobile phase solvents used were HPLC grade 
(ACN was ‘far UV’) and consisted of mobile phase A: 100 % ACN, 0.04 % TFA; mobile 
phase B: 100 % water, 0.04 % TFA with a gradient of 1 to 95 % ACN over 50 minutes. 
An elution ratio was calculated from Equation 2.3, relative to the difference in elution times 
of pAEAM100 and pNIPAm100. 
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𝐸𝑙𝑢𝑡𝑖𝑜𝑛 𝑟𝑎𝑡𝑖𝑜 =  
Elution time (sample) –  Elution time (pAEAM100)
Elution time (pNIPAM100) –  Elution time (pAEAM100)
 
Equation 2.3 - Determination of the elution ratio. 
 
2.4.2.6 Dynamic Light Scattering (DLS) measurements 
DLS measurements were taken using a Malvern instruments Zetasizer Nano at 37 °C 
with a 4 mW He-Ne 633 nm laser at a scattering angle of 173° (back scattering). For DLS 
aggregation studies, 1.024 mg of polymer sample was dissolved in 1 mL of PBS buffer at pH 
7.4 and a total of 0.5 mL of the solution was introduced in a 1.5 mL polystyrene cuvette after 
filtering with a 0.2 μm filter. 
2.4.2.7 Determination of pKa 
20 mg (5 mg.mL-1) of H100 and 1.17 g (0.05 M) of NaCl were dissolved in 40 mL of 
water. 100 μL of a 6M HCl solution was added to the polymer solution in order to make sure 
all the amine groups were protonated. The titration was performed manually at room 
temperature with a syringe pump to control the added volume and a pH meter (HI2211 Hanna 
Instruments) using a solution of 0.2 M of NaOH as the titrant. For each polymer, the range of 
pKa was determined using the maximum of the first derivative of the titration curve (Figure 
2.2). 
2.4.2.8 Dye leakage assays 
Formation of vesicles. The synthesis of vesicles was performed according to a 
protocol detailed by Lienkamp et al.56 100 mL of a first buffer (buffer A) was prepared by 
dissolving 120 mg (1.00 mmol) of NaH2PO4 in 90 mL of H2O. The pH was then adjusted to 
7.0 with a 1 mol.L-1 solution of NaOH. The total volume of the solution was then taken to 100 
mL. The calcein solution was obtained by dissolving 249 mg (0.400 mmol) of calcein dye in 
8 mL of previously prepared buffer A. The pH of the solution was adjusted to 7.0 with a 1 
mol.L-1 solution of NaOH in order to dissolve the calcein. The total volume was then taken up 
to 10 mL in order to yield a buffer of 40 mmol.L-1 of calcein. 
A second buffer (buffer B) was prepared by dissolving 1.20 g (10.0 mmol) of NaH2PO4 and 
5.26 g (90.0 mmol) of NaCl in 980 mL of H2O. The pH was adjusted to 7.0 with a 1 mol.L
-1 
solution of NaOH. The volume of the solution was then taken up to 1000 mL. 
For the PE/PG 4:1 vesicles, 6.0 mg (8 µmol) of PE and 1.6 mg (2 µmol) of PG in 0.8 mL of 
CHCl3, for the CL vesicles, 6 mg (10 µmol) of CL was dissolved in 0.6 mL of CHCl3 in a 25-
mL round bottom flask, in order to obtain a solution of roughly 10 mg.mL-1. A film was formed 
at the bottom of the flask by removing the solvent under reduced pressure, the flask kept as 
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vertical as possible. After the film was dried under vacuum, it was hydrated with 1 mL of 
buffer A and stirred for an hour with a magnetic stirring bar. After complete dissolution of the 
lipid, the solution underwent 5 freeze-thaw cycles. The solution was then filtered 15 times by 
extrusion, using an extruder from Avanti Polar Lipids (Mini-Extruder, Whatman) and 400 nm-
membranes. 96-well plates were sourced from Thermo-Fischer. The free dye was filtered 
through a Sephadex G-50 column using buffer B. The vesicle fraction from the column was 
diluted for the dye-leakage experiments according to the initial fluorescence of the solution.  
Fluorescence monitoring. Interactions of the polymers with model bacterial 
membranes composed of lipid bilayers were evaluated using liposomes consisting of a mixture 
of phosphatidylethanolamine (PE) and phosphatidylglycerol (PG) with a ratio of 4 to 1 to 
model Gram-negative bacteria and Cardiolipin (CL) for Gram-positive bacteria. The 
fluorescent dye calcein was encapsulated in a self-quenching concentration. When the 
membrane is compromised by the addition of a sample, the dye leakage would result in an 
increased fluorescence. To that end the fluorescence of the vesicle solution was monitored by 
recording the fluorescence intensity at a wavelength of 537 nm with the excitation wavelength 
set at 492 nm. The intensity of the vesicle solution was measured, then 20 μL of 1.4 mg mL -1 
solution of polymer was added 30 seconds after the start of the run, followed by the addition 
of 20 μL of a 20 % solution of Triton X 9 minutes later. The intensities were normalised by 
setting the baseline at the intensity before polymer addition and the maximum at the intensity 
reached after addition of Triton X, corresponding to 100 % leakage. 
2.4.2.9 Antibacterial susceptibility tests 
Antibacterial susceptibility was studied using two strains of Gram-negative bacteria: 
Escherichia coli (E. coli) and Pseudomonas aeruginosa (P. aeruginosa); and two Gram-
positive strains: Staphylococcus aureus (S. aureus) and Staphylococcus epidermidis (S. 
epidermidis). Minimum inhibitory concentrations (MICs) were determined according to the 
standard Clinical Laboratory Standards Institute (CLSI) broth microdilution method (M07-
A9-2012). A single colony of bacteria was picked up from a fresh (24 hour) culture plate and 
inoculated in 5 mL of Mueller-Hinton (MH) broth, then incubated at 37 °C overnight. On the 
next day, the concentration of cells was assessed by measuring the optical density at 600 nm 
(OD600). Culture suspension was then diluted to an OD600 = 0.1 with RPMI with 0.165 mol L
-
1 of MOPS in order to reach a bacterial concentration of ~ 108 colony forming unit per mL 
(CFU mL-1). The solution was diluted further by 100 fold to obtain a concentration of 106 CFU 
mL-1. Polymers were dissolved in distilled water and 100 μL of each test polymer was added 
to micro-wells followed by the addition of the same volume of bacterial suspension (106 CFU 
mL-1). The micro-wellplates were incubated at 37 °C for 24 hours, and growth was evaluated 
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by measuring the OD600 using a plate reader. Triplicates were performed for each 
concentration and readings were taken twice. The growth in the well was normalised using 
negative controls, wells without any bacteria introduced, and positive controls, wells only 
containing bacterial solution. 
2.4.2.10 Haemolysis and haemagglutination assays 
Human red blood cells (RBCs) were prepared by washing freshly collected human 
blood with PBS via centrifugation. Polymers were dissolved in PBS at desired concentration. 
The normalisation of results was achieved using positive controls (50 μg.mL-1 Concanavalin 
A for haemagglutination and 2 % Triton X-100 in PBS for haemolysis) and negative control 
(PBS) which were included on each plate. A suspension of 3 % in volume of RBCs was added 
to each well and the contents were mixed before being incubated at 37°C for 2 hours. The 96-
well plates were centrifuged at 600 x g for 10 minutes then 100 μL of the supernatant was 
transferred into a new plate. The absorbance at 540 nm was measured and normalised using 
the positive and negative control. 
2.4.2.11 Cell Culture 
Caco-2 human colorectal adenocarcinoma cells were grown in a 50:50 mixture of 
Ham’s F12 and Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10 % of 
foetal calf serum, 1 % of 2 mM glutamine and 1 % penicillin/streptomycin. NIH/3T3 mouse 
embryonic fibroblasts were grown in DMEM medium supplemented with 10% of bovine calf 
serum, 1 % of 2 mM glutamine and 1 % penicillin/streptomycin. Both cell lines were grown 
as adherent monolayers at 37 °C in a 5% CO2 humidified atmosphere and passaged at 
approximately 70-80% confluence. 
2.4.2.12 In vitro growth inhibition assays 
The anti-proliferative activity of the polymers was determined in CaCo-2 colorectal 
cancer cells and NIH/3T3 embryonic fibroblasts. 96-well plates were used to seed 5000 cells 
per well which were left to pre-incubate with drug-free medium at 37 °C for 24 hours before 
adding different concentrations of the compounds to be tested (1024 µg mL-1 - 32 µg mL-1). 
A drug exposure period of 72 hours was allowed. The XTT assay was used to determine cell 
viability. The IC50 values (concentrations which caused 50% of cell death), were determined 
as duplicates of triplicates in two independent sets of experiments and their standard deviations 
were calculated. 
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2.4.2.13 Resistance detection assay 
 
The detection of the development of bacterial resistance was studied using the 
methodology described by Gullberg et al.73 Overnight cultures of a methicillin-resistant strain 
of S. aureus (USA 300) in MH broth obtained from agar plates. Cells serially passaged by 400 
fold into 1 mL batch cultures every 24 hours for 24 days, in MH broth containing 1/10 MIC 
value of the antimicrobial agent. After every 100 generations (4 days), an antibacterial 
susceptibility was performed as described above to observe any variation in the MIC values. 
To confirm the absence of any resistant mutants, a further detection method was used. 100 μL 
of the final bacterial suspension from the resistance generation assay was taken and serially 
diluted by 10 to 107. 100 μL from each dilution was added on an agar plate containing 1 x 
MIC of the test compound and using a sterile spreader, the solution was spread across the 
entire agar plate. After incubation at 37 °C for 24 hours, the agar plate with countable single 
colonies (if present) were used to perform an antibacterial susceptibility test on each colony 
separately to confirm any increase in resistance from prior MIC values. No resistant mutants 
were detected.  
 
2.4.3 Synthesis 
 
2.4.3.1 Synthesis of Boc-AEAM 
Boc-AEAM was synthesised according to the literature.60 
 Synthesis of N-t-butoxycarbonyl-1,2-diaminoethane. A solution of 
ethylenediamine (4.41 g, 4.90 mL, 73.0 mmol) in 40 mL of DCM was added in a two-necked 
100 mL flask fitted with a condenser, a pressure equalising dropping funnel and nitrogen inlet. 
After the solution was cooled with an ice-bath, a mixture of Boc-anhydride (3.98 g, 18.0 
mmol) in DCM (20 mL) was added dropwise over 2 hours with stirring. The mixture was 
allowed to warm to RT and stirred overnight. The solvent was removed by rotary evaporation 
and a precipitate identified as N,N’-(bis-t-butoxycarbonyl)-1,2-diaminoethane was observed 
upon addition of water (50 mL). The filtrate was saturated with NaCl and extracted with 
EtOAc (3 x 60 mL). The combined organic phases were concentrated under vacuum to obtain 
a pale oil. Residual NaCl was removed by dissolving the oil in CHCl3 and filtering. The solvent 
was removed under reduced pressure to give a colourless oil identified as N-t-butoxycarbonyl-
1,2-diaminoethane (1.51 g, 9.00 mmol, 50 %). 1H NMR (CDCl3): δ = 4.93 (bs, 1H, amide 
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proton), 3.16 (m, 2H, CH2),  2.78 (m, 2H, CH2), 1.44 (s, 9H, CH3), 1.20 (m, 2H, NH2) as 
shown on Figure 2.13 
Synthesis of N-t-butoxycarbonyl-N’-acryloyl-1,2-diaminoethane. Acryloyl 
chloride (0.67 g, 0.60 mL, 7.4 mmol) was dissolved in CHCl3 (30 mL). The solution was 
cooled in an ice bath and a solution of NEt3 (0.63 g, 0.90 mL, 6.2 mmol) and N-t-
butoxycarbonyl-1,2-diaminoethane (1.0 g, 6.2 mmol) in CHCl3 (15 mL) was added dropwise 
over an hour and a half. After addition, the reaction mixture was allowed to warm to RT and 
stirred for an hour before the solvent was removed under reduced pressure. The residue was 
washed with water (20 mL) and extracted with CHCl3 (3 x 20 mL). The collected organic 
fractions were combined and the solvent was removed under vacuum to obtain N-t-
butoxycarbonyl-N’-acryloyl-1,2-diaminoethane as a white powder. The product was 
recrystallised in Et2O to yield white crystals (1.0 g, 4.9 mmol, 80 %); mp=110 °C. 
1H NMR 
(300 MHz, 298 K, CDCl3, δ): 7.0 (bs, 1H, amide proton), 6.31-6.25 (dd, J=15 Hz, J=1 Hz, 
1H, vinyl proton), 6.14-6.05 (dd, J=15 Hz, J=9 Hz, 1H, vinyl proton), 5.67-5.63 (dd, J=12 Hz, 
J=1 Hz, 1H, vinyl proton), 5.39 (bs, 1H, amide proton), 3.45 (m, 2H, CH2), 3.32 (m, 2H, CH2), 
1.37 (s, 9H, CH3) as shown on Figure 2.15. 
13C NMR (300 MHz, 298 K, CDCl3, δ): 166.73 
(CH2=CH−(C=O)−NH−), 157.38 (=N−(C=O)−O−), 131.46 (CH2=C−(C=O)−), 126.67 
(CH2=C−), 79.91 (−O−C((CH3)3), 40.98 (−NH−CH2−CH2−NH−), 40.45 
(−NH−CH2−CH2−NH−), 28.63 (−O−C((CH3)3) as shown on Figure 2.16. MS: [M+Na
+] 237.3 
(calculated) 237.2 (found), [2M+Na+] 451.5 (calculated), 451.4 (found). The IR spectrum of 
BocAEAM can be found on Figure 2.17. 
2.4.3.2 Synthesis of (propanoic acid)yl butyl trithiocarbonate (PABTC) 
The RAFT agent was synthesised according to the literature.74  
A 50% w/w aqueous sodium hydroxide solution (4.40 g, 2.20 g NaOH, 55.0 mmol) 
was added to a stirred mixture of butanethiol (5.00 g, 5.90 mL, 55.0 mmol) and water (8.5 
mL). Acetone (2.8 mL) was then added, and the resulting clear solution was stirred for 30 min 
at room temperature. Carbon disulfide (4.75 g, 1.13 eq., 62.4 mmol) was added and the 
resulting orange solution was stirred for 30 min, then cooled to < 10°C. 2-Bromopropionic 
acid (8.69 g, 1.03 eq., 56.8 mmol) was slowly added under temperature supervision, followed 
by the slow addition of a 50% w/w aqueous NaOH solution (4.50 g, 2.25 g NaOH, 57.0 mmol). 
When the exotherm stopped, water (8 mL) was added and the reaction was left to stir at RT 
for 20 hours. A further aliquot of water (15 mL) was added to the reaction mixture, which was 
subsequently cooled to below 10 °C. A 10 M solution of HCl was slowly added, keeping the 
temperature below 10 °C and stopping when pH reached 3. The orange solid separated, 
crystallised and was recovered by filtration under reduced pressure. The solid was then 
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recrystallised in n-hexane to yield yellow crystals (7.20 g, 30.3 mmol, 55 %); mp=58 °C. 1H-
NMR (CDCl3, 300 MHz, δ): 4.88 (q, 1H, J = 9 Hz, CH(CH3)), 3.39 (t, 2H, J = 9 Hz, S-CH2- 
CH2-CH2-CH3), 1.70 (m, 2H, S-CH2-CH2-CH2-CH3), 1.64 (d, 3H, J = 9 Hz, CH(CH3)), 1.44 
(m, 2H, S-CH2-CH2-CH2-CH3), 0.94 (t, 3H, J = 9 Hz, CH2-CH3) as shown on Figure 2.18. 
13C 
NMR (300 MHz, 298 K, CDCl3, δ): 222.1 (S2C=S), 177.4 (COOH), 47.8 (CH(CH3)), 37.4 (S-
CH2-CH2-CH2-CH3), 30.2 (S-CH2-CH2-CH2-CH3), 22.3 (S-CH2-CH2-CH2-CH3), 16.9 
(CH(CH3)), 13.9 (S-CH2-CH2-CH2-CH3) as shown on Figure 2.19.  
 
2.4.3.3 Typical synthesis of homopolymers and statistical copolymers 
 
For the synthesis of A-S30Boc, BocAEAM (257 mg, 1.20 mmol), NIPAM (317 mg, 
2.80 mmol), PABTC (9.54 mg, 0.0400 mmol) were dissolved in 980 µL of 1,4-dioxane and 
180 µL of water. 86 µL of a 15 mg.mL-1 stock solution of VA-044 in H2O was added to the 
mixture which was introduced in a test tube equipped with a mechanical stirrer and a rubber 
septum. The solution was then degassed with nitrogen for ca. 15 min and the polymerisation 
was then performed in a thermostated oil bath set at 46 °C. After 6 hours, the test tube was 
withdrawn from the oil bath. The quantity of reagents needed for the homopolymers and the 
statistical copolymers can be found in Table 2.8. 
 
2.4.3.4 Multiblock copolymer synthesis by iterative RAFT polymerisation 
 
 
Typical synthesis of the initial block. For the synthesis of the first block of A-D30Boc, 
NIPAM (339 mg, 3 mmol) and PABTC (10.216 mg, 0.04 mmol) were dissolved in 800 µL of 
1,4-dioxane and 100 µL of water. 97 µL of a 10 mg.mL-1 stock solution of VA-044 in H2O 
was added to the mixture which was introduced in a test tube equipped with a mechanical 
stirrer and a rubber septum. The solution was deoxygenated by bubbling nitrogen through it 
for 20 min and the polymerisation was then performed in a thermostated oil bath set at 46 °C. 
After 6 hours, the test tube was withdrawn from the oil bath and a sample was taken for 1H 
NMR and SEC analysis.  
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Typical synthesis of subsequent blocks. The test tube with the reaction mixture was 
opened and BocAEAM (275 mg, 1.3 mmol) was added with 125 µL of 1,4-dioxane and 40 
µL of a 15 mg.mL-1 stock solution of VA-044 in H2O. After the vial was re-sealed with a 
septum, the solution was degassed for ca. 20 min, then placed in an oil bath set at 70 °C for 
the polymerisation to occur. The tube was withdrawn from the oil bath after 2 hours and a 
sample was taken for 1H NMR and SEC analysis. The quantity of reagents added for each 
block extension for all diblock and mutliblock copolymers can be found in Tables 2.9-2.12. 
Determination of monomer conversions. Monomer conversions (p) were calculated 
from 1H NMR data using Equation 2.4. 
 𝑝 = 1 − (∫ I5.4−6.4ppm/ ∫ Ia/DPtargeted)  
Equation 2.4 - Calculation of monomer conversion p 
Where ∫ I5.4−6.4ppm is the integral of the three vinyl protons of the monomer, ∫ Ia is 
the integral of the three methyl protons belonging to the terminal methyl of the Z group of the 
CTA and DPtargeted is the average degree of polymerisation targeted. 
Calculation of Mn,th. The theoretical number-average molecular weight (Mn,th) is calculated 
using Equation 2.5. 
𝑀n,th =  
[M]0p𝑀M
[CTA]0 + 2𝑓[I]0(1 − e−𝑘𝑑𝑡)(1 −
𝑓𝑐
2 )
+ 𝑀CTA 
Equation 2.5 - Calculation of Mn,th. 
 
Where [M]0, [CTA]0, [I]0 are the initial concentrations (in mol.L
-1) of the monomer, 
CTA and the initiator respectively; p is the monomer conversion as determined by equation 
2.4; MM and MCTA are the molar masses (in g.mol
-1) of the monomer and the CTA, 
respectively; kd is the decomposition rate constant (in s
-1) of the azo-initiator; and t represents 
the polymerisation time (in seconds). The factor “2” accounts for the fact that one molecule 
of initiator yields two primary radicals with the efficiency f (assumed to be equal to 0.5 in this 
study). The decomposition rate constant for VA-044 at the temperature T (kd,VA-044(T)) was 
determined from the values obtained from Wako (kd,VA-044(44 °C)) = 1.92 10
-4 s-1 and Ea = 108000 
J.mol-1) using the Arrhenius equation (kd,VA-044(70 °C)) = 4.30 10
-4 s-1). The term 1 – (fc /2) 
represents the number of chains produced in a radical-radical termination event with fc 
representing the coupling factor. An fc value of 1 means that 100 % of bimolecular 
terminations occur by combination, whereas a value of 0 indicates that 100 % of bimolecular 
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terminations result in disproportionation. In this study, 100 % terminations by 
disproportionation are assumed (fc = 0). 
Determination of livingness (L). The fraction of living chains can be calculated using 
Equation 2.6, the parameters being [CTA]0 and [I]0 initial CTA and initiator concentration, 
whereas kd, f and 1-fc/2 are related to the thermal decomposition of the initiator.  
 
𝐿 (%) =  
[𝐶𝑇𝐴]0
[𝐶𝑇𝐴]0 + 2𝑓[𝐼]0(1 − 𝑒−𝑘𝑑𝑡)(
1 − 𝑓𝑐
2 )
 
Equation 2.6 - Theoretical determination of the relative amount of living polymer chains 
using an azo-initiator compound. 
 
2.4.3.5 Deprotection of the polymers 
The polymers were dissolved at a concentration of 5 mg.mL-1 in a mixture of methanol and 
1M aqueous solution of HCl (3:1) and stirred for 2 hours at 40°C. They were then dialysed 
against water and freeze-dried. 
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2.5 Supporting Figures 
 
 
Figure 2.14 - 
1
H NMR spectrum of the intermediate product N-t-butoxycarbonyl-1,2-
diaminoethane in CDCl3. 
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Figure 2.15 - 
1
H NMR spectrum of Boc-AEAM in CDCl3. 
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Figure 2.16 - 
13
C NMR spectrum of BocAEAM in CDCl3. 
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Figure 2.17 - IR spectrum of BocAEAM. 
 
Figure 2.18 - 
1
H NMR spectrum of PABTC in CDCl3. 
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Figure 2.19 - 
13
C NMR spectrum of PABTC in CDCl3. 
 
 
Figure 2.20 – 1H NMR spectra in DMSO-d6 of Boc-protected statistical copolymers for 
each composition. 
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Figure 2.21 - 
1
H NMR spectra in DMSO-d6 of Boc-protected diblock copolymers for each 
composition. 
 
 
Figure 2.22 - 
1
H NMR spectra in DMSO-d6 of A-M30
Boc
 for each chain extension.  
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Figure 2.23 - 
1
H NMR spectra in DMSO-d6 of A-M50
Boc
 for each chain extension. 
 
 
Figure 2.24 - 
1
H NMR spectra in DMSO-d6 of A-M70
Boc
 for each chain extension. 
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Figure 2.25 - 
1
H NMR spectra in DMSO-d6 of Boc-protected multiblock copolymers for 
each composition. 
 
 
Figure 2.26 - DMF-SEC chromatograms for statistical copolymers of each composition. 
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Figure 2.27 - DMF-SEC chromatograms for diblock copolymers with 30 % (A), 50 % 
(B) and 70 % (C) BocAEAM content. 
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Figure 2.28 - DMF-SEC chromatograms for successive chain extensions of A-M30
Boc
 (A) 
and A-M70
Boc
 (B). 
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Figure 2.29 - Ratio of the concentration of remaining NIPAM and BocAEAM with 
overall conversion during the polymerisation of A-S30
Boc
. 
 
 
Figure 2.30 - 
1
H NMR spectra in D2O of the deprotected statistical copolymers of each 
composition and in DMSO-d6 for H0. 
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Figure 2.31 - 
1
H NMR spectra in D2O the deprotected diblock copolymers of each 
composition and in DMSO-d6 for H0. 
 
 
Figure 2.32 - HPLC chromatograms of H0 at 20, 37 and 60 °C with a gradient of 1 to 95 
% ACN over 50 minutes. 
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Figure 2.33 - Size distribution by volume by DLS of the homopolymers (A), statistical 
(A), diblock (B) and multiblock (C) copolymers at 1 mg mL
-1
 in PBS. 
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Figure 2.34 - Dye leakage study with (A) statistical (B) diblock and (C) multiblock 
copolymers on Gram-positive bacteria model. Fluorescence was read at 537 nm (emission) 
at an excitation wavelength of 492 nm. The sample was added at 30 s measurement time and 
vesicles were lysed by addition of Triton X at 9 min. 
 
Figure 2.35 - Dye leakage study with statistical (A) and diblock (B) copolymers on Gram-
negative bacteria model. Fluorescence was read at 537 nm (emission) at an excitation 
wavelength of 492 nm. The sample was added at 30 s measurement time and vesicles were 
lysed by addition of Triton X at 9 min. 
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Figure 2.36 - MIC at 30 (A), 50 (B) and 70% (C) AEAM content of various segmentation 
for each bacteria species. 
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Figure 2.37 - TI of the SAMPs with NIH 3T3 cells against their selectivity with RBCs for 
E. coli (A), P. aeruginosa (B), S. aureus (C) and S. epidermidis (D). 
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2.6 Supporting Tables 
 
Table 2.8 - Experimental conditions used for the synthesis of DP 100 homopolymer and 
statistical copolymers of NIPAM and BocAEAM. 
 
Sample number H0 A-S30Boc A-S50Boc A-S70Boc A-H100Boc 
BocAEAM content (%) 0 32 50 70 100 
DPtotal 104 105 105 105 98 
NIPAM 
DPtargeted 104 73 53 32 0 
mmonomer added (mg) 226 317 226 136 0 
BocAEAM 
DPtargeted 0 32 52 73 98 
mmonomer added (mg) 0 257 429 600 429 
mCTA added (mg) 4.77 9.54 9.54 9.54 4.77 
Vdioxane added (mL) 0.533 0.980 0.980 0.980 0.533 
Vwater added (mL) 0.132 0.266 0.266 0.266 0.132 
Vtotal (mL) 1.834 1.246 1.246 1.246 0.665 
mVA-044 total (mg) 0.647 1.293 1.293 1.293 0.647 
[VA-044]0 (mol L-1) 3.00 10-3 3.00 10-3 3.00 10-3 3.00 10-3 3.00 10-3 
[monomer]0 (mol L-1) 3.00 3 3 3 3 
[CTA]0/[VA-044]0 10 10 10 10 10 
L (%)[a] 92 92 92 92 92 
 
[a] Livingness of the polymers, as defined in equation 2.6. 
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Table 2.9 - Experimental conditions used for the synthesis DP 100 diblock copolymers of 
NIPAM (NIP) and BocAEAM (BocA). 
 
Sample number A-D30Boc A-D50Boc A-D70Boc 
BocA content (%) 30 49 70 
DPtotal 103 90 99 
Cycles 1 2 1 2 1 2 
Monomer NIP BocA NIP BocA NIP BocA 
DPtargeted 72 31 46 44 29 70 
mmonomer added (mg) 339 275 226 429 226 1000 
mCTA added (mg) 10.2 - 9.54 - 15.9 - 
mVA-044 added (mg) 0.970 0.595 0.862 0.718 1.04 1.84 
Vdioxane added (mL) 0.800 0.125 0.533 0.493 0.640 1.710 
Vwater added (mL) 0.200 0.044 0.133 0.173 0.160 0.601 
Vtotal (mL) 1.000 1.169 0.666 1.332 0.800 3.111 
mVA-044 total (mg) 0.970 0.756 0.862 0.862 1.035 2.012 
[VA-044]0 (mol L-1) 3.00 10-3 2.00 10-3 4.00 10-3 2.00 10-3 4.00 10-3 2.00 10-3 
[monomer]0 (mol L-1) 3.00 1.10 3.00 1.50 2.50 1.50 
[CTA]0/[VA-044]0 14 18 15 15 21 11 
L (%)[a] 94 95 95 94 96 92 
Cumulative L (%) 94 90 95 89 96 88 
 
[a] Livingness of the polymers, as defined in equation 2.6. 
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Table 2.10 - Experimental conditions used for the synthesis of A-M30
Boc
, the DP 100 
heptablock copolymer of NIPAM (NIP) and BocAEAM (BocA) containing 30 % 
BocAEAM. 
Cycles 1 2 3 4 5 6 7 
Monomer NIP BocA NIP BocA NIP BocA NIP 
DPtargeted 18 10 18 10 18 10 18 
mmonomer added (mg) 226 238 226 238 226 238 226 
mCTA added (mg) 26.5 - - - - - - 
mVA-044 added (mg) 1.08 0.799 1.28 1.68 1.99 2.36 2.67 
Vdioxane added (mL) 0.533 0.261 0.460 0.405 0.351 0.350 0.281 
Vwater added (mL) 0.132 0.082 0.129 0.173 0.136 0.157 0.180 
Vtotal (mL) 0.665 1.008 1.597 2.175 2.662 3.169 3.630 
mVA-044 total (mg) 1.078 0.98 1.552 2.113 2.587 3.079 3.527 
        
[VA-044]0 (mol L-1) 
5.00 10-
3 
3.00 10-
3 
3.00 10-
3 
3.00 10-
3 
3.00 10-
3 
3.00 10-
3 
3.00 10-
3 
[monomer]0 (mol L-1) 3.00 1.10 1.25 0.51 0.75 0.35 0.55 
[CTA]0/[VA-044]0 33 37 23 17 14 12 10 
L (%)[a] 98 98 96 95 94 92 91 
Cumulative L (%) 98 95 91 86 81 75 68 
 
[a] Livingness of the polymers, as defined in equation 2.6. 
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Table 2.11 - Experimental conditions used for the synthesis of A-M50
Boc
, the DP 100 
decablock copolymer of NIPAM (NIP) and BocAEAM (BocA) containing 50 % 
BocAEAM. 
 
Cycles 1 2 3 4 5 6 7 8 9 10 
Monomer NIP BocA NIP BocA NIP BocA NIP BocA NIP BocA 
DPtargeted 10 10 10 10 10 10 10 10 10 10 
mmonomer added (mg) 113 214 113 214 113 214 113 214 113 214 
mCTA added (mg) 23.8 - - - - - - - - - 
mVA-044 added (mg) 0.862 0.601 0.747 0.815 1.00 1.15 1.23 1.39 1.59 2.07 
Vdioxane added (mL) 0.247 0.349 0.267 0.222 0.169 0.180 0.121 0.160 0.212 0.492 
Vwater added (mL) 0.086 0.087 0.075 0.096 0.069 0.077 0.084 0.094 0.110 0.139 
Vtotal (mL) 0.333 0.769 1.111 1.429 1.667 1.924 2.129 2.383 2.705 3.336 
mVA-044 total (mg) 0.862 0.746 1.078 1.293 1.617 1.865 2.064 2.31 2.622 3.233 
           
[VA-044]0 (mol L-1) 
8.00 
10-3 
3.00 
10-3 
3.00 
10-3 
3.00 
10-3 
3.00 
10-3 
3.00 
10-3 
3.00 
10-3 
3.00 
10-3 
3.00 
10-3 
3.00 
10-3 
[monomer]0 (mol L-1) 3.00 1.30 0.90 0.70 0.60 0.52 0.47 0.42 0.37 0.30 
[CTA]0/[VA-044]0 38 43 30 23 20 17 16 14 12 10 
L (%)[a] 98 98 97 96 95 95 94 94 93 91 
Cumulative L (%) 98 96 93 89 85 81 76 71 66 60 
 
[a] Livingness of the polymers, as defined in equation 2.6. 
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Table 2.12 - Experimental conditions used for the synthesis of A-M70
Boc
, the DP 100 
heptablock copolymer of NIPAM (NIP) and BocAEAM (BocA) containing 70 % 
BocAEAM. 
 
Cycles 1 2 3 4 5 6 7 
Monomer BocA NIP BocA NIP BocA NIP BocA 
DPtargeted 18 11 18 11 18 11 18 
mmonomer added (mg) 429 126 429 126 429 126 429 
mCTA added (mg) 26.5 - - - - - - 
mVA-044 added (mg) 1.07 1.13 1.55 1.80 2.16 2.49 2.82 
Vdioxane added (mL) 0.533 0.261 0.460 0.405 0.351 0.350 0.281 
Vwater added (mL) 0.132 0.082 0.129 0.173 0.136 0.157 0.180 
Vtotal (mL) 0.665 1.008 1.597 2.175 2.662 3.169 3.630 
mVA-044 total (mg) 1.078 1.4 1.94 2.343 2.812 3.266 3.731 
        
[VA-044]0 (mol L-1) 5.00 10-3 3.00 10-3 3.00 10-3 3.00 10-3 3.00 10-3 3.00 10-3 3.00 10-3 
[monomer]0 (mol L-1) 2.00 0.77 1.00 0.46 0.69 0.33 0.52 
[CTA]0/[VA-044]0 22 26 19 15 13 11 10 
L (%)[a] 96 96 95 94 93 92 91 
Cumulative L (%) 96 93 88 83 77 71 65 
 
[a] Livingness of the polymers, as defined in equation 2.6. 
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Table 2.13. Experimental conditions and characterisation data for the synthesis of the 
diblock copolymers A-D30
Boc
, A-D50
Boc
,
 
A-D70
Boc
. 
 
Block 
n˚ 
Monomer 
conversion[a] 
(%) 
M
n,th
[b] 
(g.mol
-1
) 
M
n,SEC
 [c] 
(g.mol
-1
) 
Đ[c] 
A-D30Boc 
1
st
 99 3400 10600 1.08 
2
nd
 >99 15000 16200 1.10 
A-D50Boc 
1
st
 >99 5400 8200 1.08 
2
nd
 >99 14900 17500 1.17 
A-D70Boc 
1
st
 >99 3500 5300 1.18 
2
nd
 >99 18500 19000 1.20 
 
[a] Determined by 1H NMR using equation 2.4. 
[b] Theoretical molecular weight calculated from equation 2.5.  
[c] Determined by SEC/RI in DMF using PMMA as molecular weight standards. 
 
Table 2.14. Experimental conditions and characterisation data for the synthesis of the 
heptablock A-M30
Boc
. 
Block 
n˚ 
Monomer 
conversion[a] 
(%) 
M
n,th
[b] 
(g.mol
-1
) 
M
n,SEC
 [c] 
(g.mol
-1
) 
Đ[c] 
1
st
 99 2300 - - 
2
nd
 >99 4420 6800 1.08 
3
rd
 >99 6500 9100 1.09 
4
th
 >99 8600 10900 1.09 
5
th
 >99 10630 14100 1.10 
6
th
 >99 11800 14900 1.20 
7th >99 13800 15800 1.29 
 
[a] Determined by 1H NMR using equation 2.4. 
 [b] Theoretical molecular weight calculated from equation 2.5. 
[c] Determined by SEC/RI in DMF using PMMA as molecular weight standards. 
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Table 2.15. Experimental conditions and characterisation data for the synthesis of the 
decablock A-M50
Boc
.  
Block 
n˚ 
Monomer 
conversion[a] 
(%) 
M
n,th
[b] 
(g.mol
-1
) 
M
n,SEC
 [c] 
(g.mol
-1
) 
Đ[c] 
1
st
 99 1400 - - 
2
nd
 >99 3500 5300 1.07 
3
rd
 >99 4600 6300 1.08 
4
th
 >99 6800 9000 1.09 
5
th
 >99 7900 11700 1.09 
6
th
 >99 10100 12600 1.13 
7th >99 11200 13600 1.19 
8th >99 13300 14000 1.22 
9th >99 14500 14900 1.28 
10th >99 16600 17100 1.38 
 
[a] Determined by 1H NMR using equation 2.4. 
[b] Theoretical molecular weight calculated from equation 2.5. 
[c] Determined by SEC/RI in DMF using PMMA as molecular weight standards. 
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Table 2.16. Experimental conditions and characterisation data for the synthesis of the 
heptablock A-M70
Boc
. 
Block 
n˚ 
Monomer 
conversion[a] 
(%) 
M
n,th
[b] 
(g.mol
-1
) 
M
n,SEC
 [c] 
(g.mol
-1
) 
Đ[c] 
1
st
 99 4100 - - 
2
nd
 >99 5300 7100 1.08 
3
rd
 >99 9200 10500 1.09 
4
th
 >99 10400 11100 1.14 
5
th
 >99 14300 14600 1.21 
6
th
 >99 15500 15900 1.23 
7th >99 19400 17400 1.34 
 
[a] Determined by 1H NMR using equation 2.4 
[b] Theoretical molecular weight calculated from equation 2.5. 
[c] Determined by SEC/RI in DMF using PMMA as molecular weight standards. 
 
Table 2.17 - Characterisation data of deprotected polymers. 
 
 
Sample  
AEAM 
content 
(%) 
Mn,th[a]  
(g mol-1) 
Retention 
ratio[b] 
(%) 
Z-average[c] 
(nm) 
PDI[c] 
Homopolymer 
H0 0 12000 100 580 0.016 
A-H100 100 15000 0 7 0.223 
Statistical 
A-S30 32 13300 40 6 0.536 
A-S50 50 14070 20 7 0.695 
A-S70 70 14850 10 7 0.654 
Multiblock 
A-M30 30 12900 73 6 0.326 
A-M50 50 13400 37 7 0.615 
A-M70 70 14800 23 6 0.393 
Diblock 
A-D30 30 13000 87 6 0.808 
A-D50 49 12100 67 5 0.311 
A-D70 71 14000 50 8 0.313 
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[a] Theoretical molecular weight of the protected polymers calculated from equation 2.5. 
[b] From HPLC data measured in water/ACN in a C18 column (gradient 1 to 95 % ACN in 50 minutes). Elution 
was calculated according to equation 2.3. 
[c] Measured by DLS in Phosphate Buffer Saline (PBS) at 37˚C and 1 mg mL-1 
 
Table 2.18 - Therapeutic index values of the SAMPs with Caco-2 cells. 
 
Sample 
name 
Therapeutic Index (TI) [b] 
Caco-2 
E. coli P. aeruginosa S. aureus S. epidermidis 
H0 > 1 > 1 > 1 > 1 
A-H100 < 8 < 8 < 8 < 1 
A-S30 > 1 > 1 > 1 > 1 
A-S50 1.4 0.7 11 45 
A-S70 < 0.5 < 0.5 < 8 < 16 
A-M30 2 38 5 77 
A-M50 0.1 1 2 7.7 
A-M70 < 0.3 < 1 < 8 < 8 
A-D30 1.4 22 3 45 
A-D50 1.2 1.2 10 19 
A-D70 2 2 10 19 
 
[a] IC50 was determined as the concentration at which 50 % inhibition occurred. 
[b] Therapeutic index (TI) was calculated as the ratio of the IC50 towards Caco-2 with the MIC of the bacterial 
species. 
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of ammonium and guanidinium polymers towards 
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Abstract 
 
As new treatments against MRSA are being investigated, cationic SMAMPs have 
been considered as potential long-term solutions to treating staphylococcal infections. The 
type of charge on SMAMPs has been reported to influence antimicrobial activity as well as 
haemocompatibility. In this chapter, the selectivity of guanidinium containing polymers 
towards RBCs and epithelial cells was compared to that of their ammonium counterparts for 
the treatment of MRSA. Firstly, a library of ammonium and guanidinium SMAMPs with 
varying monomer distribution was synthesised using RAFT polymerisation. Their 
compatibility with RBCs (both haemolysis and haemagglutination) and two human epithelial 
cell lines has been evaluated. The guanidinium polymers appeared to be slightly more toxic 
towards mammalian cells than their ammonium counterparts, but their haemocompatibility 
remained similar. Finally, the antimicrobial activity against both MSSA and MRSA was 
assessed. It was demonstrated that the guanidinium SMAMPs exhibited a higher potency 
towards MRSA than the ammonium copolymers. Furthermore, chapter 2 reported that 
monomer distribution can have a drastic effect on the biological properties of ammonium 
SMAMPs. Similar observations on selectivity were observed when investigating monomer 
distribution in guanidinium containing polymers. Although toxicity towards mammalian cells 
increased with increasing segregation of the cationic and hydrophobic functionalities, the 
antimicrobial activity of the diblock copolymers outperformed that of their tetrablock and 
statistical counterparts. Therefore, the guanidinium diblock appears to be the most potent 
candidate for applications against MRSA. 
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3.1 Introduction 
 
Staphylococcus Aureus (S. aureus) is a common bacterial species in both community 
and hospital-acquired infections for which the methicillin-resistant strains (MRSA) are 
causing over 50 % of nosocomial infections in patients in intensive care units (ICUs) in the 
USA.1 Vancomycin, a glycopeptide which inhibits cell wall synthesis, is currently the last-
resort antibiotic being used to treat severe MRSA infections.2 However, in the last 20 years, 
some S. aureus strains have developed reduced susceptibility or complete resistance towards 
vancomycin.3  Moreover, the glycopeptide is associated with nephrotoxicity, particularly for 
invasive infections.4 Therefore, an alternative to vancomycin which can circumvent the 
adaptability of S. aureus is urgently needed. One treatment strategy involves designing agents 
which target the bacterial membrane, as opposed to highly specific functions, to reduce the 
chance of bacteria developing resistance.5 Antimicrobial peptides (AMPs) have been 
extensively investigated in this regard as their hydrophobic and cationic residues appear to 
efficiently disrupt bacterial membranes.6-7 More importantly, the susceptibility of bacteria 
towards them seems to be maintained.5  
 
Synthetic mimics of AMPs (SMAMPs) with various hydrophobic and cationic 
functionalities have been studied.8 The type of charge can not only dictate the binding 
efficiency of a SAMP to bacterial membrane, but it is also interconnected to the overall 
amphiphilic balance of the material. Although the majority of naturally occurring AMPs 
consist largely of lysine or arginine residues, quaternary ammonium functionalities have been 
utilised in SMAMPs as their positive charge is independent to the pH of their environment.9 
However, polymers bearing quaternised amines were shown to be more hydrophilic than their 
primary amine equivalent at pH 6.10 This observation can be attributed to the protonation of 
functionalities on a polymer chain being strongly influenced by neighbouring charges. 
Therefore, hydrophobic alkyl substituents (at least 4 carbons) had to be used on the quaternary 
amines of antimicrobial polypeptides in order to reach similar levels of antimicrobial activity 
as SMAMPs with primary amines.11-12 Similarly, the effect of the type of charge was further 
investigated with methacrylamide-based copolymers bearing primary and tertiary amine 
pendant groups.13 The SMAMPs with the highest content of primary amine were shown to be 
the most potent against bacteria. These results could be explained by a difference in binding 
affinity of the various cations to bacterial membranes. Despite increased levels of haemolysis 
induced by primary amine bearing polymers, these materials retained a higher selectivity 
compared to their quaternary counterparts.10-11  
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As arginine has as greater pKa than lysine (12.5 and 8.9, respectively),
14-15 a 
considerable effect on the antimicrobial activity of the resulting polymers is expected when 
replacing one functionality by the other, although both functionalities would be protonated at 
physiological pH. Indeed, Tew and co-workers noted a superior antimicrobial potency for 
polyarginine mimics compared to polylysine mimics when using polyoxanorbornenes.16 
Similar results were obtained by Locock et al. with polymethacrylates: the antimicrobial 
activity of guanidinium polymers was higher than that of their ammonium counterparts whilst 
a low toxicity towards red blood cells was maintained.17 However, the opposite trend was 
reported with the antimicrobial effect decreasing with increased guanidinium content, in a 
study using fully cationic polymethacrylamides with ammonium and guanidinium 
functionalities.18 The discrepancy in the results could be due to the absence of hydrophobic 
character in the SMAMPs in the latter case. Additionally, the ammonium/guanidinium 
functional polymethacrylamide copolymers were shown to be more toxic towards mammalian 
cells with increasing guanidinium content.18 Despite the promising results on the antimicrobial 
activity of guanidinium SMAMPs, beside haemocompatibility studies, the toxicity of the 
polymers towards mammalian cells has not been extensively investigated to the best of our 
knowledge.  
 
Previous reports described the synthesis of guanidinium containing polymers by post-
polymerisation functionalisation.17, 19 Guanidinium monomers could also be directly 
polymerised with or without Boc protecting groups using ROMP or RAFT.16, 20-22 In addition 
to being suitable for various types of monomers, the latter technique has been utilised to 
prepare polymers with precisely defined compositions and narrow molar mass distributions.23-
24  
 
In the previous chapter, the effect of monomer sequence on both the antimicrobial 
activity and the compatibility towards mammalian cells was highlighted using ammonium 
block copolymers synthesised by RAFT. However, such an effect has yet to be reported with 
other types of cationic groups. This chapter focuses on the synthesis of guanidinium 
copolymers with different monomer distributions (statistical, tetrablock and diblock 
copolymers) via RAFT polymerisation. In order to establish a comparison between 
ammonium and guanidinium SMAMPs, the compatibility with human epithelial cells in 
addition to their toxicity towards red blood cells was examined. Following this, their potency 
against MSSA and MRSA was investigated. Ultimately, this study establishes design 
parameters which may aid in the development of efficient treatment of MRSA.   
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3.2 Results and discussion 
 
3.2.1 Synthesis and characterisation 
 
In order to study the effect of the type of cationic group on the polymer activity against 
methicillin-susceptible S. aureus (MSSA) and MRSA, acrylamide monomers were used, 
guanidino-ethylacrylamide (GEAM) and amino-ethylacrylamide (AEAM), mimicking 
arginine and lysine respectively. The acrylamide monomer family is particularly suitable for 
the synthesis of multiblock copolymers via RAFT since acrylamides possess a high rate 
constant of propagation (kp) and therefore, it is possible to polymerise them to high conversion 
with much lower initiator concentrations than other monomer families, such as 
methacrylates.25 GEAM and AEAM monomers were synthesised with Boc protecting groups 
(diBocGEAM and BocAEAM, respectively) in order to avoid any aminolysis of the 
trithiocarbonate of the RAFT agent during the polymerisation process and to facilitate the 
characterisation of the materials (Figures 3.11-3.14). BocAEAM and diBocGEAM were both 
obtained with high yields after two-step syntheses as described in the literature.20, 26 They were 
then separately copolymerised with N-isopropylacrylamide (NIPAM), which, in combination 
with AEAM at 70:30 molar ratio, has been shown to reduce the toxicity towards mammalian 
cells of cationic copolymers while maintaining antimicrobial properties.26 Therefore, all 
polymers in this study were synthesised with 30 mol % of cationic monomer. The RAFT agent 
used for the synthesis was (propanoic acid)yl butyl trithiocarbonate (PABTC) as it is suitable 
for the polymerisation of acrylamides and its synthesis is facile and scalable.26 
 
For each set of comonomers (BocAEAM and diBocGEAM, with NIPAM), a 
statistical, tetrablock and diblock copolymer (Figure 3.1) was synthesised to study the 
influence of monomer distribution on the antimicrobial activity. The final targeted degree of 
polymerisation (DP) was 100 for all the polymers, thus the shortest cationic blocks were of 
DP 15 (for the tetrablocks), which is expected to be high enough to ensure that the majority 
of polymer chains possess the correct monomer sequence.27 All materials will be referred 
below according to the type of charge (G for guanidinium and A for ammonium), the amount 
of charge (here 30 molar % for all the polymers), their sequence (S for statistical, T for 
tetrablock and D for diblock) and labelled Boc when in their protected form (Table 3.1). 
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Figure 3.1 - Library of the synthesised guanidinium and ammonium polymers. 
 
 
Table 3.1 - Synthesised Boc-protected polymers. 
 
Co-monomer Segmentation Composition Label 
Amino-
polymers 
Statistical NIPAM70-s- BocAEAM30 A-S30Boc 
Diblock NIPAM70-b- BocAEAM30 A-D30Boc 
Tetrablock 
NIPAM35-b- BocAEAM15-b-
NIPAM35-b- BocAEAM15 
A-T30Boc 
Guanidino-
polymers 
Statistical NIPAM70-s- BocGEAM30 G-S30Boc 
Diblock NIPAM70-b- BocGEAM30 G-D30Boc 
Tetrablock 
NIPAM35-b- BocGEAM15-b-
NIPAM35-b- BocGEAM15 
G-T30Boc 
 
The polymerisation of BocAEAM and diBocGEAM required higher initiator 
concentrations than for the polymerisation of NIPAM. Furthermore, the first polymerisation 
cycle generally requires a higher initiator concentration than subsequent polymerisation cycles 
in order to fully consume the initial CTA.28 Since the polymerisation of NIPAM required 
lower concentrations of initiator to achieve full monomer conversion, it was selected as the 
first block in each block copolymer synthesis in order to preserve a higher fraction of living 
chains going into subsequent block extensions. The polymerisation of diBocGEAM was 
undertaken at 46 °C since a loss of molar mass control was observed at higher temperatures 
(around 70 °C). The reaction conditions were optimised to maintain a high livingness of the 
polymer chains, which is necessary for the synthesis of multiblock copolymers (Tables 3.6-
3.9).28-29 Similarly to the polymerisation of poly(NIPAM-co-BocAEAM) described in chapter 
2, the solvents used for the synthesis of poly(NIPAM-co-diBocGEAM)  was a mixture of 1,4-
dioxane/water (8:2, v/v). For the block copolymers G-T30Boc and G-D30Boc, 7 % of EtOH was 
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added (which reduced the amount of dioxane), to help solubilise diBocGEAM further. Under 
these conditions, full monomer conversion was reached for each chain extension, allowing for 
the synthesis of the block copolymers in one pot (Figures 3.2A and 3.15). All polymers were 
obtained with the targeted molar mass and a low dispersity (Đ ≤ 1.24) according to SEC 
analysis (Figures 3.2B, 3.16-3.18, Table 3.10). Similarly to chapter 2, low and high molar 
mass populations were observed on the SEC traces, which are probably due to initiator-derived 
chains and termination events, respectively. A shift to higher molar mass after each chain 
extension was confirmed with the SEC traces, but in most cases the experimental molar mass 
Mn,SEC did not match the theoretical one Mn,th (Table 3.10), which can be explained by the 
nature of the PMMA standards used for the calibration of the instrument. 
 
A kinetic study of the statistical copolymer G-S30Boc was undertaken using 1H NMR 
and high performance liquid chromatography (HPLC) to determine the rate of incorporation 
for each monomer in the polymer. A similar study was undertaken for A-S30Boc in chapter 2. 
No compositional drift was observed in both cases, meaning that the monomers are evenly 
distributed in both statistical copolymers (Figure 3.19). 
 
 
Figure 3.2 - 
1
H NMR in DMS-d6 (A) and DMF-SEC chromatograms (B) for successive 
chain extensions of G-T30
Boc
. 
 
Following the polymerisation process, the protected guanidinium copolymers were 
deprotected using TFA, with quantitative deprotection confirmed using 1H NMR in D2O 
(Figure 3.3).20 D2O was the only deuterated solvent which dissolved the final deprotected 
polymers, but was not suitable for the protected polymers, hence DMSO-d6 had to be used 
prior to treatment with TFA. This deprotection method further justifies the choice of 
acrylamide monomers as they are more stable towards harsh acidic conditions than acrylates 
or methacrylates.30 The cationic polymers were then dialysed against a solution containing 
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NaCl to replace the TFA counter-ions with Cl- as shown by 19F NMR (Figure 3.20), and finally 
against distilled water to remove any traces of excess NaCl. The polymers were obtained as 
solids after freeze-drying. The counter-ion exchange was performed in order to directly 
compare the guanidinium copolymers to their ammonium analogues (which also possess a 
chloride counter-ion), as well as to enhance solubility and avoid any decrease in antimicrobial 
activity as reported by Tew and co-workers.31 
 
 
Figure 3.3 - 
1
H NMR spectra in D2O of G-S30, G-T30 and G-D30 after deprotection. 
 
To identify the effect of monomer distribution on the physico-chemical properties of 
the polymer library, which could in turn alter their biological activity, characterisation of the 
polymers by reverse-phase HPLC was performed with H2O/ACN as mobile phase (Figure 3.4, 
Table 3.11). The elution time of the polymers can be correlated to their hydrophobicity, where 
earlier elution times indicate less hydrophobicity. Preceding work examining the ammonium 
counterparts, but also other types of polyacrylamide-based multiblock copolymers, 
established a comparable trend between elution time of polymers with different compositions 
and hydrophobicity.32 Reverse-phase HPLC of the guanidinium polymers indicated the 
following trend, with hydrophobicity of the polymers decreasing left to right; diblock (G-D30) 
> tetrablock (G-T30) > statistical (G-S30) according to Figure 3.4B. The cloud point 
temperature of statistical copolymers has been shown to be higher than that of their diblock 
counterparts.33 This observation was attributed to the increase of the overall hydrophobicity 
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of the polymer chain with the segregation of the monomer types along the backbone. 
Similarly, in the case of G-D30, G-T30 and G-S30, the size of the discreet hydrophobic 
segments (here the polyNIPAM block) are likely affecting the overall hydrophobicity the 
polymer structures. The charge to hydrophobicity ratio strongly affects membrane interactions 
of SMAMPs and will not only alter their antimicrobial properties, but also their internalisation 
in mammalian cells.20 
 
The determination of the pKa of A-S50, A-M50 and A-D50 in chapter 2, demonstrated 
that some of the primary amines were not protonated at physiological pH. As mentioned 
previously, the pKa of the guanidine moiety of arginine is around 12.5, hence even the 
incorporation into a polymer chain would not alter its acidity enough to have deprotonated 
guanidine groups at physiological pH. 
 
 
Figure 3.4 – RP-HPLC chromatograms of the ammonium (A) and the guanidinium 
polymers (B) with a gradient of 1 to 80 % ACN in 30 minutes with a 100 mm C18 column. 
 
Next, the behaviour of the copolymers in solution was analysed by Dynamic Light 
Scattering (DLS) at 37 °C and pH 7.4 at the maximum concentration tested for the biological 
experiments (1024 μg.mL-1). Since polyNIPAM is known to possess a lower critical solution 
temperature (LCST) in aqueous solution close to physiological temperatures, it was pertinent 
to demonstrate that the copolymers do not self-assemble under such conditions.34 No self-
assembly was observed for both the ammonium and guanidinium copolymers (Figure 3.21, 
Table 3.11). These results are in agreement with the general observation that the LCST of 
polymers increases when they are copolymerised with a non-temperature-responsive 
monomer.35 Since no micellar formation was observed, any difference in the activity of the 
polymers can be directly correlated to the monomer sequence. 
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3.2.2 Toxicity of SMAMPs towards mammalian cells 
 
3.2.2.1 Haemocompatibility of SMAMPs 
 
As cationic polymers are known to be haemotoxic, defibrinated sheep blood was used 
to assess the haemocompatibility of the synthesised polymers up to 1024 μg.mL-1 over 2 hours 
at 37 °C, according to an adapted protocol from the literature.36-37 Importantly, none of the 
ammonium polymers were haemolytic in contrast to Triton X, which was used as a positive 
control (Figure 3.5A). Amongst the guanidinium polymers, G-D30 induced 10% haemolysis 
at a concentration of 1000 μg.mL-1, while the statistical and tetrablock counterparts (G-S30 
and G-T30) were not haemolytic within the concentration range tested (Figure 3.5B).  
 
 
 
Figure 3.5 - Haemolytic activity of ammonium and guanidinium SMAMPs. Normalised 
haemolysis of sheep blood cells following incubation at 37 °C for 2 hours in PBS with 
ammonium (A) and guanidinium (B) SMAMPs. 
 
Since the haemocompatibility of polymers encompasses both haemolytic and 
haemagglutination, the latter was studied with defibrinated sheep blood, using Concanavalin 
A as a positive control.38 For guanidinium containing polymers, the aggregation of RBCs was 
observed with G-S30 and G-T30, from concentrations of 8 and 32 μg.mL-1, respectively, while 
G-D30 did not induce haemagglutination (Table 3.2). Comparable results were obtained with 
the ammonium polymers as A-S30 and A-T30, which induced haemagglutination from 
concentrations of 64 and 128 μg.mL-1, respectively, whereas A-D30 did not. These 
observations are in accordance with the study in chapter 2, in which the heptablock and 
statistical poly(NIPAM-co-AEAM) also induced the formation of RBC aggregates whilst the 
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diblock copolymer did not exhibit any toxicity.26 This behaviour was explained by the 
distribution of cationic functionalities along the polymer backbone facilitating the cross-
linking of RBCs.  
 
The polymers which induced aggregation of red blood cells (statistical and tetrablock 
copolymers) were not haemolytic, suggesting that each aspect of haemotoxicity are relatively 
independent for the investigated materials. Combined, haemolysis and haemagglutination 
assays revealed that the diblocks A-D30 and G-D30 were the most haemocompatible systems, 
whereas the statistical and tetrablock SMAMPs induced haemotoxicity at low concentrations 
(Table 3.3). 
 
Table 3.2 - SMAMP-induced erythrocytes aggregation. Observation of 
haemagglutination of sheep blood cells following incubation with ammonium and 
guanidinium SMAMPs in PBS for 2 hours at 37 °C. 
 
 sample 
/concentration 
(μg/mL) 
1024 512 256 128 64 32 16 8 4 2 
A-S30 ++ ++ + + + - - - - - 
A-T30 ++ ++ ++ + - - - - - - 
A-D30 - - - - - - - - - - 
G-S30 +++ +++ +++ ++ ++ + + + - - 
G-T30 ++ ++ ++ + + + - - - - 
G-D30 - - - - - - - - - - 
 
Haemagglutination strength: +++ strong; ++ moderate; + weak; - none. 
 
3.2.2.2 Compatibility towards human epithelial cells 
 
As S. aureus was shown to persist within keratinocytes during skin infections,39-40 
SMAMPs need to exhibit a low toxicity towards these cells to warrant their clinical 
application. The toxicity of the two sets of polymers against human keratinocytes (HaCaT) 
was evaluated over a period of 24 hours using an XTT assay. The toxicity of the amine 
polymers towards HaCaT cells was surprisingly low, with an IC50 > 1000 μg.mL
-1 for all three 
compositions (Figure 3.6 and Table 3.3), indicating that the monomer sequence did not 
influence the toxicity of these polymers at the tested concentrations. For each copolymer 
composition, the guanidinium polymers were shown to be more toxic than their corresponding 
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ammonium polymers. The difference between the two tetrablock copolymers (A-T30 and G-
T30) and the two diblock copolymers (A-D30 and G-D30) was particularly significant (Figure 
3.6B and 3.6C). This result is in agreement with a previously reported work studying 
methacrylamide-based statistical copolymers containing guanidinium and ammonium 
moeites.18 By increasing the ratio of guanidinium to ammonium functionalities, the toxicity of 
the polymers were shown to increase towards MCF-7 epithelial cells. Indeed, due to their 
similarity to arginine-rich cell penetrating peptides, the guanidinium polymers could undergo 
enhanced interactions with mammalian cell membranes compared to their ammonium 
counterparts, which would affect their toxicity.41 
 
Segregation of cationic and hydrophobic functionalities also significantly increased 
the toxicity of the ammonium and guanidinium SMAMPs towards epithelial cells. According 
to the IC50 values (Table 3.3), G-D30 appeared to be the most toxic, followed by G-T30 and 
G-S30. The toxicity observed with each polymer composition correlates to their overall 
hydrophobicity (determined via reverse-phase HPLC, Figure 3.4), indicating that an increase 
in hydrophobicity accounts for an increase in toxicity. Similarly, Neanmark and co-workers 
reported an increase in cytotoxicity with hydrophobicity by using poly(ethylenimine)s bearing 
aliphatic substituents of varying lengths.42   
 
Table 3.3 - Comparison of the cytocompatibility of the ammonium and guanidinium 
SMAMPs. Haemocompatibility determined for sheep blood cells using haemolysis and 
haemagglutination assays and IC50 for HaCaT and A549 cells using XTT assays.  
 
Haemocompatibility IC
50
[c] (μg.mL
-1
) 
HC
10 
[a] (μg.mL
-1
) c
H
[b]
 
(μg.mL
-1
)
 
HaCaT A549 
A-S30 > 1024 64 > 1024 > 1024 
A-T30 > 1024 128 > 1024 700 
A-D30 > 1024 > 1024 > 1024 400 
G-S30 > 1024 8 > 1024 600 
G-T30 > 1024 32 500 200 
G-D30 1024 >1024 300 150 
 
[a] HC10 is the minimum concentration at which at least 10 % of the maximum lysis was observed. 
[b] cH is the lowest concentration at which the polymers induce aggregation of RBCs. 
[c] IC50 was determined as the concentration at which 50 % growth inhibition occurred. 
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Figure 3.6 - Cytotoxicity of ammonium and guanidinium SMAMPs towards HaCaT. 
Viability of HaCaT cells incubated for 24 hours in presence of statistical (A), tetrablock (B) 
and diblock (C) ammonium and guanidinium SMAMPs using an XTT assay.  
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As pneumonia is another common ICU-acquired infection, the toxicity of the 
polymers towards lung epithelial cells (A549) was also evaluated over the course of 24 hours 
using an XTT assay (Figure 3.7).43 With A549 cells, A-T30 and A-D30 were found to be toxic 
at relatively high concentrations (IC50 of 700 and 400 μg.mL
-1), while the guanidinium 
counterparts were again more toxic (Figure 3.7 and Table 3.3). Similarly, the IC50 decreased 
with increasing segregation of the co-monomers (G-S30 > G-T30 > G-D30). Taken together, 
the toxicity data revealed that toxicity increases with segregation, which was not shown 
before, to the best of our knowledge. 
 
 
Figure 3.7 - Cytotoxicity of ammonium and guanidinium SMAMPs towards A549 cells. 
Viability of A549 cells incubated for 24 hours in presence of ammonium (A) and 
guanidinium (B) SMAMPs of various monomer sequence using an XTT assay. 
 
3.2.3 Antimicrobial activity of SMAMPs  
 
Two clinically relevant strains of S. aureus were used to evaluate their antimicrobial 
susceptibility towards the synthesised polymers: RN1 (NCTC 8325), a MSSA strain, which is 
widely used as a model strain, and USA300 JE2, a MRSA strain, which is more virulent than 
RN1.44-45 
 
For both the ammonium and guanidinium polymers, the monomer distribution had a 
significant effect on their efficacy against S. aureus (Figure 3.8 and Table 3.4). The MIC value 
against the MSSA strain RN1 decreases with segmentation for the guanidinium polymers 
(Figure 3.8A). Indeed, for the polyarginine mimics, the statistical copolymer G-S30 appeared 
to be inactive against RN1 within the concentration range tested (MIC > 1000 μg.mL-1), 
whereas the tetrablock G-T30 and diblock G-D30 copolymers exhibited relatively low MIC 
values (from 128 and 64 μg.mL-1, respectively). The ammonium polymers followed the same 
   Chapter 3 
 
   Page | 109 
 
trend as the guanidinium SMAMPs, which was expected as it was found in chapter 2 that 
multiblock and diblock ammonium copolymers with 30 % charge content were more potent 
against bacteria than their statistical copolymer analogue. Additionally, it is worth noting that 
ammonium and guanidinium polymers of the same monomer sequence possessed similar 
MICs against the MSSA strain (Figure 3.8A). G-D30 an A-D30 were the most active against 
RN1 with a MIC of 64 μg.mL-1. As indicated by DLS measurements, these copolymers were 
not expected to form any higher-order assemblies under the physiological conditions used (c 
≤ 1024 μg.mL-1). Therefore, the potency of the diblocks could be explained by the increase in 
hydrophobicity which accompanies the segregation of polyNIPAM into one discreet block: 
the more hydrophobic the polymer, the more toxic towards mammalian cells but also towards 
bacteria. Another hypothesis would be that the positive charges exert a synergistic effect when 
localised in a single segment of a macromolecule, enhancing bacterial attachment. 
 
Similarly, the antimicrobial activity of the guanidinium SMAMPs against the MRSA 
strain JE2 increased with increasing segregation of cationic and hydrophobic functionality and 
their MIC values were similar to those observed against the MSSA strain (Figure 3.8B). 
Strikingly, the MIC values of G-T30 and G-D30 against JE2 (128 and 64 μg.mL-1, 
respectively) were decreased two-fold compared to A-T30 and A-D30 (256 and 128 μg.mL-1, 
respectively). Since the molar mass of the ammonium and guanidinium polymers are 
comparable (Table 3.11), the difference in the MIC values strongly suggests that the 
guanidinium copolymers were more potent than their ammonium counterparts, which is 
consistent with a previous study.17 While the antimicrobial activity of polymers bearing 
primary amine moieties appear to derive from their attachment to bacterial membranes, 
followed by the formation of pores, polymers bearing guanidinium moieties could have a 
different antimicrobial mechanism. Indeed, the binding of guanidine units to phospholipids 
from bacterial membrane was shown to be more labile, hence allowing an efficient membrane 
crossing.46 Recently, Good and co-workers reported that the antimicrobial activity of 
polyhexamethylene biguanidine is attributed to its differential access to, and subsequent 
condensation of, bacterial DNA over mammalian DNA, thereby inducing bacterial death.47  
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Figure 3.8 – Comparison of the MIC values of ammonium and guanidinium SMAMPs 
against MSSA RN1 (A) and MRSA JE2 (B). 
 
The antimicrobial activity of the ammonium polymers against JE2 varied with 
monomer distribution in the same manner as with RN1. However, the MIC of A-T30 and A-
D30 against JE2 (256 and 128 μg.mL-1, respectively) was double that observed against RN1 
(128 and 64 μg.mL-1, respectively) as shown on Table 3.4. It is plausible that the reduced 
methicillin susceptibility of JE2 caused a change in its membrane composition and physical 
properties (thickness, surface charge) to that of RN1, which has been shown to influence the 
sensitivity of bacteria towards SMAMPs.48-49  
 
Table 3.4 – Comparison of the antimicrobial activity of the SMAMPs. MIC values 
determined against MSSA RN1 and MRSA JE2. 
 
MIC[a] (μg.mL
-1
) 
MIC[a]  
(nmol.mL
-1
) 
RN1 JE2 RN1 JE2 
A-S30 > 1024 > 1024 > 75 > 75 
A-T30 128 256 10 20 
A-D30 64 128 5 10 
G-S30 > 1024 > 1024 > 75 > 75 
G-T30 128 128 10 10 
G-D30 64 64 5 5 
 
[a] MIC is the minimum inhibitory concentration at which no visible bacterial growth can be observed. 
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3.2.4 Selectivity of SMAMPs for bacteria over mammalian cells 
 
The selectivity of SMAMPs is defined as the ability to maximise their activity against 
bacteria whilst being non-toxic towards mammalian cells. Similarly to Chapter 2, this was 
evaluated by comparing the MIC of the polymer library towards a given bacterial strain against 
their compatibility with mammalian cells (Figures 3.9 and 3.10). The green region designates 
the area of the diagram in which the selectivity for bacteria over mammalian cells is superior 
to 1: the further from the diagonal line, the more selective the SMAMP. The ideal SMAMP 
would be located towards the top-left corner of the graph as it maximises antibacterial activity 
whilst being non-toxic to mammalian cells (Figure 3.9).  
 
Remarkably, it is clear that segregation of the cationic and hydrophobic moieties in 
the copolymer compositions improves the selectivity. Indeed, the statistical copolymers A-
S30 and G-S30 had the lowest selectivity for both RN1 and JE2. Despite an improved 
selectivity of tetrablock copolymers compared to their statistical equivalents, A-T30 and G-
T30 do not favour interactions with bacteria over RBCs. The diblock copolymers (A-D30 and 
G-D30) exhibited a high selectivity towards RBCs, outperforming their statistical and 
tetrablock copolymer counterparts against RN1 and JE2. G-D30 seems to be the ideal 
candidate for the treatment of both MSSA and MRSA as it is the most potent but remains 
compatible with RBCs up to very high concentrations (Figure 3.9). These observations are 
confirmed by the selectivity values calculated in Table 3.5, according to Equation 2.1. 
 
 
Figure 3.9 - Selectivity graphs of SMAMPs for MSSA RN1 (A) and MRSA JE2 (B) over 
RBCs. Haemocompatibility concentration (lowest value between HC10 and cH, as shown in 
Table 3.3) against the MIC for MSSA RN1 (A) and MRSA JE2 (B), which values are reported 
in Table 3.4. 
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Table 3.5 - Selectivity of the SMAMPs for MSSA and MRSA over mammalian cells. 
Selectivity values of the SMAMPs for MSSA RN1 and MRSA JE2 over RBCs (as calculated 
using equation 2.1) and TI values for RN1 and JE2 over HaCaT and A549 (as calculated using 
equation 2.2). 
 
Selectivity with 
RBCs[a] 
Therapeutic Index 
(TI)
[b] 
with HaCaT 
Therapeutic Index 
(TI)
[b] 
with A549 
RN1 JE2 RN1 JE2 RN1 JE2 
A-S30 < 0.1 < 0.1 < 1 < 1 < 1  < 1 
A-T30 1 0.5 > 8 > 4 5 3 
A-D30 > 16 > 8 > 16 > 8 6 3 
G-S30 < 0.01 < 0.01 < 1 < 1 < 0.6  < 0.6  
G-T30 0.3 0.3 4 4 2 2 
G-D30 16 16 5 5 2 2 
 
[a] Selectivity: lowest value between HC10 and cH (haemocompatibility concentration) divided by the MIC of the 
bacterial strains concerned, as described in Equation 2.1. 
[b] Therapeutic index (TI) was calculated as the IC50 of HaCaT or A549 for the SMAMP divided by the MIC of 
the bacterial species, as described in Equation 2.2. 
 
 
Subsequently, the selectivity of SMAMPs for bacteria over HaCaT cells was 
established using Figure 3.10. It is noteworthy that except for the statistical copolymers A-
S30 and G-S30, the synthesised SMAMPs were selective towards both MSSA and MRSA 
over HaCaT cells. In the case of the polylysine mimics, the diblock copolymer was the most 
selective for both RN1 and JE2 over keratinocytes. However, with the guanidinium polymers, 
the diblock and the tetrablock copolymer had similar levels of selectivity for both bacterial 
strains. Table 3.4 summarises the therapeutic indexes for all six compounds calculated using 
Equation 2.2. Comparable trends in selectivity towards MSSA and MRSA over A549 cells 
was observed according to Table 3.5: the diblock and tetrablock copolymers were the most 
selective with the lung epithelial cells out of both ammonium and guanidinium polymers. 
Although A-D30 has a similar level of selectivity to G-D30 and is slightly less toxic to HaCaT 
and A549 cells, the guanidinium diblock copolymer is a more promising alternative to 
vancomycin due to its higher potency against MRSA. 
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Figure 3.10 - Selectivity graphs of SMAMPs for MSSA RN1 (A) and MRSA JE2 (B) over 
HaCaT cells. IC50 towards HaCaT cells (values reported in Table 3.3) against the MIC for 
MSSA RN1 (A) and MRSA JE2 (B), which values are reported in Table 3.4. 
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3.3 Conclusion 
 
Ammonium and guanidinium copolymers containing NIPAM as a co-monomer were 
successfully synthesised via RAFT polymerisation. By varying both the nature of the cationic 
functionality and the monomer distribution (statistical, tetrablock and diblock copolymers), 
the effect of charge and monomer distribution on the biological properties of SMAMPs was 
elucidated with both sets of polymers. Firstly, it was demonstrated that the type of charge 
affects the selectivity of SMAMPs. Indeed, the guanidinium containing polymers were more 
toxic towards epithelial cells than their ammonium counterparts, whilst a similar level of 
haemocompatibility was maintained. However, the guanidinium SMAMPs exhibited a 
stronger antimicrobial activity towards MRSA. This increased potency could be attributed to 
a different mechanism of action with bacteria, compared to the ammonium SMAMPs, with 
the polyarginine mimics acting intracellularly rather than disrupting bacterial membrane. 
 
Finally, the influence of the monomer distribution on the characteristics of the 
SMAMPs was evaluated for both ammonium and guanidinium polymers. In both cases, the 
diblock copolymer exhibited a slightly higher toxicity towards epithelial cells than their 
statistical and tetrablock counterparts. However, the haemocompatibility was improved with 
a diblock structure, as no haemagglutination was observed for A-D30 and G-D30. More 
importantly, segregation of the cationic and hydrophobic functionalities drastically improved 
the potency against S. aureus. Despite bearing the same quantity of positive charges, the 
diblock copolymers were more active than the tetrablock copolymers, whilst the statistical 
copolymers did not exhibit any activity. Further investigations on the effect of segmentation 
in the interactions with bacterial membranes would help clarifying the advantage of a diblock 
copolymer structure over a statistical or tetrablock copolymer. After analysis of the selectivity 
of the library of polymers towards mammalian cell, G-D30 presented the best properties 
against MRSA. 
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3.4 Experimental 
 
3.4.1 Materials 
Acryloyl chloride (97 %), chloroform (CHCl3, 99 %), dichloromethane (DCM, 99 %), 1,4-
dioxane (99 %), ethylacetate (EtOAc, 99 %), ethylenediamine (≥99 %), triethylamine (NEt3, 
≥99 %) and trifluoroacetic acid (TFA, 99 %)) were purchased from Sigma-Aldrich and used 
without further purification. Sodium chloride (NaCl, Fischer-Scientific, ≥99 %), Boc-
anhydride (Fluka, 98 %) and 2,2'-azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride (VA-
044, Wako) were also used without further purification. Mili-Q water was directly used as a 
solvent for polymerisations. N-isopropylacrylamide (NIPAM, Sigma-Aldrich, 97 %) was used 
after purification by recrystallization in n-hexane. Nutrient Agar, Dulbecco's Modified Eagle's 
Medium (DMEM), Müller-Hinton Broth (MHB), Trypsic Soy Broth (TSB), Roswell Park 
Memorial Institute medium (RPMI-1640) , Phosphate Buffered Saline (PBS) tablets, 
Concanavalin A (Con A) and Triton X were purchased from Sigma-Aldrich. 96-well plates 
were sourced from Thermo-Fischer. Milli-Q filtered water was used to prepare solutions, 
according to their recommended concentration and the solutions were autoclaved prior to their 
usage in order to ensure sterility. Defibrinated sheep blood was obtained from Fisher 
Scientific.  
 
3.4.2 Methods 
3.4.2.1 Nuclear Magnetic Resonance (NMR) Spectroscopy 
1H NMR spectra were recorded on a Bruker Advance 300 spectrometer (300 MHz) at 27 °C 
in DMSO, CDCl3 or D2O. For 
1H NMR, the delay time (dl) was 2 s. Chemical shift values (δ) 
are reported in ppm. The residual proton signal of the solvent was used as internal standard.  
 
3.4.2.2 Size exclusion chromatography (SEC) 
Molar mass distributions were measured using an Agilent 390-LC MDS instrument equipped 
with differential refractive index (DRI), viscometry (VS), dual angle light scatter (LS) and 
dual wavelength UV detectors. The system was equipped with 2 x PLgel Mixed D columns 
(300 x 7.5 mm) and a PLgel 5 µm guard column. The eluent was DMF with 5 mmol NH4BF4 
additive. Samples were run at 1 mL min-1 at 50°C. Poly(methyl methacrylate) standards 
(Agilent EasyVials) were used for calibration between 955,000 - 550 gmol-1. Analyte samples 
were filtered through a nylon membrane with 0.22 μm pore size before injection. Respectively, 
experimental molar mass (Mn,SEC) and dispersity (Đ) values of synthesized polymers were 
determined by conventional calibration using Agilent GPC/SEC software. 
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3.4.2.3 Mass spectrometry (MS) 
MS analysis was carried out with Agilent1100 HPLC coupled with Agilent 6130B single 
quadruple mass spectrometer equipped with electrospray ionisation source. Mobile phase was 
80 % methanol with 20 % water at flow rate at 0.2ml.min-1. Mass spectrometer was operated 
in electrospray positive ion mode with a scan range 50-500 m/z. Source conditions are: 
capillary at 4000V; nebuliser gas (N2) at 15 psi; dry gas (N2) at 7 L.min
-1; Temperature at 300 
°C. Calibration was done with ESI tuning mix from Agilent. 
 
3.4.2.4 High performance liquid chromatography (HPLC) 
HPLC was performed using an Agilent 1260 infinity series stack equipped with an Agilent 
1260 binary pump and degasser.  The flow rate was set to 1.0 mL min-1 and samples were 
injected using Agilent 1260 autosampler with a 100 μL injection volume.  The temperature of 
the column was set at 37 °C. The HPLC was fitted with an Agilent C18 column (100 x 4.6 
mm) with 5 micron packing (100Ǻ). Detection was achieved using an Agilent 1260 variable 
wavelength detector. UV detection was monitored at λ = 309 nm. Methods were edited and 
run using Agilent OpenLAB online software and data was analysed using Agilent OpenLAB 
offline software. Mobile phase solvents used were HPLC grade (ACN was ‘far UV’) and 
consisted of mobile phase A: 100 % ACN, 0.04 % TFA; mobile phase B: 100 % water, 0.04 
% TFA with a gradient of 1 to 80 % ACN over 30 minutes. 
 
3.4.2.5 Dynamic Light Scattering measurements.  
DLS measurements were taken using a Malvern instruments Zetasizer Nano at 37 °C 
with a 4 mW He-Ne 633 nm laser at a scattering angle of 173° (back scattering). For DLS 
aggregation studies, 1.024 mg of polymer sample was dissolved in 1 mL of PBS buffer at pH 
7.4 and a total of 0.5 mL of the solution was introduced in a 1.5 mL polystyrene cuvette after 
filtering with a 0.2 μm filter.  
 
3.4.2.6 Haemolysis and haemagglutination assays 
Sheep red blood cells (RBCs) were prepared by washing defibrinated sheep blood 
with PBS via centrifugation. Polymers were dissolved in PBS. Polymers were dissolved in 
PBS. The normalisation was done using positive controls (50 μg mL-1 Concanavalin A for 
haemagglutination and 2 % Triton X-100 in PBS for haemolysis) and negative control (PBS) 
which were included on each plate. A suspension of 3 % in volume of RBCs was added to 
each well and the contents were mixed before being incubated at 37°C for 2 hours. The 96-
well plates were centrifuged at 600 x g for 10 minutes then 100 μL of the supernatant was 
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transferred into a new plate. The absorbance at 540 nm was measured and normalised using 
the positive and negative control. 
 
3.4.2.7 Eukaryotic Cell Lines and Growth Conditions 
HaCaT human keratinocytes were grown in a 50:50 mixture of Ham’s F12 and 
Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% of foetal calf serum, 
1% of 2 mM glutamine and 1%. Both cell lines were grown as adherent monolayers at 37 °C 
in a 5% CO2 humidified atmosphere and passaged at approximately 70-80% confluence. 
 
3.4.2.8 In vitro growth inhibition assays 
The anti-proliferative activity of the polymers was determined in HaCaT human 
keratinocytes. 96-well plates were used to seed 5000 cells per well which were left to pre-
incubate with drug-free medium at 37 °C for 24 hours before adding different concentrations 
of the compounds to be tested (1024 µg mL-1 – 32 µg mL-1). A drug exposure period of 24 
hours was allowed. The XTT assay was used to determine cell viability. The IC50 values 
(concentrations which caused 50% of cell death), were determined as duplicates of triplicates 
in two independent sets of experiments and their standard deviations were calculated. 
 
3.4.2.9 Bacterial Strains and Growth Conditions 
The utilised bacterial strains were S. aureus USA 300 LAC JE2 and NCTC 8325 RN1. 
Bacteria were grown in TSB at 37°C at 250 rpm for 18 hours. 
 
3.4.2.10 Antibacterial susceptibility tests 
Antibacterial susceptibility was studied using two strains of Staphylococcus aureus 
(S. aureus): RN1 and JE2. Minimum inhibitory concentrations (MICs) were determined 
according to the standard Clinical Laboratory Standards Institute (CLSI) broth microdilution 
method (M07-A9-2012). A single colony of bacteria was picked up from a fresh (24 hour) 
culture plate and inoculated in 5 mL of Mueller-Hinton (MH) broth, then incubated at 37 °C 
overnight. On the next day, the concentration of cells was assessed by measuring the optical 
density at 600 nm (OD600). Culture suspension was then diluted to an OD600 = 0.1 with RPMI 
with 0.165 mol L-1 of MOPS in order to reach a bacterial concentration of ~ 108 colony forming 
unit per mL (CFU mL-1). The solution was diluted further by 100-fold to obtain a concentration 
of 106 CFU mL-1. Polymers were dissolved in distilled water and 100 μL of each test polymer 
was added to micro-wells followed by the addition of the same volume of bacterial suspension 
(106 CFU mL-1). The micro-well plates were incubated at 37 °C for 24 hours, and growth was 
evaluated by measuring the OD600 using a plate reader. Triplicates were performed for each 
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concentration and readings were taken twice. The growth in the well was normalised using 
negative controls, wells without any bacteria introduced, and positive controls, wells only 
containing bacterial solution. 
 
3.4.3 Synthesis 
3.4.3.1 Synthesis of 1,3-Di-Boc-guanidinoethyl acrylamide diBocGEAM 
 
 
The monomer was synthesised according to the literature.20 
Synthesis of 2-[1,3-Bis(tert-butoxycarbonyl)guanidine]ethylamine. A solution of 1,3-
Bis(tert-butoxycarbonyl)-2-methyl-2-thiopseudourea (6.50 g, 27.6 mmol) in DCM (50 mL) 
was added dropwise to a solution of ethylenediamine (3.77 g, 4.20 mL, 77.3 mmol) in DCM 
(60 mL), and the reaction was stirred at RT for 2 hours. Following washes with 3 x 50 mL of 
water and 2 x 50 mL of brine, the product was dried over MgSO4 and the solvent was removed 
by rotary evaporation to obtain a white solid (6.76 g, 22.3 mmol, 80%). 1H NMR (300 MHz, 
298 K, CDCl3, δ): 11.51 (s, 1H, NH), 8.64 (s, 1 H, NH), 4.51 (s, 1H, NH), 3.46 (t, 2H, CH2), 
2.88 (t, 2H, CH2), 1.49 (s, 9H, CH3), 1.44 (s, 9H, CH3) as shown on Figure 3.11. 
 
Synthesis of 2-[1,3-Bis(tert-butoxycarbonyl)guanidine]ethyl acrylamide. 2-[1,3-Bis(tert-
butoxycarbonyl)guanidine]ethylamine (6.56 g, 21.6 mmol) was dissolved in 150 mL of DCM 
with TEA (2.63 g, 3.62 mL, 26.0 mmol) and cooled in an ice-bath. A solution of acryolyl 
chloride (1.96 g, 1.7 mL, 21.6 mmol) in 50 mL of DCM was added dropwise. After leaving 
the reaction to stir overnight at RT, 300 mL of saturated NaHCO3 was added to the reaction 
mixture and extracted with 3 x 300 mL of DCM. The organic fractions were collected and 
dried over MgSO4. The product was isolated by removing the solvent and purified by 
chromatography column (hexane/EtOAc) to yield a white solid (6.4 g, 18.0 mmol, 83 %); 
mp=142 °C. 1H NMR (300 MHz, 298 K, CDCl3, δ): 11.40 (s, 1H, NH), 8.69 (t, 5.1 Hz, 1H, 
NH), 8.12 (t, 1H, amide proton), 6.21 – 6.25 (dd, J=18 Hz, J=1 Hz, 1H,  vinyl proton), 6.11 – 
6.16 (dd, J=15 Hz, J=12 Hz, 1H, vinyl proton), 5.55 – 5.57 (dd, J=9 Hz, J=3 Hz, 1H, vinyl 
proton), 3.60 (m, 2H, CH2), 3.50 (m, 2H, CH2), 1.59 (s, 9H, CH3), 1.51 (s, 9H, CH3) as shown 
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on Figure 3.12. 13C NMR (300 MHz, 298 K, CDCl3, δ): 166.1 (CH2=CH−(C=O)−NH−), 163.1 
(−NH−(C=N−)−NH−), 158.0 (=N−(C=O)−O−), 153.3 (=N−(C=O)−O−), 131.8 
(CH2=C−(C=O)−), 125.7 (CH2=C−), 84.0 (−O−C((CH3)3), 79.9 (−O−C((CH3)3), 42.2 
(−NH−CH2−CH2−NH−) 40.6 (−NH−CH2−CH2−NH−), 28.3 (−O−C((CH3)3) as shown on 
Figure 3.13. MS: [M+Na]+ 379.41 (calculated), 379.3 (found). The IR spectrum of 
diBocGEAM can be found on Figure 3.14. 
 
3.4.3.2 Synthesis of G-S30Boc 
DiBocGEAM (320 mg, 0.900 mmol), NIPAM (238 mg, 2.10 mmol) and PABTC (7.15 mg, 
0.0300 mmol) were dissolved in 1200 µL of 1,4-dioxane and 100 µL of water. 194 µL of a 5 
mg.mL-1 stock solution of VA-044 in water was added to the mixture which was introduced 
in a test tube equipped with a mechanical stirrer and a rubber septum. The solution was 
degassed with nitrogen for ca. 15 min and the polymerisation was then performed in a 
thermostated oil bath. After the desired polymerisation time, the test tube was withdrawn from 
the oil bath. 
 
3.4.3.3 Multiblock copolymer synthesis by iterative RAFT polymerisation 
 
Typical synthesis of the initial block. For the synthesis of the first block of G-D30Boc, 
NIPAM (249 mg, 2.20 mmol) and PABTC (7.49 mg, 0.0300 mmol) were dissolved in 700 µL 
of 1,4-dioxane and 33 µL of water. 142 µL of a 5 mg.mL-1 stock solution of VA-044 was 
added to the mixture which was introduced in a test tube equipped with a mechanical stirrer 
and a rubber septum. The solution was degassed with nitrogen for ca. 20 min and the 
polymerisation was then performed in a thermostated oil bath at 46 °C. After 6 hours, the test 
tube was withdrawn from the oil bath and a sample was taken for 1H NMR and SEC analysis.  
 
Typical synthesis of subsequent blocks. The test tube with the reaction mixture was opened 
and diBocGEAM (336 mg, 0.900 mmol) was added with 240 µL of 1,4-dioxane and 60 µL of 
a 10 mg.mL-1 stock solution of VA-044 in water. After the mixture was sealed with a septum, 
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the solution was degassed for ca. 20 min, then placed in an oil bath set at 46 °C for the 
polymerisation to occur. The tube was withdrawn from the oil bath after 6 hours and a sample 
was taken for 1H NMR and SEC analysis. The quantity of reagents needed for the tetrablock 
copolymers can be found in Tables 3.7-3.10. 
Monomer conversion, theoretical molecular weight Mn,th and livingness were determined as 
detailed in chapter 2. 
 
3.4.3.4 RAFT Polymerisation Kinetics for G-S30Boc 
The polymerisation kinetics and resulting composition of G-S30Boc were investigated 
using 1H NMR spectroscopy in DMSO-d6. As the vinyl protons of NIPAM and diBocGEAM 
cannot be readily distinguished, the overall monomer conversion (diBocGEAM and HEA 
combined) was followed by 1H NMR spectroscopy using an external standard (1,3,5-trioxane). 
Additionally, RP-HPLC was used to determine the relative concentration of each monomer in 
the reaction mixture over time (Eclipse Plus C18, 3.5 μm, 4.6 x 100 mm, H2O/ACN). 
Calibration curves were established with NIPAM and diBocGEAM in order to determine the 
concentration of each monomer in the kinetic samples. The ratio of NIPAM to diBocGEAM 
was calculated and used in conjunction with the overall monomer conversion in order to 
determine the relative conversion of each monomer over time and deduce the compositional 
drift (Figure 3.18). The conversion of diBocGEAM and NIPAM over time are comparable to 
one another, indicating the absence of profound compositional drift. 
 
3.4.3.5 Deprotection of the polymers 
The polymers were dissolved in TFA and stirred for 3 hours at 40°C. The TFA was 
then removed and the polymers were precipitated in diethyl ether. In order to replace the TFA 
counter-ion, the polymers were dialysed against a NaCl solution, followed by dialysis against 
distilled water. 
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3.5 Supporting Figures 
 
Figure 3.11 - 
1
H NMR spectrum of the intermediate product 2-[1,3-Bis(tert-
butoxycarbonyl)guanidine]ethylamine in CDCl3. 
 
Figure 3.12 - 
1
H NMR spectrum of diBoc-GEAM in CDCl3. 
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Figure 3.13 - 
13
C NMR spectrum of diBoc-GEAM in CDCl3. 
 
Figure 3.14 - IR spectrum of diBocGEAM. 
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Figure 3.15 - 
1
H NMR spectra in DMSO-d6 of G-D30
Boc 
for each chain extension. 
 
Figure 3.16 - DMF-SEC chromatograms for successive chain extensions of G-D30
Boc
. 
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Figure 3.17 - DMF-SEC chromatograms for G-S30
Boc
,
 
G-T30
Boc 
and G-D30
Boc
. 
 
Figure 3.18 - DMF-SEC chromatograms for successive chain extensions of A-T30
Boc
. 
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Figure 3.19 - Ratio of the concentration of remaining NIPAM and BocAEAM with 
overall conversion during the polymerisation of G-S30
Boc
. 
 
 
Figure 3.20 - 
19
F NMR spectra in D2O of G-S30 before (A) and after (B) dialysis against 
NaCl. 
 
   Chapter 3 
 
   Page | 126 
 
 
Figure 3.21 - Volume distribution of G-S30 (A), G-T30 (B), G-D30 (C) by DLS in PBS at 
37 °C at 1.024 mg.mL-1 Size and PDI are shown in Table 3.11. 
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3.6 Supporting Tables 
 
Table 3.6 - Experimental conditions used for the synthesis of S30
Boc
. 
Sample number S30Boc 
BocGEAM content (%) 32 
DPtotal 105 
NIPAM 
DPtargeted 73 
mmonomer added (mg) 238 
BocGEAM 
DPtargeted 32 
mmonomer added (mg) 321 
mCTA added (mg) 7.15 
Vdioxane added (mL) 1.200 
Vwater added (mL) 0.300 
Vtotal (mL) 1.500 
[VA-044]0 (mol L
-1) 2.00 10-3 
[monomer]0 (mol L
-1) 2 
[CTA]0/[VA-044]0 10 
L (%)[a] 92 
 
[a] Livingness of the polymers, as defined in equation 2.6. 
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Table 3.7 - Experimental conditions used for the synthesis DP 100 diblock copolymers of 
NIPAM and diBocGEAM. 
 
Sample number D30Boc 
BocGEAM content (%) 30 
DPtotal 103 
Block n° 1 2 
Monomer NIPAM BocGEAM 
DPtargeted 63 31 
mmonomer added (mg) 249 336 
mCTA added (mg) 7.49 - 
mVA-044 added (mg) 1.14 0.724 
Vdioxane added (mL) 0.704 0.240 
Vwater added (mL) 0.176 0.060 
Vtotal (mL) 0.880 1.180 
[VA-044]0 (mol L
-1) 2.50 10-3 1.90 10-3 
[monomer]0 (mol L
-1) 2.50 0.80 
[CTA]0/[VA-044]0 14 18 
L (%)[a] 94 95 
Cumulative L (%) 94 90 
 
[a] Livingness of the polymers, as defined in equation 2.6. 
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Table 3.8 - Experimental conditions used for the synthesis of G-T30
Boc
. 
 
Block n° 1 2 3 4 
Monomer NIPAM BocGEAM NIPAM BocGEAM 
DPtargeted 33 15 33 15 
mmonomer added (mg) 147 199 147 199 
mCTA added (mg) 8.85 - - - 
mVA-044 added (mg) 0.420 0.437 0.525 0.703 
Vdioxane added (mL) 0.420 0.165 0.230 0.176 
VEtOH added (mL) - 0.055 - 0.044 
Vwater added (mL) 0.100 0.060 0.060 0.056 
Vtotal (mL) 0.520 0.800 1.090 1.366 
[VA-044]0 (mol L
-1) 2.50 10-3 1.70 10-3 1.50 10-3 1.60 10-3 
[monomer]0 (mol L
-1) 2.50 0.70 1.20 0.41 
[CTA]0/[VA-044]0 29 27 23 17 
L (%)[a] 97 99 96 95 
Cumulative L (%) 97 97 94 89 
 
[a] Livingness of the polymers, as defined in equation 2.6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
   Chapter 3 
 
   Page | 130 
 
Table 3.9 - Experimental conditions used for the synthesis of A-T30
Boc
. 
 
Block n° 1 2 3 4 
Monomer NIPAM BocAEAM NIPAM BocAEAM 
DPtargeted 37 15 33 15 
mmonomer added (mg) 79.0 64.0 79.0 64.0 
mCTA added (mg) 4.77 - - - 
mVA-044 added (mg) 0.226 0.144 0.138 0.285 
Vdioxane added (mL) 0.224 0.066 0.167 0.116 
Vwater added (mL) 0.056 0.030 0.042 0.057 
Vtotal (mL) 0.280 0.375 0.583 0.732 
[VA-044]0 (mol L
-1) 2.50 10-3 1.50 10-3 1.00 10-3 1.50 10-3 
[monomer]0 (mol L
-1) 2.50 0.80 1.20 0.40 
[CTA]0/[VA-044]0 29 36 34 18 
L (%)[a] 97 98 97 95 
Cumulative L (%) 97 95 93 88 
 
[a] Livingness of the polymers, as defined in equation 2.6. 
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Table 3.10 - Characterisation data of the final Boc-protected polymers. 
  
 
Block n° Polymer composition 
M
n,th
[a]  
(g mol-1) 
M
n,SEC
[b] 
(g mol-1) 
Đ[b] 
G-S30Boc N.A. pdiBocGEAM30-s-pNIPAM70 18900 25900 1.24 
G-D30Boc 
1st pNIPAM70 10900 11000 1.07 
2nd pNIPAM70-b-pdiBocGEAM30 17900 24900 1.24 
G-T30Boc 
1st pNIPAM35 3970 6300 1.09 
2nd pNIPAM35-b-pdiBocGEAM15 9320 12800 1.14 
3rd 
pNIPAM35-b-pdiBocGEAM15-b-
pNIPAM35 
13000 19400 1.15 
4th 
pNIPAM35-b-pdiBocGEAM15-b-
pNIPAM35-b-pdiBocGEAM15 
18400 27200 1.23 
A-S30Boc N.A. pBocAEAM30-s-pNIPAM70 15400 17900 1.09 
A-D30Boc 
1st pNIPAM70 8390 10600 1.08 
2nd pNIPAM70-b-pBocAEAM30 15000 16000 1.10 
A-T30Boc 
1st pNIPAM35 3860 5560 1.15 
2nd pNIPAM35-b-pBocAEAM15 6650 9310 1.16 
3rd 
pNIPAM35-b-pBocAEAM15-b-
pNIPAM35 
10300 14770 1.20 
4th 
pNIPAM35-b-pBocAEAM15-b-
pNIPAM35-b-pBocAEAM15 
13050 18800 1.27 
 
 
[a] Theoretical molecular weight of the protected polymers calculated from equation 2.5. 
[b] Determined for the protected polymers by SEC/RI in DMF using PMMA as molecular weight standards. 
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Table 3.11 - Characterisation data of deprotected polymers. 
 
Sample  
Cationic 
content 
(%) 
Mn,th[a]  
(g mol-1) 
Elution 
ratio[b] 
(%) 
Size[c] (nm) PDI[c] 
A-S30 32 13300 54 6 0.6 
A-T30 29 13100 69 10 0.4 
A-D30 30 13000 77 6 0.9 
G-S30 32 13900 53 4 1.0 
G-T30 31 13200 72 6 0.4 
G-D30 30 13100 78 7 0.6 
[a] Theoretical molecular weight of the protected polymers calculated from equation 2.5. 
[b] From HPLC data measured in water/ACN in a C18 column (gradient 1 to 80 % ACN in 45 minutes). The 
elution ratio was calculated according to equation 2.3 using the elution time. 
[c] Measured by DLS in Phosphate Buffer Saline (PBS) at 37˚C and 1 mg mL-1 using the volume distribution. 
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 Targeting intracellular MRSA with 
guanidinium polymers and elucidating the 
structure-activity relationship  
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Abstract 
Intracellular persistence of bacteria represents a clinical challenge as bacteria can 
thrive in an environment harboured from high concentrations of antibiotics and phagocytes. 
This persistence, combined with decreasing bacterial susceptibility to antibiotics make the 
need for an alternative to current infection treatments urgent. To tackle infections whilst 
overcoming antibiotic resistance, SMAMPs are interesting candidates as they exhibit a very 
high antimicrobial activity. In addition to bearing structural similarities to CPPs, the 
guanidinium containing SMAMPs were shown to be very potent against MRSA in chapter 3. 
Therefore, they were further investigated in the treatment of intracellular S. aureus in 
keratinocytes. Varying the distribution of functional monomers was shown to have a 
substantial influence on the interactions of the polymers with bacterial membranes: the diblock 
copolymer bound the fastest, followed by the tetrablock, whereas no binding was observed 
with the statistical copolymer. This trend was consistent with that of the antimicrobial activity 
of the guanidinium polymers. The reduction in activity of the tetrablock compared to the 
diblock was attributed to the isopropyl functionalities of the polyNIPAM block hindering the 
cationic functionalities when in the middle of the polymer chain. However, these alkyl chains 
seemed to promote the antimicrobial activity of guanidinium containing SMAMPs. In parallel, 
it was observed that all three polymers had comparable levels of internalisation into 
keratinocytes, via both energy-dependent and independent pathways. These results led to the 
investigation of the efficiency of the SMAMPs against intracellular bacteria in keratinocytes. 
The diblock structure was the most active, reducing the amount of intracellular MSSA and 
MRSA by two-fold compared to the statistical and tetrablock copolymers. Here, a potential 
treatment for intracellular, multi-drug resistant bacteria is presented, using a simple and 
scalable strategy.  
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4.1 Introduction 
 
Staphylococcus aureus (S. aureus) is one of the major causes of both community and 
hospital-acquired infections, methicillin-resistant S. aureus (MRSA) being associated with a 
mortality rate fivefold higher than that of methicillin-sensitive strains (MSSA) amongst 
patients in Europe.1-2 This issue is exacerbated with the ability of S. aureus to persist 
intracellularly.3-4 The presence of S. aureus inside epithelial and phagocytic cells has been 
associated with skin infections, tonsillitis and rhinosinusitis.5-8 Unfortunately, the most 
commonly employed antibiotics (such as vancomycin, oxacillin, and gentamycin) are not 
effective against intracellular bacteria since they are not efficiently internalised by the host 
cells, which enables S. aureus to survive.9-10 In order to address this issue, antibiotic loaded 
liposomes and nanoparticles have been explored.11 Although these systems were internalised 
by infected mammalian cells and efficiently killed intracellular bacteria, the stability and the 
drug loading efficiency of nanoparticles and liposomes were shown to be limited.12-13 To 
circumvent these challenges, recent work has focused on the use of low molecular weight 
vectors capable of promoting intracellular delivery of antibiotics.14 Amongst those systems, 
cell penetrating peptides (CPPs) conjugated to antibiotics significantly reduced bacterial 
growth in intracellular environments.15-16 However, the rapid development of resistance 
against antibiotics calls for more sustainable treatment.12, 17-19  
In this context, various studies have looked into antimicrobial peptides (AMPs), as 
they appeared to have a broad activity range. More recently, synthetic polymers, designed to 
be analogous to AMPs  (SMAMPs), have been developed since they possess greater versatility 
and potential for scale-up compared to AMPs.20-21 Interestingly, SMAMPs do not evoke 
bacterial resistance as their mechanism of action is based on interactions with the negatively 
charged surface of bacterial membrane.22-23 Previous reports demonstrated that ammonium- 
and guanidinium-rich SMAMPs were potent towards a broad spectrum of bacteria.24 Among 
those, guanidinium-rich materials, mimicking arginine-rich peptide sequences, seemed 
particularly active against MRSA, as highlighted in chapter 3. 
In parallel, a wide range of guanidinium-rich polymers were also designed, to mimic 
the proficiency CPPs possess for cellular uptake.25-27 Although the mechanism of cell uptake 
has not been entirely elucidated, the guanidinium moieties are thought to interact with 
membrane phospholipids via electrostatic interactions and H-bonding, followed by both 
endocytosis and direct translocation through the membrane.28 The stereochemistry of the 
polymeric backbone was demonstrated not to impair the internalisation of the guanidinium-
rich polymers, but other parameters such as the number of guanidinium units or the overall 
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hydrophobicity of the polymer were reported to alter cellular uptake.26, 29 By exploiting their 
antimicrobial activity in combination with their ability to enter eukaryotic cells, guanidinium 
rich polymers could be a promising alternative to antibiotics currently used against 
intracellular bacteria.30-31 In this case, the usual drawbacks associated with the use of a cargo 
such as drug attachment/ encapsulation or release would be bypassed, since the polymer is 
simultaneously performing the role of vector and therapeutic agent.  
A guanidinium-containing SMAMP, polyhexamethylene biguanidine (PHMB), 
which is utilised as a disinfectant, has been reported to be efficient against intracellular S. 
aureus in keratinocytes.32-33 However, reports of potential carcinogenic effects on humans, 
and increasing regulation over its use highlight the need for an alternative to PHMB.34 In light 
of recent studies, the biological properties of SMAMPs can be improved upon by modifying 
the distribution of cationic and hydrophobic functionalities along the polymeric backbone.35-
36 Indeed, the segregation of cationic and hydrophobic moieties appears to enhance the 
bactericidal effect whilst promoting haemocompatibility, yet PHMB has an alternating 
sequence inherent to the nature of its synthesis. Varying the monomer distribution in 
guanidinium containing copolymers could potentially improve their intracellular activity and 
reduce their haemotoxicity.  
Well-defined guanidinium-rich block copolymers with controlled monomer 
distributions have been successfully prepared using RAFT polymerisation, and materials 
made using this approach represent an attractive alternative to PHMB due to the synthetic 
versatility which RAFT polymerisation offers.29, 37 
In chapter 3, the synthesis of statistical, tetrablock and diblock guanidinium-rich 
copolymers, using the acrylamide monomer guanidinoethyl acrylamide (GEAM), was 
described in detail. In the present chapter, fluorescently-labelled derivatives of these 
guanidinium-rich copolymers were prepared in order to study the interactions of SMAMPs 
with bacterial membranes. The influence of the length of the polyGEAM domains as a result 
of varying monomer distribution was also investigated, using polyGEAM homopolymers of 
similar molar mass to the cationic block(s) of the tetrablock and diblock copolymer SMAMPs. 
The final focus of this study was to investigate the intracellular activity of the guanidinium 
containing polymers within keratinocytes as a potential staphylococcal skin infection therapy. 
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4.2 Results and discussion 
 
4.2.1 Synthesis of Bodipy acrylamide (BodipyAM) 
 
The comparison of the antimicrobial activity between ammonium and guanidinium 
containing copolymers in chapter 3 demonstrated that the guanidinium copolymers were more 
active against MRSA than their ammonium copolymer counterparts. In order to carry out 
bacterial binding and mammalian cell uptake assays, the guanidinium polymers were 
functionalised using a Bodipy dye. Bodipy-derived dyes are known to have a high quantum 
yield and have been extensively used to label polymers.38 An additional advantage of Bodipy 
derivatives is their non pH-dependent fluorescence, within the limits of their stability, which 
is necessary for accurate intracellular tracking of materials. Here, an acrylamide derivative of 
the Bodipy dye was synthesised to allow its incorporation in the guanidinium copolymers in 
a RAFT polymerisation chain-extension step (Scheme 4.1). Firstly, Bodipy acid (1) was 
synthesised in 2 steps according to the literature.39 1H NMR spectra of all intermediates can 
be found in section 4.5, Figures 4.10-4.12. 1 was then modified to obtain a N-
hydroxysuccinimide (NHS) functionalised Bodipy (NHS-Bodipy, 2). 2 was then coupled with 
amino-ethylacrylamide (AEAM, 3), obtained by deprotection of BocAEAM. Since AEAM 
was not soluble in organic solvents, most probably due to its positive charge, 1 was 
functionalised with NHS in DMF prior to reaction with AEAM in water, to limit hydrolysis. 
The obtained Bodipy acrylamide (BodipyAM, 4) was fluorescent with λex=525 nm and 
λem=537 nm (Figure 4.1).  
 
 
Scheme 4.1 - Synthesis of BodipyAM from Bodipy acid. 
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Figure 4.1- Emission spectrum of BodipyAM (λex=525 nm).  
 
4.2.2 Labelling of polymers 
 
The guanidinium-rich copolymers from chapter 3 contained NIPAM as co-monomer, 
and were synthesised by RAFT polymerisation with different monomer distributions: 
statistical, tetrablock and diblock copolymers (G-S30, G-T30 and G-D30, respectively) (Table 
4.2). The incorporation of (on average) one unit of BodipyAM per polymer chain was first 
attempted via the chain extension of the Boc-protected polymers using RAFT. Following the 
chain extension with BodipyAM, the Boc protecting group of the polymer was hydrolysed 
using TFA. Once the deprotection was complete, the polymer did not exhibit any fluorescence 
(Figures 4.2 and 4.13). A possible explanation would be that the Bodipy moiety might degrade 
under the harsh acidic conditions used in the deprotection step.  
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Figure 4.2 – Emission spectra of Bodipy functionalised polymers (λex=525 nm). 
 
To circumvent this issue, the guanidinium copolymers were chain-extended with 
BodipyAM in their deprotected forms. The polymerisations were performed in a mixture of 
an acetate buffer (pH 5) and acetone (8/2) to limit aminolysis and solubilise BodipyAM, 
respectively. The excess dye was removed by precipitation in diethyl ether after further 
diluting the mixture with acetone. The Bodipy labelled statistical, tetrablock and diblock 
copolymers (G-S30Bodipy, G-T30Bodipy and G-D30Bodipy, respectively), which contained less 
than 5 % of free dye, were characterised using high performance liquid chromatography 
(HPLC) and fluorescence spectroscopy (Scheme 4.2, Figures 4.2, 4.3 and 4.13). The intrinsic 
fluorescence was determined for each polymer in order to obtain a correction factor used to 
account for a difference in the incorporation of BodipyAM between the three copolymers 
(Table 4.7). The fluorescence HPLC spectrum overlapped with that at 280 nm for each 
copolymer, indicating their fluorescence. 
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Scheme 4.2 – Library of Bodipy functionalised guanidinium polymers. 
 
Figure 4.3 - HPLC chromatograms of the fluorescent polymers (solid line – λ=280nm; 
dashed line - λex=525 nm and λem=537 nm) with a gradient of 1 to 95 % ACN in 35 
minutes with a 100 mm C18 column. 
 
4.2.3 Interactions with bacterial membrane 
 
The antimicrobial activity of the guanidinium SMAMPs towards JE2, a MRSA strain, 
was assessed in chapter 3. Interestingly, their potency increased with segregation of functional 
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regions: G-S30 did not exhibit any activity within the concentration tested (MIC > 1000 
μg.mL-1), whereas G-T30 and G-D30 were both active with MIC values of 128 and 64 μg.mL-
1, respectively. The variation in the minimum inhibitory concentration (MIC) values could 
either be explained by a difference in bacterial binding or ability to efficiently kill bacteria.  
In order to determine if the binding efficiency between bacteria and guanidinium 
copolymers was influenced by monomer distribution, the Bodipy-functionalised guanidinium 
polymers were utilised. In mass concentration, the MIC of the fluorescent polymers were 
double that of their unlabelled counterparts (256 and 128 μg.mL-1 for G-T30Bodipy and G-
D30Bodipy, respectively), as shown in Table 4.3. Although the MIC values of the fluorescent 
polymers (in molar concentration) against both RN1 and JE2 were slightly higher to that of 
the unlabelled polymers, a significant antimicrobial activity was maintained after 
incorporation of BodipyAM, in turn validating the experiment (Table 4.3). The MRSA strain 
JE2 was incubated at 37 °C with each polymer at a concentration of 128 μg.mL-1 for 15, 30 
and 120 minutes (Figure 4.4). For the 30 and 120 minute time points, propidium iodide (PI), 
which stains bacteria possessing a compromised membrane, was added 15 minutes prior to 
the end of the experiments. The bacterial suspensions were then washed and fixed on a glass 
slide to be viewed using an optical microscope. Three different filters were utilised to assess 
the interactions between the polymers and bacterial membranes: the brighfield (BF) channel, 
the green channel (Bodipy functionalised polymers) and the red channel (PI stained bacteria). 
As there was no staining with PI for the 15 minute time point, in order to demonstrate 
that the bacterial binding of guanidinium polymers is independent of the presence of PI, Figure 
4.4A displays only the BF and green channel (including a merge of the two). The images 
indicate that G-D30Bodipy was bound to bacteria within 15 minutes of incubation. According to 
the BF image, the bacteria appeared to be compromised in the presence of G-D30Bodipy, as the 
shape of the majority of the bacterial population is poorly defined. In contrast, G-S30Bodipy and 
G-T30Bodipy did not appear to bind bacteria as effectively within this timeframe, evidenced by 
the absence of noticeable fluorescence in the green channel. Additionally, the shape of the 
bacteria remained intact, indicating that the polymers did not compromise bacterial 
membrane. 
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Figure 4.4 – Bacterial membrane interactions of SMAMPs. Binding assay with JE2 of the 
guanidinium SMAMPs after 15 minutes without PI (A) Binding assay with JE2 after 30 
minutes in presence of PI (B) Binding assay with JE2 after 2 hours in presence of PI, no image 
was presented for G-D30 after 2 hours no bacteria were left under these conditions (C). The 
scale bar represents 5 µm. 
 
For the 30 minute time-point, Figure 4.4B displays images from the BF, Bodipy, PI 
channels and a merge of the Bodipy and PI channels. Following 30 minutes of incubation, 
both G-T30Bodipy and G-D30Bodipy bound to bacteria. Although the fluorescence intensity 
appeared to be greater following incubation with G-T30Bodipy than G-D30Bodipy for this time 
point, the BF images reveal that the number of bacteria was significantly lower following 
treatment with G-D30Bodipy. Furthermore, after 30 minutes in presence of G-D30Bodipy, most of 
the visible bacteria possess polymer bound to their surface and a compromised membrane, as 
can be seen with the overlay image of the Bodipy and PI channels, and are unhealthy, as 
indicated by their shape (BF). These pores would allow the polymers to diffuse out of the cell, 
which could explain a reduction in fluorescence intensity. Interestingly, bacteria interacting 
with G-T30Bodipy were also exclusively the ones stained by PI. These results demonstrate that 
membrane attachment and disruption occur jointly and in a short time span: within 15 minutes, 
the polymer binds and disrupts the membrane. This observation would question the hypothesis 
that guanidinium-rich polymers induce cell death via a different mechanism to pore 
formation.40 These results are in contradiction to a study from Tew et al., which investigated 
the effect of guanidinium-functional polyoxanorbornene on the membrane integrity of S. 
aureus using PI.40 Although the polymer showed a bactericidal effect against S. aureus, none 
of the bacteria were stained with PI after 30 minutes, indicating that bacterial membrane was 
not compromised. Comparable observations were reported by Good and co-workers after 
treatment of E.coli with PHMB. No permeability of bacterial membrane was observed in 
presence of PHMB after 60 minutes at 37 °C, when using SYTOXⓇ Green as a membrane 
integrity probe, despite the potency of the polymer against E. coli. Following this experiment, 
it was suggested that complexation of PHMB with bacterial DNA was responsible for the 
antimicrobial character of the polymer, which could also be the mechanism of action of 
guanidinium-functional polyoxanorbornene.41 The disruption of membrane integrity 
associated with G-T30 and G-D30 could be due to the action of the isopropyl groups of the 
NIPAM units - the polyoxanorbornene and PHMB did not bear any pendant alkyl chains, 
hence could likely cross bacterial membrane without compromising it (Scheme 4.3).40 In the 
present case, both pore formation and bacterial DNA binding could be occurring and 
collectively contributing towards bacterial death. 
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Scheme 4.3 – Chemical structure of (A) polyguanidinium oxanorbornene40 and (B) 
PHMB
41
. 
 
Following incubation with G-D30Bodipy for 2 hours, no bacteria were observed, most 
probably because they were killed and subsequently removed during the washing step (Figure 
4.3C). In the presence of G-T30Bodipy more bacteria were stained after 2 hours of incubation, 
compared to 30 minutes. Again, co-localisation between G-T30Bodipy and PI reinforces the 
previous observation that membrane disruption is a consequence of polymer binding. The BF 
image confirms the loss in membrane integrity for the majority of bacteria following 2 hours 
of incubation with G-T30Bodipy. Although no bacteria were stained by G-S30Bodipy, even after 
2 hours, a few of them were stained with PI. A negative control experiment with PBS and PI 
was performed and no membrane disruption was found (Figure 4.14). Therefore, in the case 
of G-S30Bodipy, the statistical copolymer would have interacted with JE2 over the course of 2 
hours, hence inducing membrane disruption, but to a limited extent. 
In summary, G-D30Bodipy underwent stronger interactions with the bacteria compared 
to G-T30Bodipy (within 15 to 30 minutes, respectively), whilst G-S30Bodipy only had limited 
interactions with JE2 even after 2 hours (Figure 4.3C). This trend correlates with the MIC 
values, as the tested concentration (128 μg.mL-1) corresponds to the MIC of G-D30Bodipy and 
half that of G-T30Bodipy (G-S30Bodipy was not active up to 1000 μg.mL-1), as shown in Table 
4.3. 
 
4.2.4 Synthesis and properties of guanidinium homopolymers 
 
The difference in the MIC values of the guanidinium polymers raises the question 
whether there is a minimum length requirement of the cationic block for the polymer to 
interact with bacterial membrane. To investigate this, guanidinium homopolymers of DP 15 
   Chapter 4 
 
   Page | 149 
 
and 30, which corresponds to the DP of the cationic block(s) in G-T30 and G-D30, 
respectively, were synthesised. As with the copolymers, polyGEAM15 and polyGEAM30 were 
synthesised by RAFT polymerisation of diBocGEAM followed by hydrolysis to remove the 
Boc protecting groups (Tables 4.4 and 4.5, Figures 4.5 and 4.15). Additionally, the role of the 
isopropyl (NIPAM) functionalities in the antimicrobial activity of G-S30, G-T30 and G-D30 
can be elucidated in the following study. 
The antimicrobial activity of the homopolymers was tested against two clinically 
relevant strains: a MSSA and MRSA strain, RN1 (NCTC 8325) and JE2 (USA 300), 
respectively (Figure 4.6A, Table 4.6). The MIC of the homopolymers polyGEAM15 and 
polyGEAM30 were similar (7 nmol.mL
-1 for both), meaning that the molar mass of the 
homopolymers did not appear to affect the antimicrobial activity in this particular case. These 
results would assert that a cationic block of DP 15 was sufficient to promote effective 
interaction with bacterial membrane. However, as G-T30 did not bind as efficiently to bacteria 
as G-D30 (Figure 4.4), it is plausible that the polyNIPAM block sterically hinders the 
interaction of the polyGEAM block with bacterial membrane in the tetrablock copolymer 
structure.  
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Figure 4.5 - Characterisation of the guanidinium homopolymers. (A) DMF-SEC 
chromatograms of polydiBocGEAM15 and polydiBocGEAM30. (B) RP-HPLC chromatograms 
of the guanidinium homopolymers with a gradient of 1 to 80 % ACN in 30 minutes with a 100 
mm C18 column (λ=280 nm). 
 
The effect of the isopropyl moieties on the antimicrobial activity of the copolymers 
was evaluated by comparing the potency of the copolymers with the cationic homopolymers 
of similar polyGEAM length. If the hydrophobic moieties are considered as “non-active” 
towards bacteria, the standard MIC values should be corrected to account for the content of 
“active” moieties in the respective polymers by multiplying the MIC expressed in molar 
concentration with the molar percentage of guanidinium functionalities in each polymer. 
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According to Figure 4.6 A, the re-evaluated MIC of G-T30 and G-D30 was less than half that 
of polyGEAM15 and polyGEAM30, respectively. This suggests that the polyNIPAM blocks 
participate in the antimicrobial activity of the polymers.  
 
Figure 4.6 – Antimicrobial and haemolytic activities of the guanidinium homopolymers. 
(A) Corrected MIC of polyGEAM and the guanidinium block copolymers against MRSA 
strain JE2 obtained by multiplying the MIC expressed in molar concentration with the molar 
percentage of guanidinium functionalities in each polymer. (B) Haemolytic activity of the 
guanidinium homopolymers and their associated copolymers. Normalised haemolysis of 
sheep blood cells following incubation at 37 °C for 2 hours in PBS with guanidinium 
SMAMPs. 
 
In order to estimate the influence of the co-monomer on the biocompatibility of the 
guanidinium polymers, the toxicity of the cationic homopolymers towards mammalian cells 
was evaluated. The haemocompatibility was first studied by incubating the polymers with 
defibrinated sheep blood over 2 hours at 37 °C. Not only did polyGEAM15 and polyGEAM30 
induce haemagglutination at concentrations as low as 2 μg.mL-1, but they also caused over 10 
% of haemolysis from 128 μg.mL-1 (Table 4.1 and Figure 4.6B).  
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Table 4.1 – Guanidinium homopolymers induced erythrocytes aggregation. Observation 
of haemagglutination of sheep blood cells following incubation with guanidinium SMAMPs 
in PBS for 2 hours at 37 °C. 
 
 sample 
/concentration 
(μg/mL) 
1024 512 256 128 64 32 16 8 4 2 1 0.5 
G-S30 +++ +++ +++ ++ ++ + + + - - - - 
G-T30 ++ ++ ++ + + + - - - - - - 
G-D30 - - - - - - - - - - - - 
polyGEAM15 +++ +++ +++ +++ +++ ++ + + + + - - 
polyGEAM30 +++ +++ +++ +++ +++ +++ ++ ++ ++ ++ + - 
 
Haemagglutination strength: +++ strong; ++ moderate; + weak; - none. 
 
To further investigate the toxicity of the polymers against mammalian cells, an XTT 
assay was performed on HaCaT (human keratinocytes) and A549 (lung epithelial) cells. The 
toxicity profile was very acute for both cationic homopolymers towards HaCaT cells (Figure 
4.7) following 20 hours incubation. The IC50 values, which is the minimum concentration 
required for a 50 % cell growth inhibition, were as low as 40 and 60 μg.mL-1 for polyGEAM30 
and polyGEAM15, respectively. Similar results were obtained with A549 cells (Figure 4.16). 
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Figure 4.7 – Cytotoxicity of guanidinium SMAMPs towards HaCaT cells. Viability of 
HaCaT cells incubated for 24 hours in presence of guanidinium homopolymers and their 
associated copolymers using an XTT assay. 
 
This set of experiments confirms that the cationic homopolymers were toxic towards 
RBCs and epithelial cells from a low concentration and that the incorporation of NIPAM in 
the guanidinium-rich copolymers reduce their toxicity in vitro. Most importantly, the 
isopropyl functionalities seem to enhance the potency of the guanidinium polymers towards 
bacteria, which is consistent with previous work investigating the role of hydrophobic 
domains in SMAMPs.42 Due to the dual action of the guanidinium-rich materials against 
bacteria, the isopropyl functionalities could promote pore formation within bacterial 
membrane, but also improve membrane crossing followed by possible condensation of 
bacterial DNA, in the hypothesis of a dual action of the guanidinium materials against bacteria. 
 
4.2.5 Effect of segmentation on cell uptake of guanidinium copolymers 
 
As mentioned previously, in addition to mimicking the action of AMPs, guanidinium 
containing polymers resemble CPPs. The potency of SMAMPs on intracellular bacteria 
strongly depends on their ability to enter mammalian cells. Therefore, the uptake of the 
guanidinium-rich polymers by keratinocytes was studied to elucidate the effect of monomer 
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distribution on their internalisation. For this assay, HaCaT cells were incubated at 37 °C for 2 
and 16 hours with the Bodipy-labelled polymers at a concentration of 128 μg.mL-1. The extent 
of uptake was quantified by measuring cellular fluorescence using a plate-reader, followed by 
correction with the intrinsic fluorescence of each copolymer (Figure 4.8 and Table 4.7). 
Following 2 hours incubation with G-S30, G-T30 and G-D30, similar levels of cellular 
fluorescence were observed in each case. Comparable levels of were also observed for all 
three SMAMPs fluorescence following 16 hours of incubation (Figure 4.8), with only a slight 
increase in uptake observed despite the substantially longer incubation time (from 2 to 16 
hours), indicating that the internalisation of the guanidinium containing polymers occured 
mostly during the first 2 hours of incubation. With this copolymer system, monomer 
distribution does not seem to have a significant impact on the internalisation of the SMAMPs 
by HaCaT cells. On the contrary, Martin et al. reported a decrease in the cellular uptake of 
guanidinium-rich copolymers with increasing segregation of functionalities (from statistical 
to tetrablock to diblock copolymer).29 This discrepancy could be explained by the 
hydrophobicity of the overall materials as the polymers in the mentioned study used more 
hydrophilic co-monomers than NIPAM. Indeed, there is strong evidence that the 
hydrophobicity of cationic polymers largely influences the extent of cell uptake.43  
The uptake mechanism of the guanidinium polymers was further investigated by 
incubating the cells at 4 °C for 2 hours. At this temperature, not only energy-dependent uptake 
pathways are inhibited, but the overall hydrophobicity of the SMAMPs might be decreased 
due to the thermo-responsiveness of polyNIPAM.44 The internalisation of all three polymers 
was drastically reduced at 4 °C by over 70 % compared to that at 37 °C (Figure 4.8), which 
was also observed in the work by Martin et al., indicating that the guanidinium polymers are 
taken up via both membrane permeation and endocytosis.29 However, the difference in 
internalisation was not as substantial with the DMA and HEA copolymers, which could 
possibly be explained by a decrease in hydrophobicity of poly(GEAM-co-NIPAM) further 
reducing the cellular uptake of the copolymers at 4 °C. Moreover, the levels of uptake at 4 °C 
were comparable for G-S30, G-T30 and G-D30. As a result, the ratio of polymer present in 
endosomes and in the cytosol should be similar for all three SMAMPs. Nonetheless, the 
guanidinium containing polymers are likely to escape from endosomes due to their highly 
charged nature, as demonstrated with arginine-rich peptides, hence interact with bacteria 
present in the cytosol.45-46 
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Figure 4.8 – Comparison of cell uptake of guanidinium polymers with architecture. 
Cellular fluorescence measured for HaCaT cells in presence of 128 µg.mL-1 of guanidinium 
polymers for the indicated time and temperature. *: p ≤ 0.05; **: p ≤ 0.01; ***: p ≤ 0.001. 
 
4.2.6 Effect of segmentation on potency against intracellular bacteria 
 
Since the guanidinium polymers exhibited both antimicrobial activity and ability to 
be taken up efficiently by mammalian cells, their activity against intracellular bacteria was 
finally explored. To investigate this, HaCaT cells were infected either with the MSSA strain 
RN1, or with the MRSA strain JE2, by incubating them for 2 hours. The infected cells were 
then treated with a mixture of gentamicin and lysostaphin for 30 minutes to kill extracellular 
bacteria as described in the literature.47 Finally, the infected cells were incubated with the 
guanidinium compounds at a non-cytotoxic concentration of 128 μg.mL-1 at 37 °C for 2 hours. 
Lysostaphin was used as a negative control (at a concentration of 5 μg.mL-1) as this enzyme 
is known to be ineffective against intracellular bacteria, whilst killing extracellular bacteria, 
which can be released by infected cells.3 Following incubation with the guanidinium-rich 
copolymers, the cells were lysed using a saponin solution. The lysate was diluted and plated 
to obtain a bacterial count for each sample (Figure 4.9). The experiment was repeated 3 times 
in triplicates. 
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Similar levels of intracellular MSSA RN1 were recovered following treatment with 
G-S30 or G-T30 compared to the lysostaphin control (Figure 4.9A). This result indicates that 
the polymers inhibited the proliferation of extracellular bacteria released during the treatment 
to a comparable extent to lysostaphin, but did not inhibit the growth of intracellular S. aureus. 
This would help containing the infection to an extent but would not be sufficient to treat 
infections. Interestingly, G-D30 was the most active against intracellular RN1, reducing the 
number of bacteria by two-fold compared to lysostaphin (Figure 4.9A).  
 
Furthermore, treatment with G-S30 and G-T30 revealed survival levels of 
intracellular MRSA JE2 bacteria comparable to the lysostaphin treated control (Figure 4.9B). 
In contrast, G-D30 was active against intracellular JE2 with a 50 % growth inhibition of 
intracellular MRSA following 2 hours of treatment. Interestingly, the cell uptake assay 
demonstrated that all three compounds were internalised in keratinocytes to a similar extent 
and a similar fashion (ratio of endocytosis to energy-independent pathways). These results 
narrow down the possible explanations for a difference in activity against intracellular 
bacteria, which is most likely due to the divergence in antimicrobial activity between the three 
polymers (MIC˃1024 μg.mL-1 for G-S30, and MIC=128 and 64 μg.mL-1 for G-T30 and G-
D30, respectively, against both RN1 and JE2). Indeed, G-D30 exhibited the highest 
antimicrobial activity towards planktonic RN1 and JE2. The improved potency of G-D30 
against both MSSA and MRSA is responsible for the superior activity against intracellular 
bacteria compared to its statistical and tetrablock copolymer counterparts (Figure 4.9).  
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Figure 4.9 –Intracellular activity of guanidinium polymers in HaCaT cells. Counts of 
intracellular bacteria after a polymer treatment at 128 μg.mL-1 at 37 °C for 2 hours against 
RN1 (A) JE2 (B). Treatment with G-D30 at 40 μg.mL-1 for 2 hours against RN1 (C) JE2 (D). 
*: p ≤ 0.05; **: p ≤ 0.01; ***: p ≤ 0.001. 
 
Following the experiments performed at 128 μg.mL-1, treatment of intracellular 
bacteria with G-D30 was undertaken at a lower polymer concentration (40 μg.mL-1) for 2 
hours, in order to assess variation in activity against intracellular bacteria with concentration. 
A similar level of inhibition (40 % of bacteria recovered compared to the lysostaphin control) 
against RN1 at this concentration as at 128 μg.mL-1 (Figure 4.9C). Although the concentration 
of polymer treatment is of 40 μg.mL-1, the intracellular concentration of G-D30 might reach a 
similar level to the MIC value of G-D30 against planktonic RN1 (64 μg.mL-1). However, G-
D30 was not effective against intracellular JE2 at 40 μg.mL-1 (Figure 4.9D). A possible 
explanation could be that, as previously discussed, JE2 is less susceptible to SMAMPs 
compared to RN1 due to its resistance to methicillin. As G-D30 did not exhibit any toxicity at 
128 μg.mL-1 against the various types of mammalian cells tested, the guanidinium diblock 
copolymer represents a promising candidate for the use in intracellular killing of MRSA and 
MSSA. 
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Although inhibition of half of intracellular MRSA was achieved by treating infected 
keratinocytes with G-D30, scope for improvement was identified for a complete eradication 
of intracellular bacteria. S. aureus was shown to be internalised by mammalian cells via 
phagocytosis, following which various factors such as the type of host cell or the bacterial 
growth phase come into play.48 In the majority of cases, S. aureus seems to be present in 
defined locations within the host cell: inside endosomes where they can replicate, in the 
cytosol if they escape from endosomes, or in phagolysosomes (result of the fusion of a 
lysosome with a phagosome).48 Although the bacteria should be eradicated by the innate 
immune system, S. aureus has been reported to persist within phagosomes for prolonged 
periods.49 Having the bacteria compartmentalised either in endosomes or in phagolysosomes 
renders them difficult to access. This could explain why the action of the SMAMPs on 
intracellular S. aureus was not optimal. Despite phagosomes fusing with late endosomes, the 
likelihood of a phagosome containing bacteria merging with an endosome comprising a 
SMAMP is small.50 However, Good et al. reported eradication of 90 % of intracellular S. 
aureus in keratinocytes after treatment with PHMB at 4 μg.mL-1, during which co-localisation 
of the SMAMP with bacteria was observed.32 The greater intracellular efficiency of PHMB 
could also be explained by a more efficient internalisation into keratinocytes compared to that 
of G-D30. However, as previously mentioned, the fate of intracellular S. aureus strongly 
depends on experimental conditions.48 In the study with PHMB, the protocol and the bacterial 
strain employed to obtain intracellular bacteria differ from that used for the present work, 
which could have resulted in a different ratio of bacteria in the cytosol compared to that in 
endosomes and makes a direct comparison between the two studies difficult. 
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4.3 Conclusion 
 
The previous chapter in this thesis demonstrated that varying monomer distribution in 
guanidinium-rich copolymers influences their antimicrobial activity. Elsewhere, it has been 
shown that varying the monomer distribution in a similar copolymer system influences their 
cellular uptake.29 Combining these two themes, this chapter aimed to utilise the guanidinium-
rich polymers introduced in chapter 3 to determine the influence of monomer distribution on 
activity against intracellular bacteria, which has been an ongoing clinical challenge. 
G-D30 was demonstrated to be the most efficient at attaching to bacterial membrane, 
followed by G-T30, whilst no binding was observed with G-S30. This reduced binding affinity 
is probably not due to the reduction in the size of the cationic block as polyGEAM15 and 
polyGEAM30 exhibited similar antimicrobial activity. The difference between G-D30 and G-
T30 could instead be attributed to the isopropyl functionalities hindering the guanidinium 
moieties from interacting with the negatively charged phospholipids present on bacterial 
membranes. Nonetheless, there is strong evidence that these hydrophobic functionalities are 
necessary for both antimicrobial activity and their internalisation into mammalian cells. 
Indeed, the isopropyl functionalities from the polyNIPAM block of G-D30 and G-T30 were 
likely responsible for permeabilising bacterial membranes as it was demonstrated elsewhere 
that guanidinium homopolymers did not compromise bacterial membrane. This hypothesis 
was confirmed with the decrease in antimicrobial activity of polyGEAM homopolymers 
which contained no polyNIPAM. 
Interestingly, all three SMAMPs were shown to be internalised in keratinocytes to 
comparable levels via both active and passive mechanisms. This result was expected due to 
their resemblance to the structure of CPPs. Despite their cellular uptake, the statistical and 
tetrablock copolymers did not appear to be active towards intracellular S. aureus. The diblock 
guanidinium copolymer G-D30 particularly attracted attention as it inhibited the growth of 
both intracellular MSSA and MRSA by 50 % over 2 hours. Therefore, the optimised 
copolymer microstructure for the reduction of intracellular and extracellular MRSA appears 
to be the diblock copolymer G-D30, which could find applications in the treatment of 
infections, whilst limiting antibiotic induced-bacterial resistance.2 In order to further reduce 
the amount of intracellular bacteria, variation in the hydrophobic functionality, overall charge 
content or other bacteria-targeting moiety could be investigated. 
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4.4 Experimental 
 
4.4.1 Materials.  
Boron trifluoride diethyl etherate (BF3.OEt2), chloroform (CHCl3), 2,3-dichloro-5,6-, 
dichloromethane (DCM), dicyano-1,4-benzoquinone (DDQ), 1,4-dioxane, 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC), ethylacetate (EtOAc), hexane, methanol 
(MeOH), N-hydroxysuccinimide (NHS), triethylamine (TEA) and trifluoroacetic acid (TFA) 
were purchased from Sigma-Aldrich and used without further purification. 2,2'-azobis[2-(2-
imidazolin-2-yl)propane]dihydrochloride (VA-044, Wako), 4-carboxybenzaldehyde (Alfa-
Aesar), 2,4-dimethylethylpyrrole (Acros Organic) and propidium iodide (PI, Thermo-Fisher) 
were also used without further purification. Nutrient Agar, Dulbecco's Modified Eagle's 
Medium (DMEM), Müller-Hinton Broth (MHB), Roswell Park Memorial Institute medium 
(RPMI-1640) , Phosphate Buffered Saline (PBS) tablets, Concanavalin A (Con A) and Triton 
X were purchased from Sigma-Aldrich. 96-well plates were sourced from Thermo-Fischer. 
Milli-Q filtered water was used to prepare solutions, according to their recommended 
concentration and the solutions were autoclaved prior to their usage in order to ensure sterility. 
Defibrinated sheep blood was obtained from Fisher Scientific. 
 
4.4.2 Methods. 
4.4.2.1 Nuclear Magnetic Resonance (NMR) Spectroscopy.  
1H NMR spectra were recorded on a Bruker Advance 300 spectrometer (300 MHz) at 27 °C 
in DMSO, CDCl3 or D2O. For 
1H NMR, the delay time (dl) was 2 s. Chemical shift values (δ) 
are reported in ppm. The residual proton signal of the solvent was used as internal standard.  
4.4.2.2 Size exclusion chromatography (SEC).  
Molar mass distributions were measured using an Agilent 390-LC MDS instrument equipped 
with differential refractive index (DRI), viscometry (VS), dual angle light scatter (LS) and 
dual wavelength UV detectors. The system was equipped with 2 x PLgel Mixed D columns 
(300 x 7.5 mm) and a PLgel 5 µm guard column. The eluent was DMF with 5 mmol NH4BF4 
additive. Samples were run at 1 mL min-1 at 50°C. Poly(methyl methacrylate) standards 
(Agilent EasyVials) were used for calibration between 955,000 - 550 gmol-1. Analyte samples 
were filtered through a nylon membrane with 0.22 μm pore size before injection. Respectively, 
experimental molar mass (Mn,SEC) and dispersity (Đ) values of synthesized polymers were 
determined by conventional calibration using Agilent GPC/SEC software. 
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4.4.2.3 Fluorescence spectrometer 
The fluorescent intensity was monitored using Agilent Technologies Cary Eclipse 
Fluorescence Spectrophotometer. The solutions of vesicles were introduced in a polystyrene 
cuvette for the measurements. 
4.4.2.4 High performance liquid chromatography (HPLC) 
HPLC was performed using an Agilent 1260 infinity series stack equipped with an Agilent 
1260 binary pump and degasser. The flow rate was set to 1.0 mL min-1 and samples were 
injected using Agilent 1260 autosampler with a 100 μL injection volume.  The temperature of 
the column was set at 37 °C. The HPLC was fitted with a phenomenex Lunar C18 column 
(150 x 4.6 mm) with 5 micron packing (100Ǻ). Detection was achieved using an Agilent 1260 
variable wavelength detector. UV detection was monitored at λ = 309 nm. Methods were 
edited and run using Agilent OpenLAB online software and data was analysed using Agilent 
OpenLAB offline software. Mobile phase solvents used were HPLC grade (ACN was ‘far 
UV’) and consisted of mobile phase A: 100 % ACN, 0.04 % TFA; mobile phase B: 100 % 
water, 0.04 % TFA with a gradient of 1 to 95 % ACN over 35 minutes. 
4.4.2.5 Bacterial Strains and Growth Conditions 
The utilised bacterial strains were S. aureus USA 300 LAC JE2 and NCTC 8325 RN1. 
Bacteria were grown in TSB at 37 °C at 250 rpm for 18 hours. 
4.4.2.6 Antibacterial susceptibility tests 
Antibacterial susceptibility was studied using two strains of Staphylococcus aureus (S. 
aureus): RN1 and JE2. Minimum inhibitory concentrations (MICs) were determined 
according to the standard Clinical Laboratory Standards Institute (CLSI) broth microdilution 
method (M07-A9-2012). A single colony of bacteria was picked up from a fresh (24 hour) 
culture plate and inoculated in 5 mL of Mueller-Hinton (MH) broth, then incubated at 37 °C 
overnight. On the next day, the concentration of cells was assessed by measuring the optical 
density at 600 nm (OD600). Culture suspension was then diluted to an OD600 = 0.1 with MHB 
in order to reach a bacterial concentration of ~ 108 colony forming unit per mL (CFU mL-1). 
The solution was diluted further by 100 fold to obtain a concentration of 106 CFU mL-1. 
Polymers were dissolved in distilled water and 100 μL of each test polymer was added to 
micro-wells followed by the addition of the same volume of bacterial suspension (106 CFU 
mL-1). The micro-wellplates were incubated at 37 °C for 24 hours, and growth was evaluated 
by measuring the OD600 using a plate reader. Triplicates were performed for each 
concentration and readings were taken twice. The growth in the well was normalised using 
negative controls, wells without any bacteria introduced, and positive controls, wells only 
containing bacterial solution. 
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4.4.2.7 Bacterial membrane interactions 
Antibacterial susceptibility was studied using two strains of Staphylococcus aureus 
(S. aureus): RN1 and JE2. Bacteria were picked up from a frozen aliquot inoculated in 5 mL 
of Trypsic Soy Broth (TSB), then incubated at 37 °C overnight. On the next day, the 
concentration of bacteria was assessed by measuring the optical density at 600 nm (OD600). 
Culture suspension was then diluted to an OD600 = 1 with TSB and 1 mL of the diluted 
suspension was centrifuged at 5000 rpm for 5 minutes. Solutions of the labelled polymers 
were prepared with a final concentration of 128 μg.mL-1 in PBS. The bacteria were 
resuspended in the polymer solution and incubated at 37 °C for 15 minutes and 2 hours whilst 
shaking. The solutions were then centrifuged, the supernatant removed and 110 μL of a 300 
μM solution of propidium iodide (PI) was added. After incubating at 37 °C for another 15 
minutes, the bacteria were washed with PBS and finally the pellet was resuspended in 100 μL 
of PBS of which 5 μL was placed on a glass slide covered with an agarose gel. Upon drying, 
20 μL of DAPI was added and the cover slip was placed upon the sample. The samples were 
using a Leica DMi8 fluorescence microscope equipped with a FITC filter (480nm/40) used to 
view BodipyAM and a TXR filter (560nm/40) to image PI. 
4.4.2.8 Eukaryotic Cell Lines and Growth Conditions 
HaCaT human keratinocytes were grown in a 50:50 mixture of Ham’s F12 and 
Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10 % of foetal calf serum, 
1 % of 2 mM glutamine and 1 %. Both cell lines were grown as adherent monolayers at 37 °C 
in a 5 % CO2 humidified atmosphere and passaged at approximately 70-80 % confluence. 
4.4.2.9 Cell uptake assay 
HaCaT cells were seeded (2 104 cells/well) in a black 96-well plate with clear bottom. 
After 24 hours, the cells were incubated with fluorescent polymers (128 and 40 μg.mL-1) for 
2 or 16 hours depending on the specified conditions. In order to stain the nucleus of the cells, 
Hoescht 33342 was added to each well 15 minutes prior to the end of the incubation time. For 
the experiment performed at 4 °C, the plate was placed in the fridge 30 min prior to the 
polymer treatment. The wells were viewed after washing and replacing with fresh media using 
a Cytation3 Cell Imaging Multi-Mode ReaderTM from Biotek®.  Gen5TM was used to isolate 
individual cells with the blue channel. The background was removed with a rolling ball model 
(20 µm) and intracellular fluorescence was determined using the RFP filter (λex=531 nm, 
λem=593 nm) to view the Bodipy-functionalised polymers. Two separate experiments were 
conducted with triplicates. 
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4.4.2.10 Invasion assay 
The intracellular infection was performed on HaCaT cells using RN1 and JE2. 24-
well plates were used to seed 2 105 cells per well which were left to pre-incubate with 
antibiotic-free medium at 37 °C for 10 hours. A single colony of bacteria was inoculated in 
LSB overnight. The inoculum was diluted to reach an OD=0.15 and were incubated for 2 
hours to reach OD=1. After a 1:200 dilution, 1 mL of the bacterial solution was added in each 
well and the cells were incubated for another 2 hours at 37 °C. The medium was then removed 
and the wells were washed with 1 mL of PBS. 500 μL of a solution of 50 μg.mL-1 of 
gentamicin and 20 μg.mL-1 of lysostaphin in DMEM was added and the plate was left at 37 
°C for 30 min to kill the extracellular bacteria. The solution was removed and the wells were 
washed with PBS. 500 μL of polymer solution was added and the plate was incubated at 37 
°C for 2 hours, using a solution of 5 μg.mL-1 of lysostaphin as a negative control. 1 mL of a 
solution of 0.5 % of saponin was added to disrupt the membrane of mammalian cells. After 
10 minutes at 37 °C, serial dilution of each well in PBS was undertaken following a thorough 
detachment of the cells. Each serial dilution was then plated on an Agar plate and left in the 
incubator overnight. The number of bacteria was counted on the next day. 
4.4.2.11 Statistical analysis of data 
The statistical significance of the differences between cfu/mL recovered from various 
groups was analysed using the One-way ANOVA test. Differences were considered 
significant if P ≤ 0.05. 
 
4.4.3 Synthesis 
4.4.3.1 Synthesis of BodipyAM 
 
 
Synthesis of Bodipy acid. Bodipy acid was synthesised according to the literature.51 4-
carboxybenzaldehyde (0.61g, 4.06 mmol) and 2,4-dimethylethylpyrrole (1.00 g, 1.10 mL, 
8.12 mmol) were dissolved in 150 mL of DCM. After addition of a few drops of TFA, the pale 
yellow mixture turned red. The solution was left to stir at RT overnight. A solution of DDQ 
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(0.92 g, 4.06 mmol) dissolved in 100 mL of DCM was added to the reaction mixture. After 
stirring at RT for 4 hours, TEA (6.16 g, 8.5 mL, 60.9 mmol) was introduced, followed by a 
dropwise addition of BF3.OEt2 (9.22 g, 9 mL, 65.0 mmol). The reaction was left to stir for 2 
hours at RT. The reaction mixture was washed with 3 x 250 mL of water, then dried over 
MgSO4. The solvent was removed and the product was purified by silica gel chromatography 
column (EtOAc/hexane, 90:10) to yield a purple solid (110 mg, 259 μmol, 6 %). 1H NMR 
(300 MHz, 298 K, CDCl3, δ): 8.23 (d, J=6 Hz, 2H, HAr proton), 7.47 (d, J=6 Hz, 2H, HAr 
proton), 2.55 (s, 6H, CH3), 2.30 (q, 4H, HCH2CH3), 1.28 (s, 6H, HAr), 0.99 (t, 6H, HCH2CH3) 
as shown on Figure 4.10. 
 
Synthesis of NHS-Bodipy. Bodipy acid (20 mg, 47 μmol) was dissolved in 2 mL of 
DMF with EDC (13.6 mg, 71 μmol) and NHS (10.8 mg, 94 μmol). The reaction mixture was 
left to stir overnight. Upon addition of 2 mL of CHCl3, the solution was washed with 3 x 2 
mL of water and dried over MgSO4. The solvent was removed to yield a purple powder (24 
mg, 46 μmol, 98 %). 1H NMR (300 MHz, 298 K, CDCl3, δ): 8.23 (d, J=6 Hz, 2H, HAr proton), 
7.47 (d, J=6 Hz, 2H, HAr proton), 2.89 (s, 2H, CO-CH2-CH2-CO), 2.55 (s, 6H, CH3), 2.30 (q, 
4H, HCH2CH3), 1.28 (s, 6H, HAr), 1.00 (t, 6H, HCH2CH3) as shown on Figure 4.11. 
 
 
Synthesis of N-(2-aminoethyl)acrylamide. Tert-butyl (2-acrylamidoethyl)carbamate 
(BocAEAM) was synthesised according to the literature.36 The Boc protecting group was 
removed by adding TFA (500 μL) in 500 μL of EtOH with BocAEAM (100 mg, 0.47 mmol). 
The product was isolated by rotary evaporation. 1H NMR (300 MHz, 298 K, D2O, δ): 6.24-
6.20 (dd, J=12 Hz, J=6 Hz, 1H, vinyl proton), 6.16-6.12 (dd, J=16 Hz, J=2 Hz, 1H, vinyl 
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proton), 5.74-5.71 (dd, J=9 Hz, J=2 Hz, 1H, vinyl proton), 3.56 (t, 2H, CO-NH-CH2), 3.16 (t, 
2H, CH2-NH2). 
 
Synthesis of Bodipy acrylamide. NHS-Bodipy (24 mg, 46 μmol) was dissolved in a 
2 mL water/THF mixture (40:60) with N-(2-aminoethyl)acrylamide (6.9 mg, 46 μmol) and 
NaHCO3 (5.8 mg, 69 μmol). The reaction mixture was left to stir at RT overnight. The solvent 
was removed and the product was dissolved in 7 mL of CHCl3. After washing with 3 x 2 mL 
of water, the organic layer was dried over MgSO4. The solvent was removed to yield a purple 
powder (15 mg, 29 μmol, 64 %). 1H NMR (300 MHz, 298 K, CDCl3, δ): 7.95 (d, J=6Hz, 2H, 
HAr proton), 7.39 (d, J=6Hz, 2H, HAr proton), 6.36-6.31 (dd, J=15 Hz, J=1 Hz, 2H, vinyl 
proton), 6.20-6.11 (dd, J=18 Hz, J=9 Hz, 2H, vinyl proton), 5.72-5.69 (dd, J=9 Hz, J=1 Hz, 
1H, vinyl proton), 3.69 (d, 4H, NH-CH2-CH2-NH2), 2.54 (s, 6H, CH3), 2.29 (q, 4H, 
HCH2CH3), 1.26 (s, 6H, HAr), 0.99 (t, 6H, HCH2CH3) as shown on Figure 4.12. MS: 
[M+Na]+=543.42 (calculated), 543.4 (found). 
 
4.4.3.2 Synthesis of Bodipy functionalised polymers 
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G-D30 (13.9 mg, 1 μmol) was dissolved in an acetate buffer (pH 5). A solution of Bodipy 
acrylamide (0.5 mg, 1 μmol) in acetone was added, as well as a stock solution of VA-044 in 
H2O. The reaction mixture was degassed for 15 min, then placed in an oil bath at 46 °C for 5 
hours. Similar reactions were performed on G-S30 and G-T30. 
 
Concentration 
(mol.L-1) 
Mass 
(mg) 
Initiator VA-044 1.0 10-3 0.162 
polyGEAm-co-NIPAm 2.0 10-3 13.9 
Bodipy acrylamide 2.0 10-3 0.520 
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4.5 Supporting Figures 
 
 
Figure 4.10 - 
1
H NMR spectrum of Bodipy acid in CDCl3. 
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Figure 4.11 - 
1
H NMR spectrum of NHS-Bodipy in CDCl3. 
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Figure 4.12 - 
1
H NMR spectrum of Bodipy acrylamide in CDCl3. 
 
 
 
 
Figure 4.13 - Photos of 1 mg.mL
-1 
solution of the Bodipy functionalised polymers with 
(A) chain extension after deprotection and (B) deprotection after chain extension. 
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Figure 4.14 - Negative control for the binding assay with MRSA strain JE2 after 2 hours 
in presence of PI. Microscopy images with the BF, green and red channels. The scale bar 
represents 5 µm. 
 
 
Figure 4.15 - 
1
H NMR spectra of polydiBocGEAM15 and polydiBocGEAM30 in DMSO-
d6. 
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Figure 4.16 – Cytotoxicity of guanidinium SAMPs towards A549 cells. Viability of 
HaCaT cells incubated for 24 hours in presence of guanidinium homopolymers and their 
associated copolymers using an XTT assay. 
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4.6 Supporting Tables 
 
Table 4.2 - Synthesised Boc-protected polymers. 
 
Statistical 
copolymer 
NIPAM70-s- BocGEAM30 G-S30 
Tetrablock 
copolymer 
NIPAM35-b- BocGEAM15-b-
NIPAM35-b- BocGEAM15 
G-T30 
Diblock 
copolymer 
NIPAM70-b- BocGEAM30 G-D30 
 
 
Table 4.3 - Antimicrobial activity of the Bodipy functionalised compounds 
 
 
 
MIC[a] (μg.mL
-1
) MIC[a] (nmol.mL
-1
) 
RN1 JE2 RN1 JE2 
Arginine mimics 
G-S30 > 1024 > 1024 > 75 > 75 
G-T30 128 128 10 10 
G-D30 64 64 5 5 
Bodipy 
functionalised  
Bodipy
G-S30 > 1024 > 1024 > 70 > 70 
Bodipy
G-T30 256 256 16 16 
Bodipy
G-D30 128 128 8 8 
 
[a] MIC is the minimum inhibitory concentration at which no visible bacterial growth can be observed. 
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Table 4.4 - Experimental conditions used for the synthesis of polydiBocGEAM15 and 
polydiBocGEAM30. 
 polydiBocGEAM15 polydiBocGEAM30 
DPtargeted 14 26 
mmonomer added (mg) 71 107 
mCTA added (mg) 3.18 2.38 
mVA-044 added (mg) 0.324 0.404 
Vdioxane added (mL) 0.268 0.400 
Vwater added (mL) 0.065 0.100 
Vtotal (mL) 0.333 0.500 
[VA-044]0 (mol L
-1) 3.00 10-3 2.50 10-3 
[monomer]0 (mol L
-1) 0.60 0.60 
[CTA]0/[VA-044]0 13 8 
L (%)[a] 94 91 
 
[a] Livingness of the polymers, as defined in equation 2.6. 
 
 
Table 4.5 – DMF-SEC data of the Boc-protected guanidinium homopolymers. 
 
Mn,th
[a]
 (g.mol
-1) Mn,SEC
[b] (g.mol-1) Đ 
polydiBocGEAM15 5200 5600 1.15 
polydiBocGEAM30 9500 10100 1.19 
 
[a] Theoretical molecular weight of the protected polymers calculated from equation 2.5. 
[b] Determined for the protected polymers by SEC/RI in DMF using PMMA as molecular weight standards. 
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Table 4.6 – MIC values for the guanidinium homopolymers. 
 
Compounds 
MIC[a] (μg.mL
-1
) 
MIC[a] 
(nmol.mL
-1
) 
MIC x % 
GEAM[b] 
(nmol.mL
-1
) 
RN1 JE2 RN1 JE2 RN1 JE2 
Poly(NIPAM-
co-GEAM) 
G-S30 > 1024 > 1024 > 75 > 75 > 25 > 25 
G-T30 128 128 10 10 3 3 
G-D30 64 64 5 5 1.5 1.5 
polyGEAM 
polyGEAM
15
 16 16 7 7 7 7 
polyGEAM
30
 32 32 7 7 7 7 
 
[a] MIC is the minimum inhibitory concentration at which no visible bacterial growth can be observed. 
[b] Corrected MIC with the molar % of GEAM content.  
 
 
 
Table 4.7 - Fluorescence intensity and correction factor due to the discrepancies in the 
intrinsic fluorescence of the polymers (calculated using a calibration curve). 
 Slope 
α[a] 
Correction 
factor β[b] 
Original 
value[c] 
Corrected 
value 
G-S30 9.57 1.00 3412 3412 
G-T30 5.21 1.84 1723 3164 
G-D30 4.99 1.92 1303 2499 
[a] Fluorescence intensity=α.[concentration] 
[b] βi= α(G-S30)/ αi 
[c] Cellular fluorescence values obtained for intracellular fluorescence of HaCaT after 2 hours at 37 °C 
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 Conclusion and outlook 
 
Since the effectiveness of antibiotics against bacteria is progressively diminishing, the 
need for alternative treatments of bacterial infections is becoming a pressing clinical issue. In 
an attempt to aid the development of such alternatives, SMAMPs have been extensively 
studied in order to determine the important features which confer effective antimicrobial 
activity. The scope of this thesis was to establish the relationship between the primary 
microstructure of cationic SMAMPs and their antimicrobial activity, thereby outlining 
synthetic approaches for optimising the selectivity of such materials.  
Chapter 2 focused on the synthesis of a library of SMAMPs containing a primary 
amine functional acrylamide monomer (AEAM), designed to mimic lysine, and a hydrophobic 
co-monomer (NIPAM). The library contained several general compositions with a range of 
AEAM content (0, 30, 50, 70 and 100 molar %), while for each general composition the 
monomer distribution was also varied (statistical, multiblock and diblock copolymer 
microstructures). Statistical and block copolymers with controlled molar mass and molar mass 
distribution were readily obtained via RAFT polymerisation. The potency of the SMAMP 
library against four different strains of bacteria (two Gram-negative and two Gram-positive) 
was evaluated, in addition to their compatibility towards mammalian cells. In addition to the 
AEAM content, the monomer distribution of the copolymer systems was found to affect the 
physico-chemical and biological properties of the SMAMPs.   
As monomer distribution had a significant impact on the selectivity of the ammonium 
polymers, another series of cationic polymer was studied to demonstrate that these 
observations may be true for other copolymer compositions containing different cationic 
moieties. In chapter 3, copolymers incorporating 30 % of a guanidinium functional acrylamide 
(GEAM) monomer, designed to mimic arginine, and NIPAM were synthesised with variation 
in their monomer distribution (statistical, tetrablock and diblock copolymers). Again, well-
defined polymers were prepared using RAFT polymerisation, and analogous ammonium 
(AEAM-based) counterparts were prepared following protocols established in chapter 2. The 
main aim of this chapter was to establish the influence of the nature of positive moieties, and 
their distribution along polymer backbone, on their selectivity towards MSSA and MRSA. 
These bacterial strains were of particular interest since reduced susceptibility have emerged 
against vancomycin, which is the last resort antibiotic currently used against MRSA. The type 
of positive charge and segregation of cationic and hydrophobic functionalities affected the 
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antimicrobial activity as well as the toxicity of the polymers towards mammalian cells, and 
can hence be used to tune the properties of SMAMPs. 
In addition to an increasing resistance, another challenge antibiotics currently need to 
tackle during infections is the intracellular persistence of bacteria. In parallel to being explored 
as SMAMPs, guanidinium containing polymers have successfully been utilised to mimic CPPs 
in previous studies, and are therefore interesting candidates for the treatment of intracellular 
bacteria. In this context, chapter 4 concerns the use of the guanidinium-rich polymers 
introduced in chapter 3 towards the reduction of intracellular MSSA and MRSA within 
keratinocytes. To investigate this, the polymers were fluorescently-labelled with a Bodipy-
functional acrylamide monomer. The influence of monomer distribution on the cellular uptake 
of the SMAMPs as well as the effect on their interactions with bacterial membrane were 
determined. Following these experiments, the treatment of intracellular bacteria with 
guanidinium containing polymers was explored. 
The synthesis of statistical and (multi)block copolymers via RAFT polymerisation 
was a simple and versatile method which enabled the preparation of ammonium- and 
guanidinium-containing polymers. As quantitative monomer conversion was obtained for 
each block extension, all copolymers syntheses could be performed in a one-pot fashion. By 
optimising the reaction conditions, polymers with a targeted molar mass and narrow molar 
mass distributions were obtained (Ð ≤ 1.38).  
From these studies, some key parameters were found to significantly influence the biological 
properties of the polymers. 
 
Effect of charge to hydrophobicity ratio 
Firstly, the charge to hydrophobicity ratio played an important role, as previously 
reported in the literature. By characterising the cationic polymers by reverse-phase HPLC, the 
charge to hydrophobicity ratio was demonstrated to increase with increasing AEAM content. 
Not only did haemolytic activity increase with increasing AEAM content, but 
haemagglutination was also shown to be favoured, with polymers with an AEAM content of 
50 % or above possessing very poor haemocompatibility. Additionally, the toxicity of the 
cationic polymers to other mammalian cells was enhanced with increasing charge to 
hydrophobicity ratio. Indeed, the incorporation of NIPAM into the SMAMPs was shown to 
drastically improve the compatibility of the materials towards mammalian cells. Therefore, it 
is necessary to establish an optimal AEAM content for any new system based on these 
copolymer compositions. Additionally, it is worth noting that the selectivity of SMAMPs 
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towards RBCs decreased when the AEAM content was increased. However, no clear trend 
was observed with varying charge to hydrophobicity ratio for the selectivity of the SMAMPs 
towards fibroblasts. For clarity purposes, the following points will be discussing the cationic 
polymers with 30 % of charge content. 
 
Effect of the type of charge 
Despite possessing a comparable content of cationic monomer, the ammonium and 
guanidinium SMAMPs had different biological properties. Indeed, a slight increase in toxicity 
towards epithelial cells was observed with guanidinium containing polymers, whereas similar 
levels of haemocompatibility (both haemolytic activity and haemagglutination) was observed 
for each type of cationic copolymer. Interestingly, the guanidinium moiety seemed to promote 
the potency of SMAMPs against MRSA compared to ammonium functionality. This increase 
could be attributed to a difference in the mechanism of antimicrobial action of the cationic 
polymers. The ammonium polymers were demonstrated to be membrane active: a fluorescent 
dye was encapsulated in lipid vesicles, mimicking bacterial membranes, and by monitoring 
fluorescence levels dye leakage was observed in the presence of the ammonium SMAMPs. 
Although membrane disruption was also observed with the guanidinium tetrablock and 
diblock copolymers using PI staining on an MRSA strain, previous work with guanidinium 
polymers bearing no pendant alkyl groups reported a mechanism of action based on DNA 
complexation rather than pore formation. When in combination with cationic functionalities, 
the presence of hydrophobic isopropyl groups from NIPAM could induce bacterial death by 
disrupting membrane integrity. Therefore, both mechanisms - bacterial DNA binding and 
membrane disruption - could be taking place simultaneously in presence of the guanidinium 
copolymers, hence enhancing their antimicrobial activity compared to ammonium analogues. 
However, the mechanism of action of guanidinium SMAMPs towards bacteria should be 
further investigated to confirm their complexation to bacterial DNA. Furthermore, the 
selectivity towards RBCs were similar for both types of cationic polymers, but the 
guanidinium containing SMAMPs exhibited lower selectivity towards epithelial cells than the 
ammonium copolymer counterparts.  
 
Effect of segregation of the cationic and hydrophobic functionalities 
In addition to the aforementioned features, the distribution of monomers along the 
backbone played an important role in adjusting the properties of SMAMPs. The first effect 
which was observed, as characterised by HPLC, with both ammonium and guanidinium 
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polymers was the change in the overall hydrophobicity of the chain with monomer sequence: 
the more segregated the cationic and hydrophobic functionalities (diblock > multiblock > 
statistical copolymer), the more hydrophobic the polymer. Importantly, for the cationic 
copolymers (ammonium and guanidinium functional) with 30 % charge content, monomer 
distribution had an impact on antimicrobial activity. Indeed, A-M30 and A-D30 had a 
significantly greater activity than A-S30 towards both Gram-negative and Gram-positive 
bacteria. However, there was no distinct trend observed between A-M30 and A-D30 regarding 
the MIC against all bacterial strain. For the guanidinium containing polymers, G-S30 was non 
active, whereas G-T30 and G-D30 were both active against MSSA and MRSA, with the 
diblock copolymer being the most potent. From these results, the antimicrobial activity of 
SMAMPs seems to increase when the cationic and hydrophobic functionalities are segregated. 
This trend was not only independent of the type of cationic moiety, but also of the formation 
of any self-assembly, since no aggregates were observed within the range of concentrations 
tested. By studying the membrane interactions of guanidinium polymers with a MRSA strain, 
the reduction of the MIC values with segregation of functionality was correlated to the degree 
of efficiency with which they interact with bacterial membranes. Indeed, the diblock 
copolymer interacted with bacteria faster than the tetrablock copolymer, whereas the statistical 
counterpart did not exhibit any attachment. The lower rate of membrane interaction of G-T30 
compared to G-D30 was not due to the length of the cationic block of G-T30 being inadequate 
to interact with bacterial membrane, shown by comparing polyGEAM of DP 15 and 30, which 
both interacted in similar ways with membranes. This reduced efficiency could instead be 
explained by the isopropyl functionalities of the polyNIPAM block which, when present in 
the middle of the polymer chain, hinder the positive charges from the phospholipids of 
bacterial membrane. Therefore, the polyNIPAM block should be segregated from the cationic 
domain for an optimised bacterial binding. 
Surprisingly, monomer distribution did not have a significant effect on the haemolytic 
activity of SMAMPs, whereas haemagglutination was shown to be affected. For both 
ammonium and guanidinium containing polymers, although the diblock copolymers did not 
induce aggregation of red blood cells, their statistical and tetrablock counterparts did. Indeed, 
the distribution of cationic monomers along the polymer backbone (for the tetrablock and 
statistical copolymers) could be promoting the cross-linking of red blood cells. 
On the contrary, toxicity towards mammalian cells from tissues was shown to increase 
with segregation of functionalities for both types of cationic copolymers, using two epithelial 
cell lines and fibroblasts. This trend was similar to that of the potency of SMAMPs against 
bacteria. Indeed, the increase in toxicity of the cationic polymers could also be explained by 
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enhancement of membrane interactions with mammalian cells when the isopropyl 
functionalities are segregated from the cationic groups.  
Subsequently, the effect of monomer distribution on the selectivity of SMAMPs was 
evaluated. The diblock copolymers A-D30 and G-D30 displayed the highest selectivity 
towards RBCs due to their great haemocompatibility combined with high antimicrobial 
activity against most bacterial strains tested. Although the toxicity towards epithelial cells and 
fibroblasts increased with segregation of functionality, the effect was not as significant as that 
on antimicrobial activity. Therefore, the diblock copolymers possessed the highest therapeutic 
index compared to the multiblock and statistical counterparts. 
In addition to mimicking AMPs, guanidinium containing copolymers display 
structural similarities with cell-penetrating peptides (CPPs), a pertinent design feature for 
treatment against intracellular bacteria. Although, as mentioned earlier, monomer distribution 
altered the interactions of the polymers with mammalian cells, it did not affect the 
internalisation of guanidinium SMAMPs in keratinocytes, as all three polymer compositions 
(statistical, tetrablock and diblock copolymers) resulted in comparable levels of uptake. The 
cell uptake by keratinocytes was dictated by both endocytosis and energy-independent 
pathways. Additionally, the isopropyl functionalities from polyNIPAM were likely to promote 
the internalisation of the guanidinium-rich SMAMPs into mammalian cells, since they 
increased the overall hydrophobicity of the polymers.  
Finally, segregation of the cationic and hydrophobic functionalities was shown to be 
necessary for activity against intracellular MSSA and MRSA. Indeed, the statistical and 
tetrablock guanidinium copolymers did not inhibit the growth of intracellular bacteria, as 
similar amounts of bacteria were recovered with a lysostaphin treatment, a control antibiotic 
which can only treat extracellular bacteria.  However, G-D30 halved the quantity of 
intracellular MSSA and MRSA compared to the lysostaphin treatment, within 2 hours. The 
increased activity of G-D30 towards intracellular bacteria was attributed to a greater 
antimicrobial activity, as all three polymers had similar internalisation levels into 
keratinocytes. 
One of the major challenges with the use of SMAMPs to eradicate intracellular 
bacteria is the colocalisation of the cationic polymers with bacteria within the cell. Due to the 
guanidinium polymers being internalised by keratinocytes via both energy-dependent and 
independent pathways, the polymers would be located in endosomes as well as in the cytosol. 
Nonetheless, the cationic character of the polymers should allow them to escape from 
endosomes, hence most of the internalised SMAMPs would eventually be present in the 
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cytosol of the keratinocytes. However, the guanidinium polymers utilised only possess 30 % 
molar content of GEAM, which might not be sufficient to efficiently induce endosomal 
escape. It would be of great interest to vary the size of the polymers or increase the charge 
content of these guanidinium copolymers to enhance their colocalisation with bacteria, though 
this would most probably significantly enhance the toxicity of the SMAMPs and reduce their 
uptake, as seen previously. 
In addition to these findings, the cationic polymers did not seem to elicit any bacterial 
resistance. Indeed, the MIC of the ammonium polymers against an MRSA strain remained 
constant over the course of 4 weeks. This experiment demonstrated that the cationic SMAMPs 
could be promising alternatives to currently used antibiotics such as vancomycin. 
To conclude, RAFT polymerisation has been demonstrated to be a powerful technique for 
screening libraries of functional SMAMPs, importantly providing access to subtle levels of 
microstructural control (i.e. multiblock copolymers), which allowed for the investigation of 
structure-activity relationships. The effect of charge to hydrophobicity ratio as well as type of 
charge were shown to impact the selectivity of the polymers. However, monomer distribution 
had a more significant effect on the interactions of the polymers with bacterial and mammalian 
cells, as it can render a non-antimicrobial active and non-haemocompatible polymer, G-S30, 
into a SMAMP inhibiting the growth of intracellular MRSA, G-D30, by sole segregation of 
cationic and hydrophobic functionalities. Taken together, the observations made in the various 
studies which comprise this thesis will hopefully be useful for the design and development of 
future SMAMPs in clinical treatment. 
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